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ABSTRACT

AN ETHICAL JUSTIFICATION OF WEIGHT LOSS SURGERY

By
Amy M. VanDyke
May 2013

Dissertation Supervised by Gerard Magill, PhD
This dissertation provides an ethical justification of surgical weight loss
interventions for the treatment of obesity. Situating obesity as not merely a public health
concern but also fundamentally a problem of clinical medicine confronting individual
patients and physicians, the dissertation argues that the time frame of public health
interventions is too long for individuals presently facing obesity and its deleterious
physical and social co-morbidities. It argues that failure to address weight loss on an
individual level, and specifically to consider the clinical appropriateness of weight loss
surgery (WLS), raises serious questions about failure to respect autonomy and promote
patient welfare. Moreover, social skepticism or rejection of WLS as a treatment option
raises concerns about fairness, as this failure indicates that obesity is not regarded in
relevantly similar ways to other life-threatening and health-impairing conditions.
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The dissertation examines various reasons that obesity and its myriad
interventions, including WLS, are inadequately addressed in the clinical setting. It argues
that considerations with cultural and ethical valence play a critical role in obesity‘s
different and unfair treatment within clinical medicine. Gendered and theologically
informed attributions of blame, self-blame, shame, and self-stigma influence the attitudes
and actions of both patients and clinicians with regard to addressing obesity.
Inappropriate and conceptually confused ascriptions of responsibility impede social
acceptance of, and access to, WLS. The dissertation‘s criticism and subsequent
reconceptualization of these ascriptions of responsibility from a perspective informed by
feminist epistemology and ethics provide the foundation upon which to consider reform
of current clinical practices surrounding treatment of obesity. This dissertation concludes
that WLS is both ethically and clinically justified.
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Chapter One: Statistics, Trends, and Factors Contributing to Obesity
Although it may seem that the problem of obesity is obvious—after all, people
wear the problem not just on their sleeves but on their entire bodies—the obesity problem
nevertheless is both complex and sometimes obscure. This chapter demonstrates that
obesity is not only scientifically and medically complex, but also conceptually and
socially complicated in ways that are sometimes obscured by its status as an alleged
medico-scientific fact. Indeed, the scientific ―facts‖ and social norms surrounding the
definition, measurement, and etiology of obesity constitute a contested terrain within
which interventions to address obesity are developed, debated, accepted, or rejected.
This chapter provides relevant background information on the problem of obesity.
Specifically, Section A focuses on the scope of the current problem by examining the
increase in obesity‘s prevalence and severity, both in the United States and in other parts
of the world. Section A also addresses the controversial definition and measurement of
obesity. Section B discusses the myriad effects of obesity on physical health and quality
of life..The far-reaching deleterious physical co-morbidities and reduction in quality of
life indicators associated with obesity are explicated.. These first two sections establish
that there is substantial, though not perfect, consensus that obesity is a growing and
complex health problem. Subsequent sections take up the contentious issues of how the
problem should be framed and addressed. Specifically, section C of this chapter discusses
various highly contested terrains surrounding the diagnosis of obesity, the acceptance of
obesity as a disease, the understanding of obesity as modern-day epidemic, and the
approval or rejection of various interventions applied to this problem. This section
examines numerous problems of communication about obesity which exist in society in
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general and in the healthcare system specifically. Section three argues that
communication problems, combined with varying degrees of understanding or acceptance
of the myriad causes of obesity, impede the application of typical ethical standards
applied in health care such as those found in informed medical decision making, as well
as considerations of justice, and argues that ultimately patient welfare is sacrificed.
Analysis of ethical standards and considerations initiated in this chapter will be examined
in depth throughout the dissertation. Finally, this chapter claims that inappropriate
ascriptions of blame, often based in communication errors, have implications for the
social acceptance of various treatments including weight loss surgery (WLS). The first
section of the chapter reflects the interplay of measurable facts and social context as it
reveals the points of consensus and controversy involved in defining obesity by
examining the scope of the obesity problem and its trends.
A. Scope of the Problem
The first section of this chapter illuminates what is generally perceived to be the
increasing problem of obesity both in the United States and across the globe. A review of
the trends and disparate impact of obesity is necessary to understand both the present
scope of the problem of obesity and its potential for the future. It is also relevant to
examine those foundational issues where consensus is lacking. The first subsection will
focus on the definition of obesity and on the various means of measuring it. The lack of
consensus around these foundational concepts will be shown to complicate both
appropriate identification and the treatment of obesity. The second subsection will
provide national and international statistics on trends in the prevalence and incidence of
overweight and obesity. These statistics will reveal particular populations in which
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obesity has been shown to have become more deeply embedded than others. The
following subsection begins by identifying the definitions of overweight and obesity and
the contested nature of how it is measured.
A.i Obesity: Its Definition and Measurement
In order to understand the scope of the obesity problem, it is important to have
knowledge of the manner by which it is most commonly diagnosed, along with proposed
alternative methods of diagnosis, and controversies which surround its measurement.
Historically, the definition of obesity and the means of diagnosing it have been fraught
with controversy. 1 However, measuring the body mass index (BMI) of an individual has
emerged as the most common diagnostic tool for overweight and obesity. The use of BMI
has been accepted as the measurement of adiposity by the Centers for Disease Control
and the World Health Organization. 2 The measurement of BMI provides an estimate of
the percentage of body fat based on an individual‘s height and weight. BMI is calculated
by dividing a person‘s weight (in kilograms) by the square of their height (in meters):
BMI = kg/m2.3 A person with a BMI of below 18.5 kg/m2 is considered to be
underweight, and a BMI between 18.5 and 24.9 kg/m2 is considered average or normal. A
person with a BMI equal to or greater than 25 kg/m2 is considered to be overweight; a
BMI of 30 kg/m2 is considered obese, and a BMI of 40 kg/m2 is considered to be
morbidly, severely, or extremely obese. 4
The widespread usage of BMI is generally attributed to a contingent social fact—
namely, the ease with which height and weight can be obtained in a clinical setting. 5
Primary care physicians and office staff can take these measurements rapidly without
expensive equipment or time-intensive activities. 6 The use of BMI to define and measure
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obesity is thus attractive in clinical practice. Additionally, this rough formula, which
estimates the lean tissue ratio relative to adipose tissue, has achieved widespread usage in
social science research. Replacing BMI with a different system of measurement may
impair the usefulness of data captured under BMI in comparison with data captured with
newer, perhaps better, diagnostic tools. 7
Nonetheless, the use of BMI as the index by which to define and measure obesity
has been widely criticized.8 These criticisms may best be understood in light of the
development and evolution of BMI as a practical tool. Lambert Adolphe Quetelet, a
Belgian mathematician, developed the Quetelet Index in 1832 as a part of a larger project
to define the typical human of the time. 9 This tool was later renamed the Body Mass
Index in 1972 by Ancel Keys. 10 Quetelet‘s quest was to identify the ―normal man‖—i.e.,
to identify and document the standard proportions of the human (male) build of the time.
He set out to measure various characteristics, including arm length and the age at which
men married. Quetelet collected measurements from several hundred people in his native
country of Belgium, in the area of Brabant. What Quetelet found was that the weight
among those he studied varied in proportion to the square of height. Quetelet‘s research
on the proportional relationship between height and weight was used to refine of the
earlier work of French military doctor Paul Broca, who proposed that weight varied in
direct proportion to height. Quetelet‘s findings on weight and other standard proportions
of Belgian people in the nineteenth century was published in the book A Treatise on Man
and the Development of His Faculties.11 During Quetelet‘s lifetime, his heuristic device
had little influence in the medical community. Its purpose was descriptive, not diagnostic,
and was of little practical value at that time. It was not until the following century that the
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use of the BMI became a standard by which weight anomalies, including overweight and
obesity, were defined. Subsequently, critics have questioned the wisdom of generalizing
results obtained from a relatively small sampling of a specific population group
(primarily male citizens from the Brabant region of Belgium in the 1800s) and
developing a standard measurement tool based on those results.12
The most common and perhaps the most serious criticism of using BMI to define
and measure obesity is that the BMI is only an indirect measurement of adiposity and that
it does not account for lean body mass (bone, muscle) relative to other body mass
(adipose tissue).13 This important distinction between types of body mass, for which BMI
cannot account, may well be crucial in determining the relative health risks associated
with weight of those individuals on either end of the weight continuum. Instead of using
BMI as a screening tool, the current practice is to use the BMI as a diagnostic tool which
is considered informative with regard to health risk. What this means is that merely by
being categorized as overweight or obese, an individual is assumed to carry significantly
more risk based on weight as related to health than are those of normal weight (again, as
measured and defined by BMI). Such categorization and attribution of risk is thought to
be problematic on many levels—conceptual, medical, social, and ethical—as this
categorization is seen by many to be but a small part of the overall risk assessment for an
individual screened for being beyond the norms of weight. 14
Other criticisms of using BMI to define obesity include that it does not account
for the location of the adipose tissue and thus fails to enable distinction between the
relative risks of carrying excess visceral or subcutaneous adipose tissue. More recent
research has shown that there are significant risk differences in the nature and magnitude
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of health risks based upon where one carries excess weight. 15 Another criticism is that
BMI measurement does not take into account what might be considered normal bodily
changes with aging. These normal weight changes associated with aging may or may not
be associated with greater health risks. 16 By ignoring the relevance of age and adipose
location to weight-related health risk, the use of BMI as a weight measurement risks
being both insufficiently sensitive and insufficiently specific. Use of BMI may result in
false negatives and false positives when used to diagnose obesity and associated risk
factors.17
Finally, BMI and the weight categories it is used to create are criticized for being
treated as absolute and rigorously evidence-based, when in reality the thresholds assigned
to various BMI levels and weight categories are grounded in perceptions of clinical
exigency. 18 In fact, the category thresholds have changed over the years. In 1998 the
National Institutes of Health (NIH) altered its category designations to accept those used
by the World Health Organization. The NIH at that time lowered the normal weight and
overweight cut-off points from a BMI of 27.8 to a BMI of 25. This had the effect of
immediately assigning the designation of overweight to approximately twenty-five
million Americans who had previously been categorized as being of normal weight. 19
While the BMI categories used by the United States and the WHO are now the same,
other countries—including Japan and Singapore—have set cut-off points for categories at
lower levels than those used by the United States and the WHO. 20 Those lower thresholds
are thought to reflect the smaller physical stature of the individuals from those
countries. 21 Some in the United States have even suggested that BMI insufficiently
accounts for physical variability present between African Americans and Caucasians. 22

6

Other measurements of overweight and obesity such as hip-to-waist ratio, skinfold thickness, and the measurement of waist circumference have been proposed as
replacements for BMI. These proposed replacements are thought to have greater
diagnostic usefulness for predicting health risk relative to adiposity. 23 However, these
methods have not yet been widely adopted in clinical settings. Thus, despite what some
would term serious flaws that may endanger health, BMI continues to be the most widely
used clinical measurement of normal and anomalous weights, including the designation
of overweight and obesity. 24 The following section will discuss the trends being observed
in obesity in the United States and other parts of the world. Even with the controversies
surrounding which is the most appropriate tool for diagnosis, obesity appears to be
increasing both in prevalence and in severity.
A.ii Trends in Obesity
There is widespread agreement, based on national and international data, that the
problem of overweight and obesity in the United States and in other developed nations is
increasing. 25 Indeed, the prevalence and incidence of overweight and obesity has been on
the rise for several decades. 26 Prior to the 1950s, there were no reliable estimates of the
incidence and prevalence of overweight and obesity. 27 Some have stated that there was
little need to capture these statistics because the problem of obesity was rare and in itself
unremarkable.28
It was not until the 1960s that statistics relative to weight began to be captured.
Statistics on the health and nutritional status of adults and children in America, including
data on obesity trends, have been collected by the US Department of Health and Human
Services through the National Center for Health Statistics (part of the Centers for Disease
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Control and Prevention) since the early 1960s. The National Health Survey Act of 1956
provided legislative authorization for gathering health and nutritional statistics, as well as
data on the effects of illness and disability in the United States.29 Surveys were
implemented to collect data from three main sources: direct interviews, clinical tests and
physical examinations of individuals, and information recorded in doctor‘s offices,
hospitals, and other settings through which people access medical treatment. Among the
information collected were data on various ―risk factors, aspects of a person‘s life-style,
constitution, heredity or environment that may increase the chances of developing a
certain disease or condition.‖ 30 Included were factors such as drug use, alcohol
consumption, sexual practices, and weight. The same mandate included obesity among
―diseases, medical conditions and health indicators to be studied.‖ 31
The first in the series of National Health Examination Surveys (NHES), later
renamed the National Health and Nutrition Examination Survey (NHANES), was
conducted from 1960 to 1962. Since the first of these, at least eight such surveys have
been conducted. Over the years the survey‘s focus has changed to reflect the most
prominent health concerns of the time, such as children‘s health issues, chronic diseases,
and obesity. 32 In response to medical research in the 1970s which reported a relationship
between nutritional status and health indicators, the survey began to focus additional
attention on the relationship between diet or nutrition and health status, such as the
relationship between what one eats and the development of obesity and its co-morbidities
(e.g. diabetes or cardiovascular disease). 33
The outcome of the first survey (1960–1962), with 6000 participants, found that 31.5 percent of
Americans were overweight, with 13.4 percent being obese and 0.9 percent being extremely obese. 34 These
preliminary results serve as the baseline from which subsequent survey results have been
8

compared. There were two NHANES conducted in the 1970s. The NHANES I was
conducted between 1971 and 1974 and included almost 13,000 individuals, while the
next survey conducted between 1976 and 1980 and included fewer than 12,000
participants.35 Statistics from these two surveys began to show an increase in the
prevalence of overweight and obesity across categories. Survey results from 1970
through 1974 showed those who were overweight at 32.3 percent, obese at 14.5 percent,
and those with extreme obesity were 1.3 percent of the population. Late in that same
decade the number of overweight individuals stood at 32.1 percent, those with obesity
were at 15.0 percent, and those having extreme obesity had increased to 1.4 percent.36
The 1988–1994 NHANES survey of 14,000 found that while there was only a
small increase in the number of people who met criteria for overweight, those who met
criteria for being obese or extremely obese had seen greater increases. 37 The percentage
of those who were overweight was 32.7 percent. Obesity and extreme obesity were at
23.2 percent and 3.0 percent respectively. These figures translate to an eight-point
increase in obesity and slightly more than double the number of people with extreme
obesity (up from 1.4 percent) in just eight years. The number of those surveyed between
1988 and1994 was over 14,000 people.38 In 1997 in the United States, the number of
adults with a BMI falling into the category indicating obesity was approximately 27
percent, with some sources citing as much as 33 percent.39 These figures represent almost
double the prevalence of obesity just twenty years earlier.
In the nutrition and health surveys conducted between 1999 and 2000 and again
between 2001and 2002, the numbers of those being surveyed was noticeably smaller
(between 3,600 and 3,900 participants). However, the participants themselves had
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continued to increase in size. As discussed earlier in this chapter, the threshold for
designating an individual as overweight or obese was lowered in 1998 to be in line with
the categories accepted by the WHO. 40 Survey participants who would previously have
been considered to be of normal weight were recategorized as overweight based on this
threshold realignment. The increasing rates of overweight, obesity, and extreme obesity
continued to show increases during these time frames as well. The increased rates for the
two survey periods were as follows: overweight individuals at 33.6 percent and 34.4
percent, obese individuals made up 30.9 percent and 31.3 percent, and those with extreme
obesity were at rates at 5.0 percent and 5.4 percent.41
In the two most recent surveys this unfortunate trend has continued across almost
all categories. NHANES (2003–2004), with a survey group of just over 3,700
participants, showed the rate of overweight at 33.4 percent, obesity at 32.9 percent, and
extreme obesity at 5.1 percent of the population. NHANES (2005 –2006), with just under
4,000 participants, found overweight came in at 32.2 percent, obese at 35.1 percent, and
extremely obese individuals at 6.2 percent of the American population. 42 Based upon the
most recent statistics available, during the years 2005–2006, the prevalence of obesity
(including all those with a BMI greater than 30) and extreme obesity (including all those
with a BMI greater than 40) in the United States stood at approximately 41.3 percent.43
The US population is currently estimated at approximately 310,718,864 people. 44
Therefore, at present there are approximately 128 million Americans who are overweight
or obese.
Data collected from the first survey to the present survey have shown an
interesting sex-based disparity in the trends found in overweight and obesity. Across the
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surveys men have comprised a greater percentage of those occupying the category of
overweight, while the greatest percentage of those categorized as obese has been
occupied by women.45
In addition to agreement that obesity is increasing in the United States (and much
of the world), there is also growing consensus that obesity is associated with a variety of
demographic factors.46 In the US, those most vulnerable to weight concerns are minority
groups (primarily African Americans and Hispanics), low-income or low socioeconomic
groups, men and women over 60, as well as women ages 20 –34 who are
disproportionately represented among those diagnosed with obesity. 47 While the
increasing prevalence of obesity can generally be seen across the nation, there are
particular states in which the problem is exacerbated. These states include Alabama,
Mississippi, Oklahoma, South Carolina, Tennessee, and West Virginia. These states also
report having a high concentration of minorities and lower per capita incomes. 48
The increasing prevalence of obesity in the United States is not limited to adults.
Current studies indicate that approximately 15.5 percent of children and adolescents meet
the clinical criteria for obesity and approximately 16 percent are diagnosed as
overweight.49 An additional 34 percent of children and adolescents are at risk for
overweight.50 Since the 1970s, the obesity rate has more than doubled for children ages
2–5 and adolescents between the ages of 12 and 19. In the age range of 6 –11 the rate of
obesity has more than tripled. 51 The myriad health problems associated with obesity in
adults may well be surpassed by those found among obese children in this generation,
resulting in a lower life expectancy for this generation of children than for their parents. 52
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These trends in obesity are being observed throughout other parts of the world in
both developed and developing countries. Specifically, countries such as Australia,
Russia, Brazil, Malaysia, and even China are showing obesity as an increasing problem
among their populations.53 It is estimated by some that in the future obesity will overtake
tobacco-related diseases as the number one public health problem leading to patient
mortality. 54
The following section discusses two areas which are affected by overweight and
obesity. This section discusses impairments in physical health and quality of life
indicators for those who are obese.
B. Obesity‘s Effects on Physical Health and Quality of Life
The following section explores the effects of obesity on various aspects of
physical health and longevity as well as on associated non-health quality-of-life
indicators. A point of widespread agreement regarding obesity is that, in general terms, it
has negative effects on physical health and quality of life. From a health perspective,
progression along the spectrum from merely being diagnosed as overweight to being
diagnosed with more serious obesity is generally associated with progressively elevated
risks of life-threatening and debilitating physical co-morbidities which ultimately have
the effect of decreasing longevity and quality of life. 55 It has been said that ―the medical
problems caused by obesity begin with the head and end with the toes and involve almost
every organ in between.‖56 This section is divided into two parts. The first subsection will
address the effects of obesity on physical health while the second subsection addresses
the effects of obesity on other quality of life indicators.

12

B.i Physical Health
Being either overweight or obese is linked to numerous medical sequelae
including: type II diabetes, coronary artery disease, hypertension, sleep disturbances, acid
reflux disease, fatty liver disease, joint disease, depression, infertility, fetal abnormalities,
various malignancies, asthma, incontinence, lower back pain, various skin disorders, and
kidney disease.57
Approximately 300,000 Americans die each year from obesity-related diseases. 58
This number is approaching the estimated 400,000 deaths that are annually attributed to
smoking and tobacco-related diseases.59 Additionally, in children who are overweight or
obese, the latency period between developing obesity and developing secondary diseases
may be diminished. This means that diseases such as hypertension or diabetes develop
more rapidly in obese children and adolescents than would occur in obese adults.60
Research has frequently focused on single co-morbidities such as diabetes or the
presence of heart disease. 61 A limitation of such studies is that they are not able to shed
light on the relative risk of multiple co-morbidities present in those who are overweight
or obese. With this limitation in mind, one particular study undertook a meta-analysis of
the twenty chronic diseases thought to be associated with overweight and obesity. Comorbidity specific studies which included these twenty associated chronic diseases were
reviewed. In this meta-analysis, the authors sought, in part, to provide a more
comprehensive picture of the relative disease risk across chronic diseases related to being
overweight or obese for men and women. The authors confirmed that indeed there are
elevated health risks associated with being diagnosed as overweight or obese and that
relative risk increases based on the severity of an individual‘s overweight. 62 Hence, the
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more overweight a person is, the greater the relative risk for developing debilitating
chronic, co-morbid disease. Additionally, the greatest health threat appears to be from
developing type II diabetes. However, elevated relative risk for certain cancers (breast,
colorectal, endometrial, esophageal, kidney, ovarian, pancreatic, and prostate), various
forms of cardiovascular diseases (hypertension, coronary artery disease, congestive heart
failure, pulmonary embolism, and stroke), as well as asthma, gallbladder disease,
osteoarthritis, and chronic back pain, is associated with overweight and obesity. 63 The
authors conclude that ―findings confirm that overweight and obesity carry a profound
health burden and will have a significant impact on health expenditures.‖ 64 Each of these
additional chronic diseases is associated with it its own trajectory of potential medical
complications so that an overweight or obese person diagnosed with type II diabetes
incurs additional risks for medical complications such as kidney disease. In effect,
overweight and obesity can increase the threat to health and longevity exponentially, as
the individual is now susceptible to developing further tertiary disease which carries with
it its own set of potential serious life-limiting or mortality-producing medical
complications.
Another important and highly stigmatizing, though perhaps not strictly
physiological, co-morbidity related to being overweight or obese is an increased risk for
developing various mental health disorders.65 Individuals diagnosed with obesity also
tend to have an increased incidence of clinical depression, which in turn has been
positively correlated to adverse childhood experiences including self reports of physical,
sexual, and verbal abuse as well as neglect. 66 Specifically, those individuals who report
exposure to all four types of abuse have the greatest level of severity of both obesity and
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depression. The reported long-term repercussions of abuse on the development of both
depression and obesity may reflect issues of ―powerlessness, loss, and humiliation,‖
according to Stunkard et al.67 A related analysis suggests that the development of obesity
might reflect an attempt at a protective adaptive function for people who have been
sexually abused, with the excess weight effectively producing an emotional and physical
barrier that may adaptively assist the obese individual in controlling further unwanted
attention or thwarting future abuse. 68
Obesity was found to be associated with significant increases over the general
population risk not only of major depression, but also bipolar disorder, panic disorder,
and agoraphobia during the subject‘s lifetime. 69 Other studies have shown a more robust
association between anxiety disorders and obesity than between mood disorders and
obesity, as well as a strong association between obesity and post-traumatic stress
disorder.70 Whether developing a mental health disorder is a result of the societal
stigmatization of those who are overweight and obese, or whether a predisposition to
mental health disorders precedes their diagnosis and overweight and obesity are
secondary, appears to remain an unresolved question.
The presence of overweight or obesity has been shown to diminish quality in
various non-health related areas. The following subsection explores these areas of
diminished quality of life.
B.ii Quality of Life
Similar to physical co-morbidities, the presence of psychiatric co-morbidities can
have the effect of reducing quality of life and longevity. 71 Each additional co-morbidity,
whether physical or psychological, has the consequence of adding to the aggregate health
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and well-being burden for the individual diagnosed with obesity. Moreover, health is only
one dimension of well-being or quality of life. Factors comprising quality of life are those
factors which make living pleasant.72 Those items which are considered to be
contributing factors to an individual‘s quality of life assessment are quite diverse and
highly subjective. Assessment of quality of life is highly individualized as it is based on
the unique combination of factors found in particularly appealing ratios for each person.
Hence, there is wide disparity among which or how much of each particular factor makes
a life one of quality. 73
Evidence suggests that in general, individuals who are overweight or obese report
lower levels of satisfaction or quality of life based on several commonly accepted
attributes of a quality of life. 74 Indicators of quality of life commonly employed in
research include a person‘s educational attainment, employment status, earning potential
(both present and future), opportunities for career advancement, the presence of
significant intimate relationships (such as marriage or a similarly committed
relationship), having children, the ability to get around, and where one resides. 75
Commonly accepted quality of life indicators have all been reported to be inversely
related to the presence of overweight or obesity76—the more overweight a person is, the
less likely he or she is to have attained a high level of education, high income, and
significant personal relationships. Numerous reports in the popular press in recent years
have pointed out that current and future projected earnings and opportunities for career
advancement are inversely related to above normal weight.77 Research further indicates
that parents of overweight and obese children provide less college support for their
overweight children than for their thinner offspring.78 This was found to be true even
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when controlling for factors such as parental income and student grades.79
Puhl and Brownell, in an article on bias and discrimination against those who are
obese, reviewed available research in three primary areas of potential discrimination and
bias against those with obesity. Those areas included employment, education, and health
care. 80 Their analysis of various research studies on the topic concluded that there is
―clear and consistent scientific literature showing pervasive bias against overweight
people‖ across these domains.81
The third section begins to address communication problems surrounding how
obesity is talked about and how this can lead to subsequent problems with commonly
applied ethical standards such as those seen in informed consent, considerations of
justice, and possible violations of patient welfare. Additionally, the following section will
begin to address the effect of inappropriate ascriptions of blame and the implications for
acceptance or rejection of various weight-loss interventions.
C. Framing the Ethical Problem
The final section of this chapter discusses the contentious nature of properly
framing issues around obesity and the resultant problems of communication which arise
in accepting particular frameworks. This section will argue that accepting particular
frameworks results in associated problems of communication both in society in general
and within the clinical healthcare system charged with providing assistance in solving an
individual patient‘s obesity. This section will introduce the argument that problems of
communication arising from errors in framing lead to breaches in commonly accepted
and applied ethical standards in health care, which ultimately serve to violate obligations
to patients who are obese. The first subsection addresses various problems in accurately
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and adequately communicating about obesity and elucidates problems in the healthcare
system which arise from failures in communication. The second subsection focuses on
the way in which obesity is conceptualized and the associated ethical issues which arise
from these conceptions. The final subsection discusses how blame is assigned in obesity
and the way in which blame can impair or reinforce acceptance of various weight loss
interventions. The discussion begins with problems in communicating about obesity.
C.i Problems of Communication and Failure of the Healthcare System
Despite general consensus about increased rates of obesity and demographic
trends, as well as substantial consensus about the association of obesity with various lifelimiting, life-threatening, and quality-of-life-diminishing co-morbidities, multiple points
of controversy remain. Among these are contested views about the etiology of obesity, its
social characterization or construction, and the most appropriate way to frame the
problem of obesity and the range of appropriate solutions to the problem. 82 In essence
these are problems in communicating about obesity which have potentially far reaching
consequences. Moreover, in reality, it remains likely that these three dimensions of the
obesity problem will remain contested. For each of the three, the reality is more complex
than any one of the proffered explanations, characterizations, and conceptualizations. In
this regard, obesity will remain problematic. The etiology of obesity has been and
continues to be widely debated. Most believe that obesity is caused by some combination
of factors which include but are not limited to genetics or biological factors, the
environment, and social policies such as farm subsidies which have altered the way in
which Americans access and consume food.83 Several factors considered contributory to
the development and maintenance of obesity are discussed below.
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C.i.a Genetics
Though some progress has been made, the role of genetics in the development of
the obesity problem is not entirely clear. First-generation investigation into the role of
genes in the development of obesity included heritability studies done with identical and
nonidentical twins. These studies found that the heritability rate for obesity based on
genetic factors falls in the range of 70–80 percent. The only other characteristic which
rates consistently higher for heritability is an individual‘s height.84
Some genetic disorders clearly have an obesity component as a primary
manifestation, such as Praeder-Willi syndrome or Bardet-Biedl syndrome.85 These
syndromes typically have a developmental anomaly associated with them as well.
Additionally, monogenetic obesity syndromes exist which do not carry with them
developmental disabilities or other aspects of mental retardation. 86 These syndromes
include among them congenital leptin deficiency in which obesity can be corrected with
therapeutic doses of leptin. 87 Newer research techniques which include genetic mapping
have permitted these particular genetic anomalies to be identified; however, this has been
possible in only a small number of obesity-related disorders.
Through genome-wide association studies, several other gene mutations have
been implicated in the obesity problem, but their full role remains unclear. Moreover, the
genes implicated in the development of less specific obesity patterns are thought to be
part of the biological system that regulates energy balance. 88 The mutations are thought to
cause disregulation in these systems with obesity as the result. It remains ―unclear
whether such genes contribute to obesity through many different single-gene mutations or
through potentially complex interactions involving several genes each having small
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effects of their own (or a combination of both).‖89 The relationship between social policy
and the social environment in relationship to obesity is discussed below.
C.i.b Social policy and social environment
Recently and historically, American social policies have been implicated in the
onset of obesity as population-wide problem in the United States.90 The rise of obesity
may have its historical roots in World War II (1941–45) when mandatory food rationing
was enacted. The United States sought to overcome the scarcity of food by reformulating
the appeal of certain foods, including a campaign to increase consumption of organ
meats, which was ultimately unsuccessful. 91 Despite this and other efforts, the net result
was that the typical population food patterns were substantially disrupted during this war
era. A relationship between increased body fat and episodic food shortages was first
proposed in 1994 by Deitz. 92 In a case study, he proposed that there might be a
relationship between ―food choices or physiologic adaptations in response to episodic
food insufficiency‖93 which could cause increased body fat.
The phenomenon he was tentatively describing is what is now called food
insecurity. Food insecurity is defined as limited or uncertain availability of nutritionally
adequate and safe foods, or limited or uncertain ability to acquire acceptable foods in
socially acceptable ways. 94 A related concept is that of food restriction, which is the
externally imposed restriction of intake due to lack of access to food or foods one would
otherwise choose.95 This term can also be applied to a self-imposed restriction—for
example, by dieting. Recent research has shown a relationship between food insecurity
and the presence of both disordered eating patterns (binge eating) and obesity. 96 Episodes
of mild food insecurity or food restriction, such as those found in America during World
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War II, may have mimicked the conditions of food insecurity, based on imposed food
restrictions, as we now understand this phenomenon. On the heels of World War II, with
unprecedented growth and prosperity in the United States, food was abundant. 97 The
implications of food rationing, and the mandated changes in food consumption
immediately prior to this time, may have had unforeseen effects on the obesity problem
which arose in the decades of abundance that followed.
More recently, agricultural policy has also been cited as a contributing factor in
the development and maintenance of the obesity problem in the US. ―From 1985 to 2000,
the real price of fresh fruits and vegetables went up almost 40 percent in the United
States, while the real price of fats and sugars declined.‖ 98 This trend, driven by fifty years
of farm policy, has directed farmers toward overproduction of particular crops such as
corn and soybeans, resulting in low-cost oils and the availability of high-fructose corn
syrup (which has been added as a less expensive replacement for other sugar sources). 99
In the last thirty years, farm policies which support corn and soybean crops have resulted
in an increase in the consumption of high-fructose corn syrup of over 1,000 percent.100
The US consumption of added fats increased more than 35 percent during that same
time.101 It has been stated that ―the problem with the extensive use of these cheap
commodities in food products is that they fall into the very dietary categories that have
been linked to obesity: added sugars and fats.‖102
These less expensive commodities have replaced more expensive counterparts
and have served to drive down the cost of unhealthy foods while simultaneously limiting
the availability of locally grown, less expensive, and healthier choices in the American
diet. For economically constrained individuals, who are disproportionately represented
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among the obese, the opportunity to purchase lower cost food may be viewed as a
desirable consumer option, even though such food is less healthy than more expensive
alternatives. 103 Indeed, purchasing low-cost unhealthy foods may seem the only viable
option. Another area for consideration which is addressed below is the way in which
housing, roads, and green space are currently being utilized which may facilitate
sedentary lifestyles, overweight and obesity.
C.i.c Built environment
Characteristics of the modern built environment have also been charged with
producing the conditions necessary for obesity to flourish. 104 The built environment
includes how land is used in designing and developing housing plans, neighborhoods, and
cities.105 Characteristics such as vehicular and pedestrian traffic patterns, green space set
asides for recreational activities, the availability of sidewalks for pedestrian traffic,
bicycle lanes, and the proximity of grocery and other stores are features of the built
environment that affect the ability of those living in the area to be physically active and
have access to affordable healthy food without depending on motorized transport. 106 A
meta-analysis of research conducted between 1966 and 2007 on the association between
the built environment and obesity found that ―eighty-four percent[of studies] reported a
statistically significant positive association between some aspect of the built environment
and obesity‖107 The authors conclude that ―understanding the mechanisms through which
environmental factors may influence obesity will aid in developing future communitylevel intervention strategies.‖108 There have been many other factors posited as being
contributory to the development of obesity. Several of these additionally proposed areas
are discussed below.
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C.i.d Additionally proposed etiology
There have been several other associations proposed as possible contributing
factors in developing obesity. A few of these correlative relationships include the length
of time mothers breast-feed their children and the social network theory. In a study of the
Helsinki Birth Cohort, it was found that those who had been breast-fed for less than two
months or greater than eight months had the highest adult rates of BMI and percentage
body fat.109 Of those who were breast-fed the shortest duration, the authors suggest that
the higher rate of obesity might be explained by the fact that growth factors or hormones
available in breast milk might program the baby in ways that protect against developing
adipose tissue in later life. On the upper end of breast-feeding duration, it is thought that
prolonged exposure to breast milk may predispose the body to seek high-lipid foods later
on, which could contribute to weight gain and a high BMI.110
In a study which spanned thirty-two years, the relationship between one‘s social
network members and the potential of developing obesity was examined. It was found
that a person‘s chances of becoming obese increased by 57 percent in a given time
interval if he or she had a friend who had also become obese. This was true regardless of
the proximity of the person in the social network. In other words, even if the friend did
not live in the same locale, the study discerned an interesting association among social
network members and weight gain regardless of physical proximity. 111
The theories and associations provided above are but a few of those proposed to
shed light on the etiology of overweight and obesity. While these theories and
associations shed light on the complexity of the problem, they do not definitively provide
closure on the etiology of overweight and obesity. Indeed, it is most probable that
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overweight and obesity are attributable in some part to each of the above areas and
several others which have not been addressed here. The following section moves the
discussion from the disputed areas contributing to obesity to how obesity is
conceptualized.
C.ii Conceptualizing Obesity and Associated Ethical Issues
Distinct from the question of obesity‘s cause, yet related to it, is the question of
how obesity is conceptualized. Obesity can be conceived of as a health problem, personal
problem, or a social problem. Describing someone as obese can be merely a description,
an aesthetic judgment, or a medical diagnosis. Obesity can be conceptualized as a
disease, epidemic, condition, trait, or simply as a risk factor. Moreover, obesity can be
seen as the physical manifestation of gluttony, or as a social marker of personal wealth or
societal economic development.112 In labeling someone obese we can either identify a
fact or make a judgment, or both. In making the claim ―Herbert is obese,‖ several kinds
of a judgments or indeed presumptions of fact can be asserted based on one‘s point of
reference. How obesity is conceptualized by society in general and healthcare
practitioners specifically will likely have implications for what alternatives are offered to
patients with obesity who are seeking treatment. The following section discusses various
conceptualizations and briefly introduces how various commonly accepted ethical
constructs can either be supported or violated based upon the practitioners conception of
the problem and hence the appropriate solution for a patient‘s obesity.
C.ii.a Realist and nominalist conceptions of obesity
Jon Reif argues that from a realist perspective obesity is ―a fundamentally real
body category.‖113 That someone is obese is a scientific fact, an empirical matter to be
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discovered. In contrast, from a nominalist perspective, ―obesity is a culturally and
historically constructed notion.‖ 114 No one is obese but for our describing him or her that
way according to some socially determined, culturally bound criteria. Once those criteria
emerge or gain acceptance within a society, however, then whether or not Herbert is
obese is a matter of fact—a matter of either scientific or social fact, and no wishing or
thinking it otherwise can alter Herbert‘s obesity. Only an intervention resulting in his
weight loss can change his status (or diagnosis) as obese.
In support of adopting a nominalist conception of obesity is the fact that social
attitudes toward body mass and weight vary across time and across different populations,
social classes, ethnicities, and cultures. Indeed, they vary so much that different attitudes
toward obesity do not always seem to be differing attitudes toward the same thing, but
actually seem to construct obesity as something different altogether in different cultural
contexts. Within the United States, for example, various ethnic groups perceive weight in
vastly different ways. 115 Currently, among African Americans, Hispanics, and Hawaiians,
larger people are seen as being more acceptable and perhaps more sexually appealing and
desirable than more svelte counterparts.116 The same is not true among typical, modern
Caucasian Americans, for whom additional weight is considered unappealing and
sexually undesirable. 117 However, these modern conceptualizations of size and weight
have not been stable concepts across time. In fact, throughout history, the way in which
weight has been perceived has dramatically changed. 118 In medieval times, people who
were overweight were often portrayed negatively and as lacking in morals and selfcontrol.119 Similarly, ancient Asian pictures depicted the dreaded tax collector as an
overweight person and described this person as greedy and lacking a righteous
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character.120 In contrast, the ideal of American beauty in the late 1800s was epitomized
by Lillian Russell, who reportedly weighed over two hundred pounds.121 In the early
twentieth century, a time which saw rampant tuberculosis, the person who was physically
large was perceived positively. In fact, girth was seen as a sign of health and an indicator
that the person was not infected with tuberculosis, commonly referred to as consumption,
of which a primary symptom was emaciation; tuberculosis ―consumed‖ people. 122 There
was social value in being a person of substantial weight as it signaled that the person was
free from potentially deadly infection and a safe person with which to associate.
During the 1930s, a period of time with both low prevalence and incidence of
overweight and obesity, a debate emerged regarding whether obesity should be
considered a medical problem or merely a cosmetic concern.123 During World War II,
however, when many women were going into the workforce, the image of the ideal
woman began to change to project a slimmer and more capable, perhaps even more
masculine ideal. 124 Following World War II, for a time in America, the contours of the
ideal woman once again rounded out so that curvaceous women such as Marilyn Monroe
epitomized beauty. Coincidentally, this was at a time when men were returning from war
and seeking to regain jobs and return women to a more traditional domestic role. In
addition, it is thought that this shift toward a more voluptuous image of beauty and health
occurred at this time partly due to the immigrants who came to America after having
survived the Nazi death camps. Ample weight was a luxury and once again a sign of
prosperity and health. 125 In recent years, as the association between ill health and excess
weight has become more evident through research, the tides have again changed so that
excessively curvaceous, overweight, or obese bodies are the source of societal disdain.
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Moreover, other social attitudes or ascriptions, beyond those of healthy or
unhealthy, are attached to norms of beauty and body size. Present-day women who
exhibit the body contours of the ideal nineteenth-century woman are considered fat and
have a long string of negative attributes attached to them based on their weight. 126
Modern women who meet the previous ideal are considered lazy, undisciplined, sexually
undesirable, unintelligent, and hedonistic. 127 Even as they are considered sexually
undesirable, they are also considered sexually voracious, out-of-control, and threatening
for the sheer space they take up, the amount of resources (food, space) they consume, and
the insatiable desires they represent.
With respect to the stigma of being overweight and obese, men fare marginally
better than women. So long as they and their size are not ―gross,‖ overweight or obese
men are more often given socially appealing attributions related to their size than are
women. 128 They are seen as being powerful, masculine, and, if it not too fleshy, athletic.
While for men social attributions appear to be somewhat better and the range of
acceptable individual variability from the ideal is arguably broader, men certainly face
issues of prejudice in employment and discrimination in social settings based on weight.
The experience of bias for men however, allows for greater deviation from the ideal
before negative social attributes are employed as descriptors of the individual. 129 In other
words, a woman who is overweight to the same degree as a man would likely face
prejudice, discrimination, and stigma more frequently and more severely than the man.
This is in part because men in general are expected to have insatiable appetites, take up
more space, and assert themselves physically and sexually in a way not acceptable for
women. 130 Despite temporal, geographic, and cultural differences, one thing remains
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constant: societies are seldom neutral about extremes of weight. Despite the social norms
that ground a judgment that someone is obese, and despite the additional social
judgments—even moral judgments—that frequently accompany the initial judgment or
observation of someone‘s obesity within a particular society or social frame, that
someone is obese is treated as a matter of fact.
Thus, obesity is not a context in which a debate between nominalist and realist
positions can be resolved. Instead, persistent tension between the two approaches can best
be addressed by recognizing that obesity is treated as a matter of fact or medico-scientific
judgment. Two terms that have entered popular discourse reflect the dual realist and
nominalist perspectives, the emphasis on scientific discovery, or on social judgment.
―Obesogenic‖ refers to a combination of factors including environments that promote
over eating which, when combined with limited physical activity, subsequently lead to
obesity. 131 This term seems to imply toxicity in the physical and food environments of
most Americans. The combination produces damaging results. 132 In contrast, the
colloquially used term ―obeast‖ reflects a nominalist conception—even a moralized
conception—of obesity, and graphically describes a social perception of obese
individuals as in some sense beasts—something both less than fully human and also
threatening. Used somewhat differently, the term also highlights the vigilance required by
those pursued by weight who are in continual peril of being caught and suffering harms—
the harms of the (o)beast.
The presence, prevalence, and persistence of such terms reflect not only the
competing realist and nominalist conceptualizations of obesity, but also competing social
characterizations of the growing obesity problem. On one side there are legitimate social
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concerns which include its potential public health ramifications and associated costs, and
these support application of potential public health interventions. 133 On the other side are
the social attitudes toward obesity that prove detrimental to those with obesity and
ultimately to society itself. 134 Social ascriptions to the obese of both causal and moral
responsibility for their condition result in the stigmatization of obesity, discrimination
against those with obesity, and obesity-associated diminished opportunities.135 The
medical decision making of obese patients, with the assistance physicians whose personal
conception of obesity is realist, nominalist, or somewhere between, holds potentially
serious implications for those who are obese and seeking treatment. Indeed, some
research has shown significant reluctance on the part of family practitioners and primary
care physicians to address the issue of overweight and obesity with patients. 136 While
several reasons may explain this reluctance, including physicians‘ lack of training,
personal negative biases about overweight and obesity, or skepticism about the efficacy
of available treatment options, the result is that a lack of information about each of the
alternatives for treatment impedes informed medical decision making, constrains justice,
and potentially impairs patient welfare overall.
In addressing the issue of weight loss with their obese patients, it has been found
that physicians employ some measure of bias against overweight and obese individuals
they see in their own practice. 137 In fact, many physicians fail to address the options for
obesity treatment with patients at all. 138 Whether this is because physicians feel they lack
adequate time to address the issue, believe that interventions provide only marginal
success, or perceive the issue of overweight and obesity to be one of discipline and
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willpower, the outcome is that many patients never receive adequate information
regarding obesity interventions.139
Without the proper medical information, patients with obesity cannot make a
decision to pursue the option of surgery for weight loss. Some authors suggest that the
failure of physicians to fully address a health issue along with its possible interventions
constitutes abandonment of the patient.140 Abandonment of the patient is ethically unjust
and prima facie contrary to patient welfare. Failure to provide the patient with necessary
information regarding repercussions of overweight and obesity along with the full scope
of available treatment options should similarly be construed as abandonment. These
topics will be more fully addressed throughout the dissertation. At present, it is sufficient
to introduce the notion that societal conceptualizations imbedded in the framing of
obesity by physicians and other healthcare providers has deleterious effects on patients
seeking treatment for obesity by conscious or inadvertent violation of ethical principles
and standards in practice. The following section will build on the manner in which
inappropriate ascriptions of blame can also impede social acceptance of various
interventions for weight loss.
C.iii Inappropriate Ascriptions of Blame and Implications for the Social Acceptance
of Interventions
Complicating conceptualization of obesity, attributions of responsibility for its
onset, and identification of potential solutions or interventions are the competing
etiological explanations for individuals‘ obesity and for the growing social problem of
obesity. Not surprisingly, perceptions of cause shape endorsement of one or another set
of interventions to address the problem. 141 Those who emphasize built environments and
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social policies as primary causal factors in obesity are more likely to embrace policylevel public health interventions to address it.142 Emphasis on one or another set of causal
factors is also likely to affect attitudes toward the obese individual and her role in—or
responsibility for—her obesity. Yet there are multiple ways of interpreting etiology.
While discovery of obesity-associated genes might be thought to mitigate or alleviate
entirely attributions of moral responsibility—and even attributions of personal control
and causal responsibility—to individuals with obesity, identification of obesity-related
genetic factors may simply lead to greater specificity in responsibility attribution. As with
the supposed identification of genetic risk factors for alcoholism, other substance abuse,
or sexual orientation, the identification of genes associated with obesity may simply
prompt calls for those at genetic risk to use this information to motivate increased
behavioral interventions to avoid manifesting the condition. For others, the identification
of genetic or environmental factors that increase the risk of developing obesity does serve
to alleviate or at least mitigate personal and especially moral responsibility, and to
suggest that clinical, medical, public health, or social policy interventions are warranted
at the very least to support individual efforts to maintain a healthy weight.
The complex relationship between social attitudes toward obesity and etiological
explanations is evident in the terms with which the obesity problem is popularly depicted.
Obesity has been referred to in the scientific literature, the popular press, and other forms
of mass media as being an ―epidemic,‖ ―being of epidemic proportions,‖ and a ―postmodern epidemic.‖143 Despite the common thread of the term ―epidemic,‖ rather different
perspectives on obesity are revealed by these descriptions. 144 An epidemic is generally
described as ―the occurrence in a community or region of cases of an illness…or other
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related heath events clearly in excess of normal expectancy,‖ 145 or as ―an outbreak or
unusually high occurrence of a disease or illness in a population or area.‖ 146 When used
as an adjective, ―epidemic‖‘ is defined as ―spreading rapidly and extensively by infection
and affecting many individuals in an area or population at the same time, as of a disease
or illness.‖147 The presence of such a population-based problem is frequently considered
to prompt population-based interventions, such as public health measures, to combat
contagion (e.g., vaccination) or to address a common threat (e.g., sanitation measures).
In contrast to and yet building upon more traditional definitions, post-modern
epidemics have been described as ―epidemics in which unevenly medicalized phenomena
lacking a clear pathological basis get cast in the language and moral panic of ‗traditional
epidemics.‘‖148 In this characterization of the obesity problem as a post-modern
epidemic, causal and moral responsibility—for both its creation and its elimination—
become blurred. Obesity occasions not just panic, but moral panic, typically with
associated blaming, stigmatizing, and disenfranchising behaviors and attitudes—the
widespread, ostensibly morally justified fear that arises whenever a population believes
that the social or moral order is threatened.
These complex relationships among etiological explanations, social attitudes, and
moralizing attitudes about obesity influence the acceptability and adoption of different
ways of framing obesity and its potential solutions. Even though contemporary society
has largely rejected the framing of obesity as being the manifestations of sin or gluttony
for which appropriate solutions are atonement, behavioral change, and absolution,
competing frames persist within a generally medico-scientific understanding of obesity.
Obesity may be viewed as a problem at the individual level to be addressed by behavioral
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and clinical medical approaches, or as a population-level problem susceptible to public
health and public policy interventions, or some combination of these. 149 The argument of
this project embraces the importance of adopting a combined approach, but focuses its
attention on the individual level of clinical medical intervention. The social dimensions
of obesity, including moralized attitudes toward it, are nevertheless important to the
argument, because the social acceptability of interventions at the individual level depends
in part on the social attitudes toward obesity and those who are obese, as well as on
socially reinforced etiological explanations of obesity.
D. Conclusion
This chapter provided relevant background information on the problem of obesity.
The chapter began by examining controversies surrounding the most widely used tool for
the diagnosis of obesity, the measurement of BMI, along with several proposed
alternatives which might provide a more accurate clinical picture of the problem. Obesity
trends seen over the past fifty years through the NHANES system were reviewed.
Generally, these surveys have shown that obesity is becoming both more prevalent and
more serious in the United States. International indicators have shown that obesity is
increasing in other part of the world as well. Increased obesity has subsequently led to
increased physical and social co-morbidities such as diabetes, hypertension, reduced
longevity, increased mortality, and in general a lesser quality of life based on social
indicators. Contested theories on the etiology of obesity and thus various ascriptions of
blame were discussed. The implications of the contested terrain surrounding obesity were
addressed. This chapter introduced the notion that various conceptualizations of obesity,
including the appropriateness of its diagnostic tool, the acceptance of obesity as a disease,
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the understanding of obesity as a modern-day epidemic, and the subsequent approval or
rejection of various interventions as applied to this problem, may serve to violate
commonly accepted ethical frameworks such as those found in medical decision making,
considerations of justice, and patient welfare. Subsequent chapters will address the
ethical implications of various conceptualizations and the contested terrain of obesity in
greater detail. Ascription of blame has implications both for societal acceptance of
various interventions and for physician acceptance of particular interventions such as
WLS. Chapter two will take up the history of nonsurgical and surgical weight-loss
interventions, focusing on the benefits and burdens of each type of intervention along
with their perceived acceptability based on conceptualizations of personal responsibility
for obesity.
Notes
1

Richard V. Burkhauser and John Cawley, ―Beyond BMI: The Value of More Accurate Measures of
Fatness and Obesity in Social Science Research,‖ Journal of Health Economics 27, no. 2 (March 2008):
519–21.
2

Centers for Disease Control, December 23, 2010,
<http://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html>; World Health Organization,
November 20, 2010, http://apps.who.int/bmi/index.jsp?introPage=intro_3.html.
3

Jay B. Brodsky and Luiz C. Lerner, ―Anesthetic Concerns,‖ in Obesity Surgery: Principles and Practice,
ed. Cid Pitombo et al. (New York: McGraw Hill Medical, 2008), 84.
4

Centers for Disease Control, http://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html;
Henry Buchwald and Jane N. Buchwald, ―Evolution of Surgery for Morbid Obesity,‖ in Obesity Surgery:
Principles and Practice, ed. C. Pitombo et al. (New York: McGraw Hill Medical, 2008), 4.
5

A. Romero-Corral et al., ―Accuracy of Body Mass Index to Diagnose Obesity in the US Adult
Population,‖ International Journal of Obesity 32, no. 6 (June 2008): 961-62; Francisco Lopez-Jimenez and
William R. Miranda, ―Diagnosing Obesity: Beyond BMI,‖ Virtual Mentor 12, no. 4 (April 2010): 292; Paul
Sebo et al., ―Reliability of Doctors‘ Anthropometric Measurements to Detect Obesity,‖ Preventive
Medicine 47, no. 4 (October 2008): 391-92.
6

Centers for Disease Control, http://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html.

7

Richard V. Burkhauser and John Cawley, "Beyond BMI: The Value of More Accurate Measures of
Fatness and Obesity in Social Science Research," Journal of Health Economics 27, no. 2 (March 2008):
527-28; Thang S. Han, Naweed Sattar, and Mike Lean, "Assessment of Obesity and Its Clinical

34

Implications," in ABC of Obesity, ed. Naweed Sattar and Mike Lean (Malden, MA: Blackwell Publishing,
2007), 7.
8

Burkhauser and Cawley, ―Beyond BMI: The Value of More Accurate Measures of Fatness and Obesity in
Social Science Research,‖ 519-20.
9

Garabed Eknoyan, ―Adolphe Quetelet (1796–1874),‖ Nephrology Dialysis Transplantation 23 (2008): 4850.
10

Ancel Keys et al., ―Indices of Relative Weight and Obesity,‖ Journal of Chronic Diseases 25, no. 6 (July
1972): 329–43; Eknoyan, ―Adolphe Quetelet (1796–1874),‖ 331.
11

Garabed Eknoyan, "Adolphe Quetelet (1796-1874)," Nephrology Dialysis Transplantation 23 (2008):
48-50.
12

Eknoyan, ―Adolphe Quetelet (1796–1874),‖ 48-50; Keys et al., ―Indices of Relative Weight and
Obesity,‖ 339-91; Romero-Corral et al., ―Accuracy of Body Mass Index to Diagnose Obesity in the US
Adult Population,‖ 961-62
13

Centers for Disease Control, http://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html.

14

Centers for Disease Control, http://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html.

15

Caroline S. Fox et al., ―Abdominal Visceral and Subcutaneous Adipose Tissue Compartments
Association with Metabolic Risk Factors in the Framingham Heart Study,‖ Circulation July 3 2007: 40-6.
16

Han, Sattar, and Lean, "Assessment of Obesity and Its Clinical Implications," 6-7; A.M. Prentice and
S.A. Jebb, "Beyond Body Mass Index," Obesity Reviews 2, no. 3 (August 2001): 143-46.
17

Prentice and Jebb, "Beyond Body Mass Index," 143-46; Han, Sattar, and Lean, "Assessment of Obesity
and Its Clinical Implications," 4-7.
18

Burkhauser and Cawley, ―Beyond BMI: The Value of More Accurate Measures of Fatness and Obesity
in Social Science Research,‖ 527.
19

CNN, Who’s Fat? New Definition Adopted. June 17, 1998, CNN, June 17, 2011,
http://www.cnn.com/HEALTH/9806/17/weight.guidelines/.
20

World Health Organization, http://apps.who.int/bmi/index.jsp?introPage=intro_3.html; Health Promotion
Board of Singapore, Revision of Body Mass Index (BMI) Cut-Offs in Singapore. March 15, 2005, June 17,
2011,
http://www.hpb.gov.sg/hpb/default.asp?TEMPORARY_DOCUMENT=1769&TEMPORARY_TEMPLAT
E=2.
21

World Health Organization, http://apps.who.int/bmi/index.jsp?introPage=intro_3.html; Health Promotion
Board of Singapore, ―Revision of Body Mass Index (BMI) Cut-Offs in Singapore.‖
22

World Health Organization, http://apps.who.int/bmi/index.jsp?introPage=intro_3.html; Health Promotion
Board of Singapore, ―Revision of Body Mass Index (BMI) Cut-Offs in Singapore.‖
23

Alan M. Nevill et al., "Relationship Between Adiposity and Body Size Reveals Limitations of BMI,"
American Journal of Physical Anthropology 129 (2006): 153-54; Burkhauser and Cawley, "Beyond BMI:
The Value of More Accurate Measures of Fatness and Obesity in Social Science Research," 527-28.
24

Burkhauser and Cawley, "Beyond BMI: The Value of More Accurate Measures of Fatness and Obesity
in Social Science Research," 523-28; Han, Sattar, and Lean, "Assessment of Obesity and Its Clinical
Implications," 5-7.
35

25

Centers for Disease Control and Prevention, Overweight and Obesity. 2009, August 27, 2009
<http://www.cdc.gov/obesity/index.html>; Youfa Wang and May A. Beydoun, ―The Obesity Epidemic in
the United States—Gender, Age, Socioeconomic, Racial/Ethnic, and Geographic Characteristics: A
Systematic Review and Meta-Regression Analysis,‖ Epidemiologic Reviews 294 (2007): 8-21; World
Health Organization, http://apps.who.int/bmi/index.jsp?introPage=intro_3.html.
26

National Health and Nutrition Surveys CDC, January 15, 2010,
http://www.cdc.gov/nchs/nhanes/about_nhanes.htm; World Health Organization, December 15, 2010,
http://www.who.int/mediacentre/factsheets/fs311/en/index.html.
27

National Health and Nutrition Surveys CDC, http://www.cdc.gov/nchs/nhanes/about_nhanes.htm; World
Health Organization, http://www.who.int/mediacentre/factsheets/fs311/en/index.html.
28

National Health and Nutrition Surveys CDC, http://www.cdc.gov/nchs/nhanes/about_nhanes.htm; World
Health Organization, http://www.who.int/mediacentre/factsheets/fs311/en/index.html.
29

Centers for Disease Control, http://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html.

30

Centers for Disease Control, http://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html;
National Health and Nutrition Surveys CDC, http://www.cdc.gov/nchs/nhanes/about_nhanes.htm.
31

National Health and Nutrition Surveys CDC, http://www.cdc.gov/nchs/nhanes/about_nhanes.htm.

32

National Health and Nutrition Surveys CDC, http://www.cdc.gov/nchs/nhanes/about_nhanes.htm.

33

National Health and Nutrition Surveys CDC, http://www.cdc.gov/nchs/nhanes/about_nhanes.htm.

34

National Health and Nutrition Surveys CDC, http://www.cdc.gov/nchs/nhanes/about_nhanes.htm.

35

National Health and Nutrition Surveys CDC, http://www.cdc.gov/nchs/nhanes/about_nhanes.htm.

36

National Health and Nutrition Surveys CDC, http://www.cdc.gov/nchs/nhanes/about_nhanes.htm.

37

National Health and Nutrition Surveys CDC, http://www.cdc.gov/nchs/nhanes/about_nhanes.htm.

38

National Health and Nutrition Surveys CDC, http://www.cdc.gov/nchs/nhanes/about_nhanes.htm.

39

Paul E. O‘Brien and John B. Dixon, ―The Extent of the Problem of Obesity,‖ The American Journal of
Surgery 184 (2002): 4S–8S; Oregon Health Resources Commission, Bariatric Surgery: MedTAP Report,
Oregon Health Resources Commission (Oregon Health Resources Commission, October 2006).
40

National Health and Nutrition Surveys CDC, http://www.cdc.gov/nchs/nhanes/about_nhanes.htm; CNN,
―Who‘s Fat? New Definition Adopted.‖
41

National Health and Nutrition Surveys CDC, http://www.cdc.gov/nchs/nhanes/about_nhanes.htm.

42

National Health and Nutrition Surveys CDC, http://www.cdc.gov/nchs/nhanes/about_nhanes.htm.

43

Centers for Disease Control and Prevention, ―Overweight and Obesity.‖

44

United States Census Bureau, January 21, 2011, http://www.census.gov/main/www/popclock.html.

45

Centers for Disease Control and Prevention, ―Overweight and Obesity.‖

46

Wang and Beydoun, ―The Obesity Epidemic in the United States—Gender, Age, Socioeconomic,
Racial/Ethnic, and Geographic Characteristics: A Systematic Review and Meta-Regression Analysis‖ 8-14;
Albert J. Stunkard, Myles S. Faith, and Kelly C. Allison, ―Depression and Obesity,‖ Biological Psychiatry
54, no. 3 (1 August 2003): 331-32; O‘Brien and Dixon, ―The Extent of the Problem of Obesity‖ 4s.
36

47

Centers for Disease Control, August 2008, http://www.cdc.gov/obesity/data/trends.htm; Wang and
Beydoun, ―The Obesity Epidemic in the United States—Gender, Age, Socioeconomic, Racial/Ethnic, and
Geographic Characteristics: A Systematic Review and Meta-Regression Analysis‖ 8-14.
48

Centers for Disease Control, http://www.cdc.gov/obesity/data/trends.htm.

49

Thomas H. Inge et al., ―Bariatric Surgery for Severely Overweight Adolescents: Concerns and
Recommendations,‖ Pediatrics 114 (2004): 217.
50

Wang and Beydoun, ―The Obesity Epidemic in the United States—Gender, Age, Socioeconomic,
Racial/Ethnic, and Geographic Characteristics: A Systematic Review and Meta-Regression Analysis‖ 1422.
51

Institute of Medicine, 2004, August 22, 2010, http://iom.edu/~/media/Files/Report
Files/2004/Preventing-Childhood-Obesity-Health-in-the-Balance/FINALfactsandfigures2.pdf.
52

Pam Belluck, ―Children‘s Life Expectancy Being Cut Short by Obesity,‖ New York Times (New York),
17 March 2005: A1.
53

O‘Brien and Dixon, ―The Extent of the Problem of Obesity,‖ 4s.

54

O‘Brien and Dixon, ―The Extent of the Problem of Obesity,‖ 7s.

55

O‘Brien and Dixon, ―The Extent of the Problem of Obesity,‖ 5s-7s.

56

Harvey J. Sugarman, ―Pathophysiology of Severe Obesity and the Effects of Surgically Induced Weight
Loss,‖ in Obesity Surgery: Principles and Practice, C. Pitombo et al., eds. (New York: McGraw Hill
Medical, 2008), 15.
57

O‘Brien and Dixon, ―The Extent of the Problem of Obesity.‖ S4-S7; Sugarman, ―Pathophysiology of
Severe Obesity and the Effects of Surgically Induced Weight Loss,‖ 16-22.
58

Paul E. O'Brien and John B. Dixon, "The Extent of the Problem of Obesity," The American Journal of
Surgery 184 (2002): S7.
59

O'Brien and Dixon, "The Extent of the Problem of Obesity," S7.

60

Victor F. Garcia and Eric J. DeMaria, ―Adolescent Bariatric Surgery: Treatment Delayed, Treatment
Denied, a Crisis Invented,‖ Obesity Surgery 16, no. 1 (January 2006): 1.
61

Daphne P. Guh et al., ―The Incidence of Co-Morbidities Related to Obesity and Overweight: A
Systematic Review and Meta-Analysis,‖ BMC Public Health 9, no. 88 (2009): 2.
62

Guh et al., ―The Incidence of Co-Morbidities Related to Obesity and Overweight: A Systematic Review
and Meta-Analysis,‖ 13-15.
63

Guh et al., ―The Incidence of Co-Morbidities Related to Obesity and Overweight: A Systematic Review
and Meta-Analysis,‖ 3-12.
64

Guh et al., ―The Incidence of Co-Morbidities Related to Obesity and Overweight: A Systematic Review
and Meta-Analysis,‖ 15.
65

Gregory E. Simon et al., ―Association Between Obesity and Psychiatric Disorders in the US Adult
Population,‖ Archives of General Psychiatry 63, no. 7 (July 2006): 824–25.
66

T. B. Gustafson and D. B. Sarwer, ―Childhood Sexual Abuse and Obesity,― Obesity Reviews 5, no. 3
(August 2004): 131–33; Stunkard, Faith, and Allison, ―Depression and Obesity,― 331-33.
37

67

Stunkard, Faith, and Allison, ―Depression and Obesity,‖ 336.

68

Michael W. Wiederman, Randy A. Sansone, and Lori A. Sansone, ―Obesity Among Sexually Abused
Women: An Adaptive Function for Some?‖ Women & Health 29, no. 1 (1999): 96.
69

Simon et al., ―Association Between Obesity and Psychiatric Disorders in the US Adult Population‖ 82527.
70

Kate M. Scott et al., ―Obesity and Mental Disorders in the Adult General Population,‖ J Psychosomatic
Res 64, no. 1 (Jan 2006): 100-102.
71

Stunkard, Faith, and Allison, ―Depression and Obesity‖ 334-35.

72

Centers for Disease Control HRQOL, Nov 2010, January 8, 2011,
http://www.cdc.gov/hrqol/concept.htm.
73

Centers for Disease Control HRQOL, http://www.cdc.gov/hrqol/concept.htm.

74

David A. Katz, Colleen A. McHorney, and Richard L. Atkinson, ―Impact of Obesity on Health-Related
Quality of Life in Patients with Chronic Illness,‖ Journal of General Internal Medicine 15 (2000): 794–95.
75

Centers for Disease Control HRQOL, http://www.cdc.gov/hrqol/concept.htm.

76

Katz, McHorney, and Atkinson, ―Impact of Obesity on Health-Related Quality of Life in Patients with
Chronic Illness,‖ 794-95
77

CNN, Is Your Weight Hurting Your Career? March 7, 2007, June 17, 2011
http://www.cnn.com//2007/US/Careers/03/07/cb.weight/index.html?iref=allsearch; Christie M. Glass,
Steven A. Haas, and Eric N. Riether, ―The Skinny on Success: Body Mass, Gender and Occupational
Standing Across the Life Course,‖ Social Forces 88, no. 4 (June 1 2010): 1778–82.

Janet D. Latner and Albert J. Stunkard, "Getting Worse: The Stigmatization of Obese
Children," Obesity Research 11 (2003): 454-55; Rebecca M. Puhl and Kelly D. Brownell,
"Bias, Discrimination, and Obesity," Obesity Research 9, no. 12 (December 2001): 79697.
78

79

Latner and Stunkard, ―Getting Worse: The Stigmatization of Obese Children.‖

80

Rebecca M. Puhl and Kelly D. Brownell, ―Bias, Discrimination, and Obesity,‖ Obesity Research 9, no.
12 (December 2001): 788-98.
81

Puhl and Brownell, ―Bias, Discrimination, and Obesity‖ 800.

82

Jon Reif, ―The Bioethics of Obesity: Agency, Personal Responsibility and the Care of Self‖ (Ph. D. diss.,
University of Pittsburgh, 2010): 7-12; Abigail C. Saguy and Kevin W. Riley, ―Weighing Both Sides:
Morality, Mortality, and Framing Contests Over Obesity,‖ 5 (October 2005), 884–91; Regina G. Lawrence,
―Framing Obesity: The Evolution of a News Discourse on a Public Health Issue,‖ The International
Journal of Press/Politics 9, no. 3 (Summer 2004): 61-69.
83

Jeffrey M. Friedman, "Obesity: Causes and Control of Excess Body Fat," Nature 439 (21 May 2009
2009): 340-42.
84

Jeffrey M. Friedman, ―Obesity: Causes and Control of Excess Body Fat,‖ Nature 439 (21 May 2009):
341.

Suzanne B. Cassidy and Daniel J. Driscoll, "Prader-Willi Syndrome," European
Journal of Human Genetics 17, no. 1 (2008): 3-4; Cara B. Ebbeling, Dorata B. Pawlak,
85

38

and David S. Ludwig, "Childhood Obesity: Public-Health Crisis, Common Sense Cure,"
The Lancet 360 (August 10 2002): 474-75.
86

Sasaf Farooqui and Stephen O'Rahilly, "Genetics of Obesity in Humans," Endocrine Reviews 27, no. 7
(Dec 2006 2006): 711-12.
87

Farooqui and O‘Rahilly, ―Genetics of Obesity in Humans‖ 710-11.

88

Farooqui and O'Rahilly, "Genetics of Obesity in Humans," 714-15.

89

Friedman, ―Obesity: Causes and Control of Excess Body Fat‖ 341.

90

Tim Lang, David Barling, and Martin Caraher, ―Food, Social Policy and the Environment: Towards a
New Model,‖ Social Policy & Administration 35, no. 5 (December 2001): 538-41.
91

Brian Wansink, ―Changing the Eating Habits on the Home Front: Lost Lessons from WWII Research,‖
Journal of Public Policy and Marketing 21, no. 1 (Spring 2002): 90.
92

William H. Deitz, ―Does Hunger Cause Obesity?‖ Pediatrics 95 (1995): 766.

93

Deitz, ―Does Hunger Cause Obesity?,‖ 766.

94

Sue A. Anderson, ―Core Indicators of Nutritional State for Difficult-to-Sample Populations,‖ Journal of
Nutrition 120, Supplemental (1990): 1560S–600S.
95

Marilyn S. Townsend et al., ―Food Insecurity is Positively Related to Overweight in Women,‖ Journal of
Nutrition 131 (2001): 1739.
96

A. Favaro, F.C. Rodella, and P. Santonastaso, ―Binge Eating and Eating Attitudes Among Nazi
Concentration Camp Survivors,‖ Psychological Medicine 30 (2000): 464–65.; Townsend et al., ―Food
Insecurity is Positively Related to Overweight in Women.‖ 1742-1744; Sirpa Sarlio-Lahteenkorva and Eero
Lahelma, ―Food Insecurity Is Associated with Past and Present Economic Disadvantages and Body Mass
Index,‖ The Journal of Nutrition 131 (2001): 2881–883.
97

Wansink, ―Changing the Eating Habits on the Home Front: Lost Lessons from WWII Research,‖ 91-97.

98

Judy Putnam, Jane Allhouse, and Linda Scott Kantor, US Per Capita Food Supply Trends: More
Calories, Refined Carbohydrates and Fats, USDA ERS no. 25 (Economic Research Service, 2002):10.
99

Institute for Agriculture and Trade Policy, 2006, October 4, 2010,
www.iatp.org/publications.cfm?refID=1000001.
100

George A. Bray, Samara Joy Nielsen, and Barry M. Popkiin, ―Consumption of High Fructose Corn
Syrup in Beverages May Play a Role in the Epidemic of Obesity,‖ American Journal of Clinical Nutrition
79, no. 4 (2004): 540–42.
101

Putnam, Allhouse, and Kantor, US Per Capita Food Supply Trends: More Calories, Refined
Carbohydrates and Fats, 6-8
102

Institute for Agriculture and Trade Policy, www,iatp.org/publications.cfm?refID=1000001.

103

Kristen Wiig Damman and Chery Smith, ―Factors Affecting Low-Income Women's Food Choices and
the Perceived Impact of Dietary Intake and Socioeconomic Status on Their Health and Weight,‖ Journal of
Nutrition Education and Behavior 41, no. 4 (July 2009): 246-52.
104

Mia A. Papas et al., ―The Built Environment and Obesity,‖ Epidemiologic Reviews 29 (2007): 129–31.

39

105

Susan Handy and Kelly Clifton, ―Planning and Built Environment Implications for Obesity Prevention,‖
in S. Kumanyikn and R. Browson, eds., Handbook of Obesity Prevention (New York: Springer, 2007),
171–72.
106

Handy and Clifton, ―Planning and Built Environment Implications for Obesity Prevention,‖ 171.

107

Papas et al., ―The Built Environment and Obesity,‖ 129.

108

Papas et al., ―The Built Environment and Obesity,‖ 141.

109

Perrie F. O'Tierney et al., ―Duration of Breast Feeding and Adiposity in Adult Life,‖ The Journal of
Nutrition 139, no. 2 (February 2009): 423S–24S.
110

O‘Tierney et al., ―Duration of Breast Feeding and Adiposity in Adult Life,‖ 424S

111

Nicholas A. Christakis and James H. Fowler, ―The Spread of Obesity in a Large Social Network Over
32 Years,‖ New England Journal of Medicine 26 July 2007: 375–78.
112

Maryanne Davidson and Kathleen A. Knafl, ―Dimensional Analysis of the Concept of Obesity,‖ Journal
of Advanced Nursing 54, no. 3 (May 2006): 342–46.
113

Reif, ―The Bioethics of Obesity: Agency, Personal Responsibility and the Care of Self,‖ 7.

114

Reif, ―The Bioethics of Obesity: Agency, Personal Responsibility and the Care of Self,‖ 9.

115

Rashida R. Dorsey, Mark S. Eberhardt, and Cynthia L. Ogden, ―Racial/Ethnic Differences in Weight
Perception,‖ Obesity 17 (2009): 792–94; Lauren W. Kronenfeld et al., ―Ethnic and Racial Differences in
Body Size Perception and Satisfaction,‖ Body Image 7, no. 2 (March 2010): 133-35; Tess Knight, Janet D.
Latner, and Kaye Illingworth, ―Tolerance of Larger Body Sizes by Young Adults Living in Australia and
Hawaii,‖ Eating Disorders 18, no. 5 (October 2010): 429–33.
116

Dorsey, Eberhardt, and Ogden, ―Racial/Ethnic Differences in Weight Perception,‖ 792-94; Kronenfeld
et al., ―Ethnic and Racial Differences in Body Size Perception and Satisfaction,‖ 133-35.
117

Dorsey, Eberhardt, and Ogden, ―Racial/Ethnic Differences in Weight Perception,‖794; Kronenfeld et al.,
―Ethnic and Racial Differences in Body Size Perception and Satisfaction,‖ 131-32.
118

Stanley Scheindlin, ―Obesity, Body Image, & Diet Drugs: 100 Years of Change,‖ Molecular
Interventions 8, no. 2 (April 2008): 64–65; D.T. Sawbridge and R. Fitzgerald, ―‗Lazy, Slothful and
Indolent‘: Medical and Social Perceptions of Obesity in Europe to the Eighteenth Century,‖ Vesalius 15,
no. 2 (December 2009): 59–65.
119

Albert J. Stunkard, W.R. LaFleur, and T.A. Wadden, ―Stigmatization of Obesity in Medieval Times:
Asia and Europe,‖ International Journal of Obesity 22 (1998): 1141–143.
120

Stunkard, LaFleur, and Wadden, ―Stigmatization of Obesity in Medieval Times: Asia and Europe,‖ 1141

121

Scheindlin, ―Obesity, Body Image, & Diet Drugs: 100 Years of Change,‖64-66; Marilyn Wann,
FAT!SO?: Because You Don’t Have to Apologize for Your Size (Berkeley, CA: Ten Speed Press, 1998), 8990.
122

Scheindlin, ―Obesity, Body Image, & Diet Drugs: 100 Years of Change,‖ 65; Sawbridge and Fitzgerald,
―‗Lazy, Slothful and Indolent‘: Medical and Social Perceptions of Obesity in Europe to the Eighteenth
Century,‖ 59-65.
123

Scheindlin, ―Obesity, Body Image, & Diet Drugs: 100 Years of Change,‖ 65.

40

124

Scheindlin, ―Obesity, Body Image, & Diet Drugs: 100 Years of Change,‖ 65.

125

Scheindlin, ―Obesity, Body Image, & Diet Drugs: 100 Years of Change,‖ 65.

126

Carol Johnson, ―Obesity, Weight Management, and Self-Esteem,‖ in T. Wadden and A Stunkard, eds.,
Handbook of Obesity Treatment (New York: Guilford Press, 2002), 480–82.
127

Susan Bordo, Unbearable Weight: Feminism, Western Culture and the Body (Berkeley and Los
Angeles, CA: University of California Press, 2003), 185-212; Sawbridge and Fitzgerald, ―‗Lazy, Slothful
and Indolent‘: Medical and Social Perceptions of Obesity in Europe to the Eighteenth Century,‖ 59-65.
128

Susan Bordo, The Male Body (New York: Farrar, Straus and Giroux, 1999),66-83.

129

Elizabeth E. Theran, ―Legal Theory on Weight Discrimination,‖ in Kelly D. Brownell et al., eds.,
Weight Bias: Nature, Consequences and Remedies (New York: The Guilford Press, 2005), 201-207.
130

Iris Marion Young, On Female Body Experience: “Throwing Like a Girl” and Other Essays (Oxford:
Oxford University Press, 2005), 27-45; Alexandra Howson, The Body in Society: An Introduction (Malden,
MA: Polity Press, 2004) 103-109; Bordo, The Male Body, 129-152.
131

Centers for Disease Control, http://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html.

132

Centers for Disease Control, http://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html.

133

Shirley S. Wang and Kelly D. Brownell, ―Public Policy and Obesity: The Need to Marry Science with
Advocacy,‖ Psychiatric Clinics of North America 28 (2005): 240-49.
134

Rebecca M. Puhl, Marlene B. Schwartz, and Kelly D. Brownell, ―Impact of Perceived Consensus on
Stereotypes About Obese People: A New Approach for Reducing Bias,‖ Health Psychology 24, no. 5
(2005): 517–18; Deborah Carr and Michael A. Friedman, ―Is Obesity Stigmatizing? Body Weight,
Perceived Discrimination and Psychological Well-Being in the United States,‖ Journal of Health and
Social Behavior 46 (September 2005): 244–47.
135

Puhl, Schwartz, and Brownell, ―Impact of Perceived Consensus on Stereotypes About Obese People: A
New Approach for Reducing Bias,‖ 519-524; Carr and Friedman, ―Is Obesity Stigmatizing? Body Weight,
Perceived Discrimination and Psychological Well-Being in the United States,‖ 253-56.
136

Thomas A. Wadden et al., ―Obese Women‘s Perceptions of Their Physicians‘ Weight Management
Attitudes and Practices,‖ Archives of Family Medicine 9, no. 9 (Sept/Oct 2000): 854-55; Jason P. Block,
Karen B. DeSalvo, and William P. Fisher, ―Are Physicians Equipped to Address the Obesity Epidemic?
Knowledge and Attitudes of Internal Medicine Residents,‖ Preventive Medicine 36 (2003): 671-73.
137

Delese Wear et al., ―Making Fun of Patients: Medical Students‘ Perceptions and Use of Derogatory and
Cynical Humor in Clinical Settings,‖ Academic Medicine 81, no. 5 (May 2006): 456–59; Laura Epstein and
Jane Ogden, ―A Qualitative Study of GPs‘ Views of Treating Obesity,‖ The British Journal of General
Practice 55, no. 519 (October 2005): 752–54; Marlene B. Schwartz et al., ―Weight Bias Among Health
Professionals Specializing in Obesity,‖ Obesity Research 114, no. 9 (September 2003): 1036–39.
138

Laura Epstein and Jane Ogden, "A Qualitative Study of GPs Views of Treating Obesity," The British
Journal of General Practice 55, no. 519 (October 2005): 750-51.
139

J.M. Lyznicki et al., "Obesity: Assessment and Management in Primary Care," American Family
Physician 63, no. 11 (June 1 2001): 2193-95; Marlene B. Schwartz et al., "Weight Bias Among Health
Professionals Specializing in Obesity," Obesity Research 114, no. 9 (September 2003): 1036-39; Epstein
and Ogden, "A Qualitative Study of GPs Views of Treating Obesity," 752-54.

41

140

Timothy E. Quill and Christine K. Cassel, ―Nonabandonment: A Central Obligation for Physicians,‖
Annals of Internal Medicine 122, no. 5 (March 1995): 370–72.
141

Saguy and Riley, ―Weighing Both Sides: Morality, Mortality, and Framing Contests over Obesity,‖ 881902.
142

Wang and Brownell, ―Public Policy and Obesity: The Need to Marry Science with Advocacy‖ 239-40.

143

Natalie Boero, ―All the News That‘s Fat to Print: The American ‗Obesity Epidemic‘ and the Media,‖
Qualitative Sociology 30, no. 1 (2007): 57-58.
144

Boero, ―All the News That‘s Fat to Print: The American ‗Obesity Epidemic‘ and the Media‖ 41-43.

145

John M. Last, A Dictionary of Epidemiology (New York: International Epidemiological Association,
2001).
146

American Heritage Medical Dictionary, 2007, March 11, 2011 http://medicaldictionary.thefreedictionary.com/epidemy.
147

American Heritage Medical Dictionary, http://medical-dictionary.thefreedictionary.com/epidemy.

148

Boero, ―All the News That‘s Fat to Print: The American ‗Obesity Epidemic‘ and the Media‖ 41.

149

Saguy and Riley, ―Weighing Both Sides: Morality, Mortality, and Framing Contests Over Obesity‖;
Wang and Brownell, ―Public Policy and Obesity: The Need to Marry Science with Advocacy‖ 879-80.

42

Chapter Two: Obesity Treatment Options, Their Underlying Rationales, and the
History of Surgical Weight Loss Interventions
To appreciate the different responses weight loss interventions have received—
from clinicians, overweight individuals, and society in general—it is important to
understand the developmental trajectories of three categories of intervention for weight
loss: behavioral or lifestyle-focused interventions, pharmacological interventions, and
surgical interventions. This chapter‘s section A examines the history of several types of
behavior or lifestyle-mediated technologies for weight loss. The following lifestyle
interventions will be considered: self-help groups, commercial weight loss programs, and
physician-supervised weight loss. This chapter‘s section B concludes by surveying the
over fifty-year history of weight loss surgery (WLS), along with an exploration of
exceptionalism as applied to surgical technologies for weight loss.
Development, support for, and acceptance of different technological
innovations—and the term ―technology‖ is used in the sense Nikolas Rose employs—are
obviously influenced by culturally normative factors. Nikolas Rose, sociologist, defines
technology broadly as an assemblage of social and human relations within which
equipment and techniques are only one element. ―Technology, here, refers to any
assembly structured by practical rationality governed by a more or less conscious
goal…hybrid assemblages of knowledge‘s instruments, persons, systems of government,
building spaces, underpinned at the programmatic level by certain presuppositions and
assumptions about human beings.‖1
In this sense, even behavioral interventions, from talk therapy to support groups
which encourage weight loss, may be understood and analyzed as weight loss
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technologies. A discussion of various weight loss interventions supported by Rose‘s
conception of technology permits an analysis of the ethical frameworks which provide
the scaffolding for each type of technology. Specifically, the role of cultural norms,
power relationships, various perspectives on the technology itself, as well as the products
of these weight loss technologies, can be engaged.2 This conceptualization of
―technology‖ emphasizes the normative basis and hierarchical structuring of
technological intervention. To understand and criticize these culturally influenced weight
loss technologies, it is important to have knowledge of the basic methods of weight loss
intervention, the history of their development, and the particular normative frameworks
grounding each of these treatment options.
Currently in the United States, the most commonly employed advice for those
seeking to lose weight has been to reduce caloric intake and increase physical activity.3
Weight loss, simply put, is achieved either when fewer calories are consumed than are
expended, or when more calories are burned than are consumed. 4 It appears to be a
simple issue of mathematics: ―more out, less in‖ will indeed lead to weight loss.
Specifically, in order to lose one pound, it is necessary for an individual to either expend
or reduce the number of calories consumed by approximately 3,500.5
As discussed in chapter one, in post–World War II America, the problem of
obesity began to surface. 6 This burgeoning problem led to several nonsurgical methods to
support this seemingly simple equation for weight loss. When diet and exercise changes
alone were unable to ameliorate obesity, pharmacological and surgical possibilities began
to be developed and utilized with varying degrees of success and risk. The history of
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various interventions, along with their normative underpinnings, is explored below. The
following section examines various nonsurgical weight loss interventions.
A. History of Nonsurgical Weight Loss Interventions
The following section addresses the history of various types of nonsurgical weight
loss technologies. Each of these technologies has been applied to the problem of obesity
with generally low levels of sustained success. These technologies fall into four broad
categories: self-help initiatives, commercial weight loss programs, weight loss drugs, and
physician supervised weight loss by individuals. The four subsections below take up each
of these technologies, beginning with a review of self-help initiatives.
A.i Self-Help Initiatives
Several self-help initiatives have evolved in an effort to help overweight or obese
individuals lose weight. One such self-help group, TOPS Club, Inc., was founded in 1948
by Ester Manz and is still in existence. The approach of TOPS, which stands for Take Off
Pounds Sensibly, is to encourage healthy lifestyles through weight management and peer
support of ―good‖ behaviors.7 The norm-governed assumptions informing the TOPS
program are that weight control is fundamentally an individual responsibility and that
weight is controllable by the individual with the proper application of personal willpower
and group support. Participants are taught that individual motivation, willpower, personal
actions, and the development of patterns of appropriate behaviors are responsible for their
success or failure at weight loss.8 Overweight is thus the result of previous and present
failures of willpower and motivation. Participants must accept, at least to some degree,
this assignment of backward-looking responsibility in order to access the program‘s
support of forward-looking, responsible behaviors. Upon such acceptance, appropriate
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behaviors and individual changes in motivation and action are socially reinforced by
other members within the organization. Weight loss, according to this organization, can
best be supported through a group mentoring process.
The TOPS organization is comprised of individual chapters, each with voluntary
leadership, through which members receive positive reinforcement and encouragement.9
This structure of motivation is designed to assist members in sticking to healthy food
choices and exercise plans. There are modest costs associated with membership in TOPS,
Inc., including annual dues for membership (approximately $26.00) along with an
additional monthly fee paid to the local chapter in which members participate
(approximately $5.00). The annual membership fee provides a variety of goods, services,
and events that are designed to reinforce members‘ commitment to weight loss. Some of
the available options include a system of competitions, awards, and recognition for
success in meeting weight loss goals; a variety of helpful tools, including The Choice Is
Mine, a healthy lifestyle guide; retreats, rallies, and recognition events; and TOPS News,
a membership magazine.10 Local chapters offer weekly meetings to their membership.
TOPS advertises that it is comprised of men, women, and children age seven and older.
They report a membership of approximately 170,000 members in nearly 10,000 chapters
throughout the United States and Canada.11
As is typical of self-help group formats, ongoing medical monitoring is not a
requirement for members participating in this program. However, when members join,
they are asked to consult with healthcare professionals to learn what is considered a
healthy weight goal for them. Members are asked to share this information with an
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official volunteer within the chapter who records this information, presumably to
encourage member accountability and assist in the monitoring of progress.12
TOPS, Inc. has conducted research into obesity since 1966. Its website reports
that TOPS has spent over $6.5 million on developing and contributing to research on
obesity and metabolism at the Medical College in Milwaukee.13 However, the website
reveals nothing about the complex associations among biologic, environmental, and
lifestyle factors currently thought to be associated with the development and maintenance
of overweight and obesity. This empirically informed and complex relationship has been
borne out in much of the research on obesity. 14 Indeed, while biologic and environmental
factors beyond individual control have been shown to contribute to the development and
maintenance of obesity, the underlying philosophy of TOPS is that it is incumbent upon
overweight or obese individuals to address the problem from within an individualistic
framework of behavior modification.
Overeaters Anonymous (OA) is another popular self-help group option for weight
loss. OA was founded on the twelve-step intervention platform of Alcoholics Anonymous
(AA).15 Both self-help groups (in addition to Narcotics Anonymous and Gamblers
Anonymous) employ a progressive disease model. The OA program philosophy, which
accepts obesity as a disease, seems to further a normative conception which allows that
there are things affecting weight and weight loss beyond the immediate control of the
individual. 16 OA explains obesity as the result of a compulsion and thereby focuses on
the mental or psychological aspects within a bio-psycho-social model of disease. Similar
to the TOPS program, OA effectively ignores the relevance of specific genetic or other
biological factors associated with obesity. Departing from typical reliance on a disease
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model, this program contends that the factors leading to overweight and obesity are a
product of compulsion which can only be overcome by depending on the strength of the
higher power.17 In other words, this program seems to accept that the compulsive eating
which can lead to overweight and obesity is part of a disease process (similarly, OA
would describe anorexia and bulimia as the manifestation of compulsive eating amenable
to its interventions) but utilizes dependence on a supernatural intervention or divine
presence to facilitate resolution of the compulsions. This view blurs backward-focused
causal and quasi-moral responsibility for obesity. Participants must accept that a failing
or weakness in themselves resulted in their obesity and that only reliance on a higher
power can overcome that failing.
OA utilizes the twelve steps and eight tools upon which AA is based. 18 These
steps and tools are common among the Alcoholics Anonymous, Narcotics Anonymous,
Gamblers Anonymous, and Overeaters Anonymous programs. These steps and tools,
when properly used in the OA program, are designed to interrupt the disease process and
provide an alternative way of coping with the compulsive desire to overeat, a desire
which leads to overweight and obesity. The goal is to restore normal eating patterns by
relying on the assistance of a ―higher power‖ and on other group members‘ experience
and support on a shared journey to change thought and behavior patterns, which will
ultimately lead to changes in weight, restore health, and defeat obesity.
OA was founded by Roxanne S. several years after she attended a GA meeting
with a friend in 1958. In 1960, determined to overcome her weight problem she, along
with a neighbor and a fellow compulsive overeater, held the first meeting of the fledgling
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OA. Currently it is reported that 6,500 groups meet across the world in any given week.
OA reports 54,000 members worldwide working towards recovery.19
One of the primary traditions on which OA is established is that of anonymity at a
public level. 20 Therefore it is difficult to obtain adequate demographic information
regarding group membership. However, in 2010 OA undertook a membership survey as
part of the organization‘s strategic plan. The survey was distributed to a small sample of
members (n=2,400) in various parts of the world. This particular sample was chosen to
receive the survey as it was thought to be representative of the larger membership. The
survey asked questions related to the age at which food became a problem, the nature of
the problem (compulsive overeating, anorexia, or bulimia), and various demographic
questions. Survey responses revealed membership to be predominantly female, age fiftysix to sixty-five, married, white, and college-educated.21 The average return rate was 36
percent with 836 of the 2,400 surveys returned.22
Although the social structure of individual OA groups and member participation
are assumed to play a role in supporting weight loss efforts, as previously stated,
overweight and obesity are themselves viewed as the results of an individual-level
compulsive desire. 23 Unlike TOPS, which emphasizes personal responsibility for both the
behaviors that result in becoming overweight and those that remedy the problem, OA
urges members to accept the presence of a higher power that must be invoked to support
individual efforts to overcome the compulsion to overeat.24 OA states that it has ―among
its membership people of many religious faiths as well as atheists and agnostics,‖ but OA
is a spiritual program based on each members‘ personal interpretation of a ―higher
power.‖25 Most members acknowledge that participation, and therefore the opportunity
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for success in this program could be curtailed by an inability to accept some form of
higher power. This would effectively limit the utility of the OA program for those who
are religious nonbelievers.
OA interventions are based, first and foremost, on accepting powerlessness over
food and acknowledging the strength of the higher power to overcome the
powerlessness. 26 Acceptance of these factors, bolstered by the value of a shared journey
with other compulsive eaters, allegedly enables members to overcome the compulsion
with food. Only once the participant recognizes this utter powerlessness over food, and
acknowledges dependence on a higher power, can the obese individual go on to learn
new behaviors which support weight loss (e.g., portion control, making good dietary
choices, getting enough exercise). Failure to utilize and draw adequate strength from
one‘s higher power, however conceived by the individual, is conceptualized as a personal
failure that is evidenced by ongoing weight issues. If obese individuals were truly to
understand and utilize the strength of the higher power and accept their powerlessness
over food, OA maintains, they would be successful and the weight problem would
resolve. 27
While there is anecdotal evidence regarding the efficacy of self-help groups for
weight loss, 28 the private nature of such groups‘ activities does not permit the rigorous
scientific evaluation needed to determine long-term effectiveness. Therefore, it is difficult
to determine adequately the number of participants who have been able to achieve longterm, significant weight loss, to decrease or ameliorate health co-morbidities, and to
improve other quality-of-life indicators. The efficacy of these self-help weight loss efforts
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therefore remains largely unknown. 29 The following subsection discussed another often
used technology for weight loss—commercial weight loss programs.
A.ii Commercial Weight Loss Programs
Numerous commercial weight loss programs such as Weight Watchers, Jenny
Craig, OPTIFAST, and Medifast combine both calorically restrictive food plans with
various support mechanisms for individuals seeking to reduce their weight.30 Generally,
moralized norms of backward-looking responsibility, blame, and shame do not inform
these programs. Instead the programs are informed by autonomy-oriented, take-chargeof-your-life values. A new and improved ―you‖ is the product being sold. Assigning
personal blame for overweight would be contrary to the positive, self-actualizing
orientation of these commercial enterprises. Commercial weight-loss programs generally
do not characterize obesity as resulting from personal failings or character flaws, but
instead focus on cognitive-behavioral changes and the development of new habits.31
These programs‘ individual-level intervention is almost entirely forward-looking, with
little if any attention to the cause of obesity beyond the assumption that too many calories
have been consumed and too few have been expended. These programs tend to
acknowledge, albeit very simplistically, the biological factors associated with developing
obesity. They seem to reflect little understanding, however, that not all obese people are
created equal, and that even a program applied with equal diligence among participants
can produce vastly differing results depending on a variety of factors, including genetic
variation.
Unlike most self-help programs, there is some governmental oversight of
proprietary programs. Commercial weight loss programs are regulated by the Federal
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Trade Commission (FTC), not by the Food and Drug Administration (FDA) as might be
expected given their health-related focus.32 While the FDA oversees food safety and
regulates drugs and medical devices, commercial weight loss programs fall under FTC
jurisdiction because they advertise and therefore the veracity of their advertising claims
may be evaluated by the FTC. The authority of the FTC is empowered to intervene when
it believes that a program is making misleading or false claims. However, programs are
not required to disclose individual or aggregate outcome measures of success or failure.
FTC guidelines require only that commercial weight loss programs provide information
in the following four categories: key programmatic components, qualifications of the
staff, program costs, and any risks of treatment. In other words, it is difficult to
adequately ascertain how effective a particular program or intervention is in assisting
participants in losing excess weight.33
The three largest commercial weight loss programs in the United States are
Weight Watchers, Jenny Craig, and LA Weight Loss.34 Each offers moderately restricted
diets in addition to behavioral counseling and motivational interventions to increase
physical activity/exercise. These programs do not require or provide physician
supervision; therefore they advocate that members with weight-related medical concerns
should be monitored by their own physicians. Weight Watchers provides its services
using group sessions, whereas the other two programs provide services to members
through individual counseling sessions. Payment for services in the Jenny Craig and LA
Weight Loss Programs is required upon initiation of the program, whereas payment in the
Weight Watchers Program is made on an ongoing weekly basis. Of the three, only the
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Jenny Craig program requires additional purchases of prepared and prepackaged meals
and snacks.35
Of these three prominent commercial weight loss programs, only Weight
Watchers has sponsored randomized controlled trials of its program in an effort to
establish its effectiveness.36 Even in this case, there have been few studies conducted. In
one study, 423 participants were randomly assigned to attend the traditional Weight
Watchers program or to participate in a self-help intervention that included two visits
with the dietician. The results showed that participants in the Weight Watchers program
had lost 5.3 percent of their initial weight at one year. Participants were able to maintain
3.2 percent of their weight loss at two years. This result was better than that realized by
the participants in the group that had two visits with the dietician. Of that group,
participants had maintained a loss of 1.5 percent at one year and 0 percent after two
years. Weight Watchers members who attended the most meetings were able to maintain
the greatest weight loss,37 although obviously no causal effect of Weight Watchers
meeting attendance can be assumed.
An important benefit of weight loss is the reduction of co-morbid disease. With
regard to weight loss achieved by participants in Weight Watchers, it was found that the
mean weight loss reported in the randomized controlled trials (5 percent) may be
sufficient to ―prevent or ameliorate weight-related health complications‖ for its
participants.38 The other two commercial weight loss programs have not been similarly
studied, so adequate comparison of participant outcomes is not possible. Additional
research should be undertaken to assess the outcomes of these programs with regard to
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short- and long-term weight loss, maintenance of loss, and resolution of co-morbid
disease states.
Programs such as OPTIFAST and Medifast utilize very-low-calorie (420 kcal/d)
or low-calorie diet plans (≤800 kcal/d). 39 OPTIFAST originally offered the very-lowcalorie diet (420 kcal/d) but currently recommends its participants utilize the low-calorie
(≤800 kcal/d) diet plan instead. Mandatory medical supervision is built into the
OPTIFAST program.40 Medifast permits its participants to utilize either a very-lowcalorie choice or the low-calorie choice, and its lack of medical supervision within the
Medifast program may also be cause for concern as medical supervision has been shown
to be critical to the safe use of very-low-calorie diets.41
Many randomized controlled research studies conducted in academic settings
have examined either very-low-calorie or low-calorie diets. The initial results of
programs utilizing these diets are promising with regard to short-term results. During the
first three to six months, participants can expect to lose approximately 15–25 percent of
their starting weight. However, very-low-calorie diets and low-calorie diets are often
difficult for participants to maintain over a long period of time. For this reason, these
plans tend to have high attrition rates.42 Therefore, it is difficult to assess long-term
sustained weight loss and the improvements in or resolution of weight-related comorbidities associated with such severely calorie-restricted diets. Nevertheless, with the
percentage of weight initially lost, it is plausible that if even a small portion of the initial
weight loss is maintained there might be overall improvements in co-morbidities.43
Costs for participating in these programs can be prohibitive. OPTIFAST can cost
as much as $1,700 to $2,200 for the first three months alone.44 Participation in Medifast
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is far less expensive, in part due to the absence of mandatory medical supervision within
the program. The cost for Medifast is approximately $840 for a three-month period.45
Even at that reduced rate, the cost may well be out of reach for many potential
participants, as the program cost is generally not reimbursed by insurance. While
program participation and thus severe restriction in calories are not meant to be sustained
over the participant‘s lifetime, it is necessary to maintain the restrictions until the excess
weight is lost. Participants are then taught how to increase their daily caloric
consumption, with the goal being maintenance at the new healthier weight.
A.iii Pharmaceutical Interventions
Seeking weight loss through the use of anti-obesity drugs has become
commonplace in the United States.46 The development of pharmacological interventions
for the treatment of obesity reflects a dramatic shift in the normative framework
undergirding efforts to ameliorate obesity. By employing a branch of medicine
(pharmacology) to develop solutions for obesity and its subsequent co-morbidities, there
appears to be an acknowledgement of factors beyond the individual‘s immediate control.
Disordered biological systems, instead of disordered thinking or flawed character, are
seen as being foundational components of an individual‘s obesity problem. The
pharmacological focus is almost entirely forward-looking and results-oriented. Only
those developing the interventions need be concerned with obesity‘s biological causal
factors, and even these need not be entirely understood so long as the pharmacological
intervention produces the desired effect. This particular normative view represents an
evolution, as the approach is nonpunitive and nonmoralizing with regard to the obese
person‘s weight. This evolved, normative view of obesity‘s causal factors and of obese
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individuals requires and justifies particular biomedical-based interventions to address
factors contributing to obesity. Drug manufacturers insist that pharmacological
interventions must coexist with behavioral and lifestyle changes to facilitate successful
outcomes.47 This view possibly reflects a greater understanding and acceptance of the
multi-factorial nature of obesity which includes genetics, physiological systems,
environment, and lifestyle. According to the Department of Health and Human Services,
―prescription weight loss medications should be used only by patients who are at
increased medical risk because of their weight. They should not be used for ‗cosmetic‘ or
‗vanity‘ weight loss.‖48
The reason for this distinction between health-related and cosmetic or vanity
weight loss is based on the increased risk profile associated with pharmaceutical
interventions. The development of pharmacological interventions for significant weight
loss has, thus far, unfortunately been hampered by dangerous, life-threatening side effects
as well as limited long-term success.49
The therapeutic mechanisms of anti-obesity drugs fall into three categories. Some
work as appetite suppressants, others increase body metabolism, and a third category
interferes with the ability of the body to absorb specific nutrients in food such as fats
(called lipase inhibition).50 The anti-obesity drugs on the market in 2009 included
Xenical, (a lipase inhibitor available in prescription-dose Orlistat), Alli (a lipase inhibitor
available over the counter as low-dose Orlistat), and Meridia (an appetite suppressant). In
2009, global sales for each of these drugs were between $300 and $350 million. It is
estimated that an additional $300 to $600 million in sales were generated by generic
products such as phentermine, amphetamines, and sibutramine. 51 Due in part to the
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globally increasing problem of obesity and to recently published guidelines which
recommend adjunctive drug treatments to improve weight loss in patients with a BMI of
≥30, or a BMI of 27–29.9 (if medical co-morbidities are present), it is highly plausible
that the use of anti-obesity pharmaceutical treatments will continue to increase.52 It is also
likely that pharmaceutical companies will continue to work to develop more efficacious
weight loss drugs. However, one significant problem with anti-obesity drugs thus far has
been properly determining their risk-benefit ratio. Several drugs which were initially
approved for use have since been pulled from global markets due to significant lifethreatening side effects which seriously overshadow the prospect of patient benefit.53
The use of pharmacology to reduce weight began in earnest in the 1990s.54 The
mid-1990s saw doctors prescribing two drugs, either Redux or a combination of
fenfluramine and phentermine, commonly known as fen-phen. The medical community
was very optimistic following the approval of this drug combination in 1996 because it
seemed to produce significant weight loss. Reflective of the optimism that this drug
engendered, Time magazine reported in a cover story titled ―The New Miracle Drug?‖
that ―just three months after the introduction of Redux, doctors are writing 85,000
prescriptions a week.‖55 But the optimism was short-lived. In 1997 Redux was removed
from the market when the combination was found to cause severe and sometimes deadly
damage to the heart valves, pulmonary atrial hypertension, and primary pulmonary
hypertension. A 1997 New England Journal of Medicine study found that primary
pulmonary hypertension is suffered in 1 in 500,000 people normally, but occurred in 1 in
20,000 fen-phen users, indicating a greatly increased risk of suffering fen-phen-related
deaths.56 The lethal side effects of this anti-obesity drug combination led to one of the
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largest monetary settlements ever awarded.57 Currently, phenterimine (prescribed on its
own or in combination with other drugs) is still available, as this drug has been shown not
to have the same risks as its counterpart.58
Until recently there were only a few FDA-approved medications to promote
weight loss: phentermine, sibutramine, and Orlistat.59 However, in recent months the
FDA has approved two new drugs for weight loss, Belviq and Qsymia. 60 These new
offerings were approved in the summer of 2012 and will be discussed below. Of the
older-generation FDA-approved weight loss medications, all but Orlistat are considered
to be appetite suppressants. Orlistat‘s mechanism of action is to block the absorption of
approximately 30 percent of ingested fats.61 Phentermine, diethylpropion, and
phendimetrazine are approved for adult short-term use (up to twelve weeks). Orlistat is
approved for longer-term use (up to one year) and is approved not only for adults but for
children age twelve and older.62 These medications are considered to be moderately
effective in assisting (in combination with changes in diet and exercise) with weight loss.
Average users lose anywhere from five to twenty-two pounds over a one-year period.63
While these numbers may not be considered significant for someone with a hundred
pounds or more of excess weight, these medications have been shown to assist in modest
weight reduction. 64 The long-term health effects of using weight loss drugs have not yet
been determined. The longest study conducted was a four-year study on the drug Orlistat.
This study found that Orlistat was safe for usage up to one year. Other medications have
been studied for shorter durations of between six and twelve months. 65
Additional drugs have been shown to promote short-term weight loss in clinical
studies and are being prescribed off-label. These drugs include some commonly used to
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treat depression, seizures, and diabetes. Drugs such as bupropian (for depression),
topiramate or zonisamide (for seizure treatment), and metformin (for diabetes treatment)
have been prescribed for weight loss. Additionally, combinations of drugs are being
prescribed as adjunct treatment for weight loss. These drug combinations generally utilize
two drugs, such as a drug for depression combined with another drug, and are prescribed
off-label as well. 66
In response to continuing concerns around obesity, pharmaceutical companies are
continuing to work on new formulations and new drug combinations. Recently, several
drugs have been submitted to the FDA for approval. These include Onexa
(phenterimine/toperimate), Lorquess (locaserin hydrochloride), and Contrave
(Naltrexerone/bupopian). None of these newer-generation drugs received FDA approval
when it was sought during 2010.67 However, since their original FDA review, two of
those drugs have been approved.
Belviq was approved June 27, 2012, and Qysmia, formerly called Qnexa, was
approved just under a month later on July 17, 2012. These are the new first diet drugs to
be approved by the FDA in almost thirteen years. Both are intended to be used in
combination with a reduced-calorie diet and exercise regime for weight management. 68
Belviq (lorcaserin hydrochloride) is approved for use in adults with a BMI or 30
or greater (obese) with no co-morbidities, or in adults with a BMI of 27 or greater
(overweight) with at least one weight-related co-morbidity. Belviq works as an appetite
suppressant by activating the serotonin 2C receptor in the brain. The activation of this
receptor helps the person to feel full sooner after eating smaller amounts of food, leading
to weight loss. Prescribing appropriate dosage levels of Belviq is important. At dosage
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levels intended for weight loss, Belviq works as described above. 69 At higher dosages it
can turn on slightly different serotonin switches, the same as those responsible for the
effects of hallucinogens (such as LSD) and other addictive drugs which can be abused.
Higher doses of Belviq than intended for weight loss may trigger these switches, leading
to both addiction and effects similar to hallucinogenics. For this reason, Belviq is being
evaluated to determine whether it should be considered a controlled substance. If it is
deemed a controlled substance, it will only be available through certified pharmacies
when it does become available, which is expected to be later this year.70
The safety of this drug was evaluated in three randomized placebo controlled
trials.71 Combined, these trials included approximately eight thousand participants.
Participants were either overweight or obese and could have a diagnosis of type 2
diabetes or be diabetes-free. Participants were evaluated for 52 to 104 weeks. Compared
with placebo, treatment with Belviq for up to one year was found to produce an average
weight loss of 3 to 3.7 percent. For those without type 2 diabetes, 47 percent realized a
weight loss in the 5 percent range, as opposed to 23 percent who received placebo. In
participants with type 2 diabetes, 38 percent treated with Belviq saw a weight loss of 5
percent, while only 16 percent who received placebo saw similar weight loss totals.
Additionally, Belviq was found to produce positive changes in glycemic control in those
with type 2 diabetes.72 For practical purposes, an obese person weighing 275 pounds and
using Belviq for a year in combination with diet and exercise, using the high estimate of
5 percent weight reduction, would lose approximately 14 pounds during the year. After
one year they would weigh in at around 261 pounds. While any weight reduction might
reduce the potential damage of co-morbidities, this modest weight reduction seems
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unlikely to be able to ameliorate either the physical or social co-morbidities experienced
by those seeking to significantly reduce their weight and hence potential further lifethreatening damage to bodily systems. Moreover, it is recommended that Belviq be used
by patients for the rest of their lives. 73
It is recommended that Belviq be discontinued if after twelve weeks of treatment
patients fail to lose 5 percent of their body weight. Belviq is contraindicated for pregnant
women as it can cause harm to the fetus, and should not be used in combination with
certain other medications such as some that treat migraine headaches and depression. The
primary concerns with regard to this drug are that it may impair the user‘s attention or
memory. Additionally, other common side effects experienced by nondiabetic patients
included: headache, dizziness, fatigue, nausea, dry mouth, and constipation. In patients
with type 2 diabetes, common side effects were low blood sugar, headache, back pain,
cough, and fatigue. There is some further concern over the potential for other, possibly
more serious side effects. This includes the potential for heart valve damage, based on
past experience with fen-phen, the combination of fenfluramine and dexfenfluramine. As
previously stated, this drug was ultimately removed from the market. Belviq has a similar
mechanism of activation to fen-phen—both activate serotonin receptors, though in
different locations. Fen-phen, which acted on the serotonin 2B receptors (Belviq acts on
serotonin 2C receptors), was ultimately found to cause dangerous and life-threatening,
irreversible heart valve damage. Heart valve function has been evaluated in Belviq. It was
found that there was no statistically significant difference in the development of heart
valve abnormalities between Belviq and placebo.74 However, the FDA has cautioned that
Belviq should be used carefully in patients with congestive heart failure. Belviq clinical
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trials did not include patients with serious valvular heart disease, and so the manufacturer
of the medicine, Arena Phamacueticals in Sweden, will be required by the FDA to
conduct a series of post- market studies which include evaluation for negative long-term
cardiovascular outcomes and to assess the risk for major adverse cardiac events such as
heart attacks, stroke, or valve damage.75
Qysmia was first introduced to the FDA in 2010 as Qnexa but was initially
rejected due to concerns about serious potential side effects.76 The drug is a combination
of phentermine, which acts as an appetite suppressant, and topiramate, an anti-convulsant
also found to cause weight loss in obese patients and produces better control of blood
glucose and high blood pressure. Each of these drugs has been approved by the FDA for
other uses, and each has been on the market for quite some time. Phentermine was once
part of the drug known as fen-phen (see above). The combination found in Qysmia is not
thought to have the same devastating side effects, though as with any drug, side effects
do exist.77 These are discussed below.
Qsymia was found in clinical trials to assist those taking it in reducing their body
weight by about 10 percent, and the anorectic feature of this weight loss drug reportedly
works at the prescribed dosage for several weeks.78 The seemingly short duration of
effectiveness concerns some who fear that as the anorectic effect diminishes, patients
may seek or self-prescribe higher dosages of medication to get the same effect, thereby
potentially causing themselves unforeseen and potentially irreversible damage. In the
case of phentermine, its known side effects include spikes in heart rate and blood
pressure. Its mechanism of action appears to ramp up the metabolism with similar
physiological reactions to experiencing fear or excitement, potentially leading to heart
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palpitations in those who take this drug. The other active ingredient found in Topamax,
topiramate, reportedly causes a fairly high incidence of confusion, memory loss,
concentration problems, and psychomotor slowing, resulting (among other things) in
difficulty finding the correct words. Topiramate also carries warnings for depression and
mood problems, fatigue, and sleepiness. Suicidal ideation is listed as one of the more
concerning side effects of this portion of the weight loss drug cocktail. Generally, these
side effects aren‘t considered as serious as the potential for heart damage, but they are
significant in that they are experienced by a large percentage of those who take the
drug.79 It is reported that 42 percent of those taking topiramate reported one or more
cognitive or mental problems. Moreover, it has been found that babies born to mothers
who took topiramate have a higher incidence of cleft palate.80 The potential side effects
including the presence of memory loss (generally short-term) is irreversible and possibly
quite troubling to the individual taking the medication and those around him or her.
Since each of the drugs found in Qysmia has been on the market separately, the
rigorous testing which would be mandated for a novel drug is not needed for approval of
this drug combination. The FDA is considering requiring post-approval testing of this
new weight loss drug combination to ensure that heart damage is not found to be
disproportionately burdensome among those who are taking Qysmia. With an anticipated
weight loss of up to 10 percent of body weight, this drug may prove valuable to those
who use it, at least in the short-term. As there is no long-term data available on its use
and its ability to effect sustained weight loss. Additional weight loss drugs are set to be
considered by the FDA in the near future. In all likelihood these drugs, like any
technological intervention, will carry the potential for troubling, possibly irreversible side
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effects for those who use them. The question will of course be whether the risks and side
effects, both reversible and not, are worth the potential benefits of weight loss, for
whatever period of time it is sustained.
There has been significant anticipation among those who participated in the
various clinical trials of each of these newly approved drugs but who have not been able
to access them since the end of the trials. Additionally, physicians seeking effective nextgeneration drug interventions for their patients are eager to have new products upon
which to draw.81 According to the FDA, there appear to be sufficient data to warrant
approval of these medications to aid in the fight against obesity. However, both of these
drugs have potentially irreversible and concerning side effects, both require patients to
remain on them for the duration of their lives, and both have only short-term outcome
data to assess the long-term risk of harm or benefit to those taking the medication.
Moreover, the anticipated amount of weight loss appears to be modest for most. 82
What seems apparent, however, is that pharmaceutical companies will continue to
seek the magic pharmacological bullet for eliminating obesity which would provide
significant financial remuneration as well as assisting to eliminate a thorny and seemingly
increasing global problem. In addition to past and present risk-benefit concerns when
using pharmacological interventions, the development and use of effective nextgeneration pharmaceutical interventions may be hampered by misunderstanding and
misuse of the drugs that are developed. Some overweight individuals may employ
pharmacological interventions without the recommended interventions in diet/exercise
and lifestyle, thereby rendering the interventions less effective. Yet social attitudes may
also plague the realistic and nonmoralized acceptance of such pharmaceuticals. Some
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may view use of weight loss drugs as an inappropriate ―quick fix‖ for weight loss. Rather
than viewing weight loss drugs as part of an overall treatment plan, much as
antidepressants can enhance the effectiveness of psychotherapy and facilitate
development of different cognitive and behavioral patterns, the weight loss drugs may be
used by some and criticized by others as an easy solution to a complex, multi-factorial
condition. The societal conception of even effective weight loss drugs with a positive
risk-benefit profile as a ―quick fix‖ or an ―easy way out‖ may decrease the acceptability
of the drugs‘ usage among those who may indeed benefit from them.
A.iv Physician-Supervised Weight Loss Interventions
Safe and effective pharmaceutical intervention, as well as some features of
commercial and self-help weight loss programs, such as nutritional counseling, could be a
part of physician-supervised weight loss interventions. Currently, however, ―physician
supervised weight loss interventions‖ refers to primarily to behavioral counseling by
physicians, usually in primary care settings, along with monitoring of weight lost.83 The
U.S. Preventative Services Task Force has recommended that clinicians screen all adult
patients for obesity and offer intensive counseling and behavioral interventions (at least
two visits per month for the first three months) to promote sustained weight loss for
obese adults.84 Additionally, the American Medical Association (AMA) and the
American College of Physicians (ACP) have published guidelines for how clinicians
might best manage this task with their patients.85 These guidelines suggest that physicians
should engage the topic of weight with patients routinely in the normal course of
conducting an office visit. Patients who are at a healthy weight should be encouraged to
maintain the lifestyle supporting that weight. For those who are in danger of becoming
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overweight, concrete suggestions should be provided regarding dietary changes and
increases in exercise, which would reduce the risk of becoming overweight.
Conversations should also include information on the potential for developing weightrelated co-morbidities. For those currently overweight or obese, regular counseling on
dietary changes and modest increases in activity should be encouraged. Adjunctive
pharmacological therapies should also be considered for those who have been
unsuccessful with dietary changes and increased activity alone. 86 It is suggested that the
focus be on achieving modest weight loss goals. 87
The placement of such behavioral counseling interventions within the healthcare
setting explicitly acknowledges the potential importance of as yet unidentified medical
interventions to effect long-lasting weight changes which serve to improve overall patient
well-being. The focus in primary care physician (PCP)–provided intervention is on
behavior, specifically on assisting patients in making positive and sustainable behavioral
changes.88 Like most psychotherapeutic and especially cognitive behavioral counseling,
this approach is forward-looking and solution-focused, eschewing attributions of personal
blame for an individual‘s current overweight condition. A limitation of this individuallevel intervention is that it generally does not involve exploration or resolution of factors
outside of those which are primarily behavioral in nature. It fails to consider causal
contributions either at a broader social level or at the level of individual genetics and
physiology.
Tsai and Wadden synthesized several studies of PCP—provided weight loss
interventions and concluded that practitioners and researchers know little about the
efficacy of behavioral weight loss interventions that can be delivered in primary care
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practice. 89 All studies included in the review were randomized controlled trials which met
CONSORT criteria used to assess the overall quality of a study. One type of study
reviewed utilized behavioral counseling conducted either by the PCP directly or by
another provider (e.g., nutritionist or dietician) working in the PCP office. The amount of
weight lost by patients participating in the low- to-moderate-intensity behavioral
counseling efforts was not statistically significant—defined as ≥5 percent of initial
weight.90 The authors note that ―current evidence does not support the use of low-tomoderate-intensity physician counseling for obesity, by itself, to achieve clinically
meaningful weight loss.‖91 Two studies reviewed met criteria for being both randomized
controlled trials and providing behavioral counseling of higher intensity (at least twice a
month). Of these two studies, in only one did subjects achieve clinically significant
weight loss (7.7 kg). The other study which provided high-intensity behavioral
counseling produced an average weight loss of 4.3 kg, which is not considered clinically
significant weight loss.92 The authors conclude that research on the management of
obesity in primary care is simply not yet advanced enough to provide data that may
improve the provision of effective clinically significant weight loss services within this
venue. The authors further point out that ―without effective therapies, greater resources in
their practices, and more adequate reimbursement, PCPs alone cannot be expected to
provide effective weight management for all of their patients who require it.93
In the section below weight loss interventions which utilize a higher level of
physician technical skill along with the application of technology will be addressed.
These interventions are broadly termed weight loss surgical interventions or bariatric
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surgery. As the technology has evolved significantly since its initial use the review below
focuses on improvements in technique and outcomes since their use began.
B. History of Surgical Interventions for Weight Loss
Similar to the genesis of pharmacological interventions, the application of
medical knowledge and highly specialized medical skill has also been employed in the
development of surgical weight loss interventions. Surgery for weight loss began in the
1950s before the problem of obesity had reached its present proportions and become the
public health concern—some would say crisis—which it reportedly is today.94 The use of
laparoscopic surgical interventions has grown exponentially in the years since its
introduction. It is estimated that approximately 200,000 people undergo bariatric surgery
of some sort every year.95
Since the first WLS was performed, over fifty and possibly as many as one
hundred variations of the surgery have been done. 96 The surgical interventions currently
available fall into three broad categories.97 The first category includes purely restrictive
interventions, which reduce the capacity of the individual to ingest food by making the
stomach pouch smaller.98 A second category includes primarily malabsorptive
interventions. In this type of procedure, the individual‘s anatomy is altered so that the
body is no longer able to absorb all of the calories and nutrients which are provided by
the food ingested. In this way some nutrients are lost along with a portion of the calories,
thereby reducing the individual‘s overall absorption.99 The third surgical variation
incorporates both restrictive and malabsorptive properties.100
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B.i Early Surgical Interventions
The following subsections discuss the progression and evolution of early surgical
interventions for weight loss. The discussion will reveal improvements both in technique
and patient outcomes since those first surgeries. The discussion will begin with a review
of the earliest documented procedures.
B.i.a The 1950s—The first documented bariatric surgical procedures
By the early 1950s, years of clinical observation had shown physicians that a
shortened gut leads to weight loss. Physicians began to wonder whether short-gut might
be induced as a treatment for those who were morbidly obese. 101 The most noteworthy
clinical observations had come from surgeries dating as far back as 1884 on patients who
required surgery to repair gastric ulcers. For these patients, a portion of the
gastrointestinal system was bypassed or shortened to remove the diseased tissue. From
coincidental clinical observations of subsequent weight loss came early attempts to
harness this surgical side effect. The use of this clinical observation to develop surgical
options for the treatment of people with obesity turned a negative and unintended side
effect into a potential medical benefit for an unrelated population of patients.
The first effort at surgical weight loss intervention has been attributed to Victor
Henrikson of Sweden. He published his efforts in 1952 in the Journal of Nordisk
Medicine. His article was translated as ―Can Small Bowel Resection Be Defended as a
Treatment for Obesity?‖ in 1994.102 In this article Henrikson briefly and rather
unscientifically, by modern standards, describes a small bowel resection performed on a
―thirty-two-year-old woman suffering from obesity, constipation, something that slowed
her metabolism (without myxedema) and the inability to complete a weight loss program
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successfully.‖103 By his own admission, the surgery had a ―numerically bad result‖ in that
the patient did not lose weight from the surgery as hoped and in fact reportedly weighed
two kilograms more fourteen months postoperatively than she had preoperatively.
Henrikson further reported, however, that the patient was, ―subjectively speaking,
content, and feels healthy and energetic.‖ 104 This initial pioneering effort was the first
attempt at utilizing a bariatric procedure to induce weight loss and reduce co-morbidities.
In the United States, the first surgical intervention performed on a human was a
malabsorptive procedure which was only briefly mentioned in a veterinary publication
discussing the small intestines of dogs. In that 1954 article, a brief reference was made to
a patient who had received a jejunoileal bypass (JIB, a malabsorpitve procedure) for
weight loss. 105 In fact, the 1950s ended without any detailed published report of the first
American surgeries, their outcomes, or the specific procedures done. The lack of
publication on this surgical intervention is thought to ―reflect a lack of interest by
surgeons and others in this concept.‖106 No reason for this perceived lack of interest is
proposed. Perhaps these efforts were seen as having limited use, as the number of patients
for whom this intervention might be efficacious was minimal at the time. Perhaps the
lack of interest in surgical weight loss interventions was a product of a societal view that
overweight and obesity were primarily caused by personal moral failings or character
defect on the part of the patient, and therefore medical intervention in obesity would be as
foreign as employing Antibuse to treat alcoholism, which was also perceived at that time
as a problem of weak will and poor character. The seriousness of the surgical side effects,
along with the rudimentary knowledge base of best practices at this time, made the
widespread discussion and utilization of this option premature.107
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B.i.b The 1960s— Attempts to reduce side effects and standardize pouch size
The next decade saw continued evolution of the surgical interventions available.
Efforts undertaken during this time period were primarily focused on reducing the
deleterious side effects of the surgery, which often necessitated its reversal, and on
standardizing the size of the remaining stomach pouch. Both malabsorptive procedures
and restrictive procedures evolved during the 1960s. The primary operation at the
beginning of this decade was the continuation of the JIB surgery. During this decade,
numerous surgeons were involved in developing surgical variations on a theme in an
effort to reduce the debilitating side effects of this type of surgery. 108 Side effects were so
serious that they often necessitated reversal of the surgery, which also reversed any
weight loss the patients had seen.109 The goal of the surgical interventions developed
during this period was to achieve the obese individual‘s desired weight loss without
causing him or her to overshoot the weight loss target, which would then likely require an
additional surgery to restore more typical gastrointestinal functioning once the patient
had achieved ideal body weight. It was not uncommon in the early years for two surgeries
to be required. One surgery was to initiate the weight loss, and a subsequent surgery was
performed to halt the weight loss and restore more typical function once the nimiety of
weight had been lost. In 1969 surgeons Payne and DeWind reported that ―we and others
have tried to develop a technic [sic] which could be applied with safety and would avoid
the necessity of a second operation to restore intestinal continuity with consequent
serious weight gain.‖110
Another surgical option which evolved during the latter 1960s was both
malabsorptive and restrictive. This surgery, done by Mason and Ito at the University of

71

Iowa, involved reducing the size of the stomach pouch in addition to bypassing a portion
of the small intestine. The efforts of Mason and Ito are marked in weight loss surgical
history as the original gastric bypass procedure. The gastric bypass surgery decades later
―easily supplanted the jejunoleal bypass but was not free of problems.‖ 111 Complications
from this surgical variation included iron deficiency, anemia, dumping (rapid gastric
emptying), vitamin malabsorption leading to secondary medical problems, increased
potential for bowel obstruction that could potentially cause rupture if left untreated, and
loss of ability to visualize the bypassed parts of the stomach. 112 Variations on a surgical
theme focused on determining the correct size to which the stomach pouch should be
reduced. Stomach pouch alterations during this time were either too large or too small.
By the end of the decade, the first standard size (50 ml) was recommended. At the end of
the 1960s, the JIB surgery was still the most prominent option, but that trend would
eventually change. 113
The 1960s saw more extensive pools of patients receiving surgical weight loss
interventions. Patient outcomes were followed more closely, with various surgical
techniques and the individual case outcomes being compared against each other in an
effort to discern more scientifically best patient outcomes, reduce risk, and maximize
patient benefit. 114
In applying the bioethics and medical calculus of benefits versus burden, the
benefits did not seem to outweigh the burdens for patients at this time because the side
effects of the surgery made typical gastrointestinal functioning almost impossible for the
patient post-surgery.115 Additionally, since the complications were potentially life-
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threatening, the intervention often had to be reversed, and any gain seen was eventually
lost as patients regained their formerly obese status.
B.ii Surgical Interventions for Weight Loss Refined
Following on the footsteps of the earliest weight loss surgeries which often
produced unfavorable results and side effects for patients those earliest interventions
began to be improved. Increased skill in technique as well as changes in the tools used to
conduct the surgery began to produce superior outcomes. The following subsections
explore various areas of improvement in technique, reductions in side effects, and overall
patient outcomes.
B.ii.a The 1970s—New procedures developed
The volume and speed of development of surgical treatments for weight loss
increased during 1970s. The efforts of this decade included the development of a new
malabsorptive procedure called the biliopancreatic diversion (BPD) and work done on
various ways to partition the stomach to maximize patient outcomes. 116 Additionally,
refinements to established malabsorptive and restrictive surgeries continued, the
procedural forerunners of what would become gastric banding took place, and modern
malabsorptive procedures were developed.117 Specifically, additional work was done to
improve technique in the JIB surgery in an effort to reduce complications. Ultimately
however, during this decade, the JIB surgery was supplanted by a different malabsorptive
surgery—the biliopancreatic diversion. The primary work done on this surgery was
performed by Dr. Scopinaro.118 One of the goals of this new surgical technique was to
induce a state of malabsorption without the potentially dire side effect seen in the JIB of
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bacterial overgrowth which led to serious, sometimes life-threatening liver damage. In
this surgery,
―bile and pancreatic fluids released into the duodenum to digest food and break
down fats, carbohydrates and proteins are diverted away from ingested food—
hence the name biliopancreatic diversion. The digestive enzymes eventually join
the ingested food—but at a point in the distal small intestine where there is much
less chance for complete breakdown and absorption.‖ 119
BPD requires the physical removal of a large portion of the stomach, up to 70 percent.
The side effects of this surgical procedure also had many unappealing and life-limiting
side effects which made the surgery an unattractive option to patients who suffered from
undigested fats which cause gas and loose, foul-smelling bowel movements.120
During this decade, work by Alden and Griffen altered how the stomach was
partitioned. These efforts built on the earlier work of Mason from the previous decade. 121
The modifications to this malabsorptive/restrictive surgery, called the Roux-en-Y
gastrointestinal bypass, allowed patients to achieve the same levels of weight loss as the
JIB surgery with fewer and less serious complications. The modifications were reported
to have changed the face of bariatric surgery and for the next two decades established
gastric bypass as the dominant operation in this field. 122 Mason turned his work towards
restrictive operations during the 1970s. His work during this time was on a purely
restrictive operation called gastroplasty, which partitioned the stomach using the newly
introduced mechanical staplers. These operations were designed to avoid the
complications of the JIB, but this purely restrictive bypass did not seem to result in
sustained or satisfactory long-term weight loss.123
During the same period, the procedural forerunners of what would become gastric
banding took place. Wilkinson placed the first nonadjustable mesh band around a portion

74

of the stomach to separate the upper portion of the stomach from the lower portion. While
this surgery was not successful in the long run, as the upper pouch eventually stretched
and permitted patients to ingest larger quantities of food, variations on this theme would
advance and become prominent several decades later.124
Other innovations in the 1970s attempted to alter the lateral hypothalamus to
cause weight reduction. Efforts by Quaade et al. in 1974 were described as ―stereotaxic
stimulation and electocoagulation of sites in the lateral hypothalamus.‖125 These efforts
produced transient results, but the weight lost was significant in the short-term. Literature
on the use of jaw wiring as an intervention for weight loss, although not specifically
surgical, began to be seen during this decade as well. 126
B.ii.b The 1980s—Gastric bypass surgery: variations on a theme
The scientific advancement of 1980s occurred in three primary areas: the
evolution of several forms of gastric bypass surgeries, including multiple variations of the
Roux-en-Y gastric bypass first performed in the previous decade; progress in verticalbanded gastroplasty; and the development of the precursors to what would become
gastric banding.127 Variations in gastric bypass techniques included such things as
dividing and stapling the stomach vertically instead of horizontally, adding a band to
reinforce the outlet, the introduction of a long-limb variation designed to produce better
results in treatment for the ―super obese,‖ and the addition of a silastic ring as part of the
procedure, among other improvements. The Roux-en-Y surgery is still considered by
many to be the ―gold standard‖ of surgical interventions for weight loss. 128
During this time period, numerous surgical variations were undertaken on vertical
banded gastroplasty. Gastroplasty is a restrictive procedure in which the stomach is
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modified by dividing it in order to reduce its size and capacity without bypassing portions
of the intestine. Some variations which were also being seen in partitioning the stomach
as part of the Roux-en-Y surgical techniques described above were also being undertaken
in gastroplasty. These included partitioning the stomach vertically with the use of
surgical staples, or using both staples and surgical sutures, or in some instances
introducing polypropylene mesh or a silastic ring at the site of the partition.129
Pitombo et al. note that ―clinical progress with gastric banding, a purely restrictive
procedure, in the 1980s was rather dormant; however, the basic interventions necessary
for the popularity of gastric banding were introduced during this decade.‖ 130 The
technical innovations which were introduced into gastric banding would eventually
increase the popularity of this weight loss intervention. The first adjustable gastric bands
were used on patients during this decade. Kuzmak devised a gastric band which was lined
with an inflatable balloon in 1986. The balloon essentially allowed for the adjustment of
the band to either tighten it to increase weight loss or loosen it to reduce weight loss.131
These bands were placed during open surgical procedures.
B.iii Introduction of Laparoscopy
A series of discoveries led to the eventual adoption of laparoscopic techniques for
surgery. These techniques used in many different types of surgeries began to be used in
bariatric surgeries as well. The evolution of weight loss surgeries utilizing laparoscopic
techniques is discussed below.
B.iii.a The 1990s—A Less invasive technique
Surgical innovations during the 1990s included the introduction of laparoscopy, a
modification to the biliopancreatic diversion called the duodenal switch (found primarily
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in the United States), and the first attempts at electrical pacing of the stomach to induce
weight loss. The introduction of laparoscopic procedures has been enduring and lauded as
an advancement which has improved patient outcomes and reduced patient risk.132
Historical precursors to laparoscopic surgery can be traced to Philip Bozzini as far
back as 1805. He was the first to attempt to use candles and reflecting mirrors to direct
light into internal body cavities for better visualization. Decades later, Maximilian Nitze
and Josef Leiter introduced the first rigid endoscope, introduced in 1879, the same year
Thomas Edison invented the light bulb. The first rigid endoscope contained a built-in
light, but it was not until the 1990s that the technology had advanced sufficiently for
practical application in this venue.133
Laparoscopic procedures, whose first reported use in weight loss surgical
interventions was published in 1994, utilized several small openings in the patient‘s
abdomen through which a camera would guide the movements of the surgeon performing
the procedure without requiring the surgeon‘s hands to physically enter the patient‘s
body.134 The standard until that time had been open surgery during which a large incision
was made vertically along the patient‘s abdomen through which the surgery would be
performed. Laparoscopy permitted specially trained surgeons to use less-invasive surgical
techniques that reduced patients‘ recovery time and reduced the complications associated
with open surgery.135 Gastric bypass procedures using the laparoscopic technique began
to be widespread during this decade. While it was not and is still not possible to perform
all WLS via laparoscopy, this significant advance has served to reduce patient risk and
shorten patient recovery times.136
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The introduction of laparoscopic surgery also facilitated the popularity of
adjustable gastric banding. Adjustable gastric banding, considered less invasive and more
easily reversed than other surgical interventions, had been hampered by the need to place
the band during an open surgical procedure. The introduction of laparoscopy reduced the
reliance on that invasive technique and permitted more patients to have easier access to
the placement of adjustable gastric bands for weight loss. 137
Continued evolution in malabsorptive surgeries, which had begun late in the
previous decade, continued in the 1990s.138 Specifically, Hess and Marceau worked to
introduce the duodenal switch (DS) in the United States. This surgical innovation was
designed to be an improvement on the earlier BPDs which were prominent in the 1970s
and 1980s. The primary difference between the BPD and the DS is the shape of the
stomach that remains. In the BPD the stomach is cut horizontally, while in the DS the
stomach is cut vertically. This change was introduced because the duodenum has better
resistance to acid, and therefore the incidence of ulcers was thought to be decreased as a
side effect from this new modification.139
There remain sustained efforts to improve techniques and outcomes for patients.
Additionally, there remain areas of debate and contention regarding WLS. These are
addressed here.
B.iv Current Efforts and Current Debates
Nearly sixty years following the introduction of surgical interventions for weight
loss, most surgeries are performed laparoscopically, and the surgical options are more
varied than ever.140 Malabsorptive, restrictive, and combination malabsorptive/restrictive
surgeries continue to be performed. The most common procedures include gastric bypass,
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adjustable gastric band, and biliopancreatic diversion with duodenal switch. Most of
these procedures are performed laparascopically using minimally invasive techniques. 141
While some of the original procedures have fallen by the wayside, several others
(e.g., adjustable gastric banding), considered less invasive and more reversible, have
grown in use.142 Early surgical weight loss procedures did indeed have side effects that
may have seriously overshadowed the potential benefits to the patient, but current
surgical interventions have been refined such that surgical risk is now largely predictable
and manageable.143
In addition to the acknowledged risks of any type of surgery, such as
complications which develop from general anesthesiology or exposure to hospitalacquired infections, there are complications and risks specific to bariatric surgical
procedures. These complications can be divided into three general categories:
postoperative complications generally related to the surgery itself, short-term
complications (occurring within the first year following surgery), and long-term
complications (including surgical, metabolic, and nutritional concerns).
Immediate postoperative risks can include increased susceptibility to infection at
the surgical site or intra-abdominal infection, as well as leaks, venous thrombosis, and
bowel obstruction causing acute gastric distention. Additionally, the development of
gallstones and the persistent presence of nausea and vomiting can also be observed
immediately following surgery for weight loss. Longer term complications can include
those listed above as well as nutritional and metabolic concerns caused by malabsorption
of key nutrients.144 A study conducted by Abell and Minocha examined the most often
seen complications from obesity surgery. They identified the ten most commonly
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reported complications found in restrictive procedures or procedures combining
restrictive and malabsorptive features. In general, the more complex the surgical
procedure, the greater likelihood that complications will manifest. The most commonly
seen complications, irrespective of the type of procedure performed, are, in descending
order of prevalence: dumping (rapid emptying of gut contents into the small bowel,
which can cause nausea, cramps, and vasomotor symptoms), vitamin/mineral
deficiencies, vomiting/nausea, staple-line failure, infection, stenosis/bowel obstruction,
ulceration, bleeding, splenic injury, and death.145 Additionally, the authors reported that
there may be other issues related to rapid weight loss, including bacterial overgrowth and
diarrhea. Abell and Minocha note that ―since the complications of bariatric surgery are
treatable once proper diagnosis is made, all physicians seeing post-bariatric surgery
patients need to be aware of potential complications so that diagnosis and therapy can be
promptly made.‖146
Mortality is a concern of all surgical procedures, including bariatric surgery. In a
review of 110,000 bariatric surgeries performed by 495 bariatric surgeons associated with
American Society of Metabolic and Bariatric Surgery (ASMBS) Centers for Surgical
Excellence, it was reported that the postoperative in-hospital mortality rate was
approximately 0.14 percent immediately following surgery. The postoperative mortality
rate reported at thirty days was 0.29 percent, and at ninety days was 0.35 percent.147 Data
gathered from a variety of other studies reporting on hospital mortality and postoperative
mortality rates at thirty and ninety days post–WLS show similar results.148 In yet another
study conducted by the agency for Health Care Research and Quality, it was reported that
the death rate from bariatric surgery is 0.5 percent.149 The mortality risk immediately
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following WLS is approximately equal to that of patients undergoing gallbladder
surgery.150 This statistically small risk has been shown to be offset by a gain in lifespan
of one to six years depending on the patient‘s age at time of surgery. Younger patients
experienced a higher gain in lifespan. 151
The current risk-benefit analysis appears to be favorable for those choosing
bariatric surgery. Research has been conducted on outcome measures which have
established the positive impact of WLS on co-morbid, obesity-related diseases such as
type 2 diabetes, heart disease, and sleep apnea. In two separate studies on the potential of
gastric bypass surgery to resolve type 2 diabetes, it was found that this particular type of
intervention resolved diabetes in approximately 80-90 percent of patients.152 Gastric
banding surgery was found to resolve type 2 diabetes in approximately 73 percent of
patients.153 Another major health risk for those who are obese is coronary artery disease.
The risk of developing obesity-related coronary artery disease was cut by 50 percent in
those who underwent gastric bypass surgery.154 Additionally, sleep apnea was resolved in
more than 85 percent of gastric bypass patients.155
In a prospective study that followed patients who received surgical intervention
for weight loss, 119 subjects were studied between January and December of 2005. The
study noted that there was a large reduction medication usage in subjects across comorbid conditions. Diabetes medication usage was reduced by 72 percent, and depression
medication use was reduced by 50 percent at one year post-surgery. The authors estimate
that the cost of the surgery can be recouped in approximately seven years based solely on
the cost savings from reduced medications.156
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A well-known study, the Swedish Obese Subjects Study, followed patients at
various intervals post-surgery. The research matched bariatric surgery and conventionally
treated patients. The study was designed to examine the amelioration of metabolic and
cardiovascular risk at various time intervals post-intervention. The authors concluded that
compared with conventional therapy, bariatric surgery appears to be a viable option for
the treatment of severe obesity. It results in long-term weight loss, recovery from
diabetes, improved lifestyle, and the amelioration of risk factors which had been elevated
at the point of surgical intervention.157
Patients undergoing these interventions were also found to improve life
expectancy by 89 percent and to reduce the risk of premature death by 30-40 percent.158
Co-morbid death risks from diabetes, cancer, and coronary artery disease were reduced
by 92 percent, 60 percent, and 56 percent respectively. 159 Surgical interventions have thus
established themselves as ―the first effective therapy for the disease of morbid
obesity.‖160 Weight loss surgical interventions are intended to be used as a tool in the
arsenal used to fight severe obesity. In addition to surgical intervention, those undergoing
WLS are reminded that, similar to other types of weight loss technologies, ongoing diet
and exercise changes must be incorporated in order to sustain long-lasting results.161
In spite of the reported low long-term success rates of self-help, pharmaceutical,
and commercial interventions, the more successful option of WLS continues to be a
contentious and confounding intervention. The debate continues to rage over whether
WLS should be widely promoted as a solution for individuals struggling with obesity and
its potentially life-threatening co-morbidities. 162 Weight loss surgery is sometimes
criticized for focusing at the individual level, rather than on the social and environmental
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causes of obesity associated with viewing obesity as a public health problem. Weight loss
surgery, like pharmacological interventions, is also criticized for being a ―quick fix‖ for
what is viewed as either a complex, multi-factorial health problem or a failure of
willpower and character. But in fact, surgical interventions seem to recognize obesity as a
complex health problem involving genetic and other physiological factors as they interact
with the current social and physical environment. The utilization of WLS as a treatment
and as a potential cure for secondary life-threatening co-morbidities effectively treats
obesity as a medical condition for which moralizing, dependence on a higher power, or
application of purely behavior modification programs have been shown to be ineffective
and inefficient.163
One debate has centered on the appropriateness of utilizing a physically invasive
technique such as surgery to treat obesity. This stance assumes that other technologies are
significantly less invasive simply because they are not physical in nature. The following
section articulates this debate and argues that it misunderstands various forms of
invasiveness and their potential for irreversibly altering lives.
B.v The Exceptionalism Debate
The term ―exceptionalism‖ was first used in an article published in 1991 on
human immunodeficiency virus (HIV) testing and results.164 Since its entrance into our
healthcare vernacular, the concept has been applied as a critique of treating a medical
condition or particular healthcare information as being so unique or special, so different
from the norm, that the application of more stringent ethical and legal standards and
safeguards is warranted.165 By elevating the level of suspicion with which particular
interventions or information is regarded, it then follows that the development and
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application of additional safeguards, designed to protect the patient, would be prudent.
Thus, exceptionalism can be used to justify a person‘s or group‘s choosing to not
recommend or even consider a common idea or activity that has widespread
acceptance. 166 In other words, exceptionalism can be used in attempts to justify
paternalism.
In the case of HIV testing, exceptionalism has meant that the information gleaned
is thought to be qualitatively distinct from other medical data, such as height or blood
type, and therefore requires additional safeguards in order to protect the individual from
harm that might occur due to the misuse of such sensitive and potentially easily
misconstrued information. 167 Specific harm such as discrimination in insurance coverage
and employment opportunities, as well as potentially rash behaviors on the part of the
patient such as attempting to harm himself in light of the information, have been cited as
reasons to treat such information as being exceptional and therefore subject to additional
levels of ethical consideration and regulatory safeguards.168 In the case of HIV test
results, genetic information, and neuro-imaging, claims for such exceptional treatment
have largely been rejected, save for a few legal safeguards. 169 Critical analyses of the
factors once thought to justify exceptionalist treatment of such information have
determined these factors to be insufficient reasons for exceptionalism. Some of these
reasons are centered on the disease itself or the characteristics of the people diagnosed.
Exceptionalism has been deemed inappropriate.
Exceptionalism has also been applied to surgery. 170 Surgical exceptionalism
means that this surgical intervention is thought to be essentially different from other
interventions and thus warrants enhanced safeguards and limitations—or particularly
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strict criteria—for its use. Those who engage in surgical exceptionalism see surgery as
radical, invasive, irreversible, immediately life-threatening, and fraught with the potential
for adverse effects in a way and to a degree not true of other interventions. For those who
would adopt an exceptionalist position, surgery is a last-resort intervention to be avoided
whenever possible.
The exceptionalism applied to surgery is based in part on a narrow and strongly
held physicalist view of the risks and other characteristics associated with a spectrum of
medical interventions. Surgery is indeed a physical somatic intervention. It generally
requires damaging the body by cutting into it in some fashion. In the case of surgery, the
body experiences not only the sought-after transformation but also collateral damage. It is
necessary to do harm in order to achieve a desired intermediate outcome—e.g., removal
of a tumor or the restructuring of a valve─which is thought to (re)establish superior
physiological outcomes or functioning with the ultimate goal of the patient‘s improved
health and functioning. Surgical exceptionalists‘ preoccupation with the physical—
physical bodily invasion, physical collateral damage, physical repair, which are
admittedly required to restore the patient‘s functioning through surgical means—may
nevertheless disguise them from nonphysical but otherwise similar aspects of nonsurgical
interventions. 171
A purely physicalist understanding of alteration and change grounds the view that
surgery is irreversible and deflects attention from the ways in which, for example,
psychotherapy can irreversibly alter a patient‘s self-concept, worldview, responses to
others, or values and priorities. Psychotherapy ―may utilize insight, persuasion,
suggestion, reassurance, and instruction so that patients may see themselves and their
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problems more realistically and have the desire to cope effectively with them.‖ 172
Through the process of psychotherapy, the emotional defenses of the person receiving
treatment are often stripped away, laying bare much of the individual‘s capability to
protect herself psychologically. This therapeutic technology relies on an invasive
technique as surely as surgical weight loss. One key difference is the degree to which the
invasion is readily observable. During a surgical procedure such as WLS, the wounds
brought to bear on the body from the laser or the scalpel when the instrument cuts into
the patient are readily observable. There is blood loss, and upon completion of the
intervention, wounds are sealed by stitches, surgical glue, or other means. In contrast to
the invasiveness of psychotherapy or the effects of hormonal pharmacological
interventions, surgery is an invasion which is physically apparent. In the case of
psychotherapy the invasion may be equally life-changing and invasive, but it is easier to
perceive this intervention as noninvasive or less invasive because there may well be no
physical remnants of the intervention. There are likely no discernible physical scars, no
observable bandages, and no residual traces of the invasion and its aftermath.
Psychotherapeutic interventions, like surgical ones, are not readily reversible,
however. In fact, much of the basis of psychotherapy has the purpose of effecting lasting
or irreversible personal change which fundamentally alters the way in which the patient
might view, approach or respond to the world or situations in the world.173 Collateral
damage may be experienced as the changes in the individual further cause lasting
changes in intimate relationships and friendships. In many instances, psychotherapy has
been known to facilitate ending relationships that, while perhaps comfortable, are no
longer productive or that might in fact be damaging. The changes can indeed be life-
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altering and the aftermath may be irreversible. Accessing psychotherapy does not require
more stringent criteria for its use. In fact, as long as one can afford such an intervention
either through insurance or private pay, and assuming the availability of a therapist, there
are no restrictions applied to accessing psychotherapeutic interventions.
Claims that surgery is exceptional and warrants special safeguards or a higher bar
to warrant its use must be predicated on comparison to other relevant interventions.174 In
the case of obesity, technologies relevantly comparable to WLS include diet and exercise,
pharmacology, commercial weight loss programs, and behavioral interventions. Weight
loss surgery and the obese seeking it must be sufficiently different from other weight loss
interventions or other patients seeking surgical remedies for their conditions as to warrant
a more robust application of ethical analysis or stricter criteria for its use. 175 In order for
this surgery to warrant a more suspect and cautionary approach, and for stricter criteria to
be applied to obese patients seeking WLS than to other patients seeking surgical
solutions, the argument goes; WLS and obese patients must be of a different order than
other interventions and other patients. But such claims of difference are mistaken, though
their origin may be understandable. The obviousness and physical nature of the collateral
damage resulting from surgical intervention—e.g., damaged tissue, loss of functioning
organ tissue, perhaps iatrogenic infection—eclipse recognition of the ways in which other
weight loss interventions also are invasive, risky, irreversible, and may involve collateral
damage or adverse consequences when they are ineffective, even when they do provide
sustained weight loss.
For instance, the application of diet and exercise, either by an individual or
through a more guided experience such as commercial weight loss programs whose goal
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is to ameliorate obesity, will require a long-term alteration of the obese person‘s
resources, both financial and time. 176 Perhaps time formerly spent at work earning money
will need to be curtailed in order to apply the necessary level of intensity to the activities
of exercise or food preparation required to lose weight. The financial effect may not be
insignificant in the overall picture. Choosing healthier foods or paying for a gym
membership will likely add an additional financial burden to the obese person and his
family.177 The obese person will need to come to see himself differently as well. Family
activities that focus on meals or food will need to be changed in some manner to
accommodate the new focus on diet and exercise. Once the obese person loses weight
through these various technologies, he may have different expectations of his life and his
partnerships. What had formerly been acceptable may no longer be for the person who
has lost one hundred pounds. Familial relationships might be put to the test or altered in
irreversible, not always better ways. As new patterns are established, old patterns that
involve others will out of necessity change. 178 These irreversible changes may or may not
be acceptable in those relationships. These relationships may be improved or damaged in
response to those changes. Indeed, there may be a cascade effect seen in applying
something as seemingly uncontroversial as changes in diet and exercise.
This is true of other technologies for weight loss as well. Pharmacological
interventions, as seen in the past, have had the irreversible effect of damaging the body in
a manner so significant and so unanticipated as to jeopardize the life of the patient who
uses this type of intervention. Additionally, pharmacological interventions are meant to
be combined with diet and lifestyle changes and so would be subject to many of the other
ramifications discussed above. For those seeking weight loss by employing one of the
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self-help groups such as OA, accepting a higher power and admitting their relative
powerlessness involves an irreversible alteration in their worldview and self-concept.
Although this is not a physical change, the potential ramifications should be noted. For
each of the technologies that might be applied for weight loss, there will likely be
irreversible changes, sometimes drastic and long-lasting, which will be both necessary
and potentially deleterious to the individual physically and emotionally. 179 Since these
changes, though irreversible and life-altering, are often not readily perceived, the obese
person seeking to lose weight is generally not subject to stricter criteria for accessing
these technologies.
Patients seeking WLS are not relevantly different from others seeking surgical
intervention to solve a medical condition or disease. Candidates for WLS in the majority
of cases cite concern over health as their primary motivation. 180 In each case, the surgical
candidate must meet some set of clinical criteria for the surgery. The question asked is,
will the surgical intervention have an acceptable probability of resolving the medical
problem relative to other possible interventions?181 As part of this analysis, the surgical
candidate, regardless of the type of surgery sought, is evaluated for physical
appropriateness for the intervention. Activities to assess the strength of the cardiac
system, lack of active infection, and other possible contraindications are considered.
Additionally, some evaluation of the patient‘s ability to follow up with appropriate postsurgical changes will likely be considered by the medical team. Whenever surgery is
considered an option, the medical evaluation should be based on appropriate medical
criteria and done in keeping with standards of care.182
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The recognition that each technology for weight loss intervention carries with it
potentially irreversible and life-altering ramifications, and the fact that the obese patient
is not relevantly different from other patients seeking surgical intervention, should be
especially troubling with regard to adopting an exceptionalist position. This knowledge is
especially relevant in light of the fact that WLS has been shown to produce superior
results in comparison to other types of weight loss technologies. 183 Since each of the
possible technologies that could be applied carry with them irreversible and life-altering
consequences which might not always be positive or desirable, and given the fact that the
greatest chance for long-term weight loss is with surgical intervention, the surgical
exceptionalist demand for a higher bar before considering the use of surgery must be
questioned. Earlier in this chapter, the success measurements of WLS relative to other
interventions were discussed in detail. Weight loss surgery produces sustained weight
loss for longer periods of time, along with superior amelioration of disease and
psychosocial co-morbidities than other interventions. 184
Surgical exceptionalist reservations regarding WLS may decrease the likelihood
that clinicians will discuss WLS with patients. Together with other value-laden social
attitudes associated with responsibility for obesity and its treatment, the surgical
exceptionalist view of WLS may lead clinicians to withhold information about it.185 They
may do so in the mistaken belief that they are preventing patients from choosing an
unnecessarily risky, radical, irreversible intervention. This paternalistic approach is not
only unwarranted because it is not clear that avoiding WLS is in the best interests of
obese patients, but it is also perhaps motivated by value-laden perspectives on both WLS
and obesity. These issues are explored further in chapter three.
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The efficacy of surgical weight loss interventions has been established.186 The
interventions ameliorate obesity along with its health and quality of life co-morbidities.
However, there appears to be ongoing and significant societal ambivalence in accepting
this medically beneficial intervention with manageable risks. The following chapter will
outline and discuss various social, cultural, and theological constructs influencing societal
ambivalence toward both weight and obesity interventions.
C. Conclusion
This chapter explored the numerous technologies and their associated normative
frameworks which have been employed to treat obesity. Each of these technologies has
met with varying degrees of success. Where possible, the chapter addressed available
research data on the overall success of each program or intervention both in assisting
obese people to lose weight and ameliorating physical and quality of life co-morbidities.
Among organized self-help initiatives and commercial programs, it was found that
Weight Watchers, Inc. provided participants with superior weight loss results which may
assist in diminishing co-morbidities associated with excess weight. Overall, self-help
initiatives and commercial weight loss companies have a normative framework of selfreliance, with some additional guidance offered to assist in overcoming a problem with
myriad contributory factors. Often these programs choose to diminish one or several of
the identified factors which are beyond an individual‘s direct control but which have been
associated with the development or maintenance of obesity. In general, rigorous
assessment of the efficacy of self-help initiatives and commercial weight loss programs is
difficult because of particular features of these programs such as participant anonymity or
a paucity of research. Largely disappointing or failed efforts at pharmacological
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interventions were reviewed as well. Pharmacological interventions for obesity have
traditionally suffered from either poor overall results or from an imbalanced risk-benefit
ratio for patients prescribed these medications. The result of this imbalanced equation has
been serious and irreversible patient outcomes which have necessitated the removal of
some weight loss drugs from the market. Two new medications have been introduced,
Belviq and Qysmia, which are thought to hold promise to overcome the serious concerns
found earlier-generation weight loss drugs. However, as two of these drugs were
introduced just recently, their long-term efficacy is at present unknown. The use and
development of pharmacological treatments have advanced the normative framework to
include an understanding that obesity may require a more robust intervention than diet
and exercise alone can produce. Indeed, obesity may be amenable to medical
technologies. Finally, this chapter reviewed the development of various surgical
interventions for weight loss which have developed over the course of the past halfcentury. Data were provided from various research studies that indicate that surgery for
weight loss thus far provides the best long-term outcomes when combined with
subsequent lifestyle changes, and that the risks of surgery have been greatly diminished
to the point of being considered manageable and similar to those experienced by patients
when the gallbladder is removed. In spite of the efficacy of WLS and its manageable
risks, exceptionalism has been and continues to be erroneously applied to this
intervention. The application of exceptionalism to WLS is inappropriate and should be
avoided in the same way that charges of exceptionalism to genetic information or HIV
status were ultimately determined to be unfounded. Continued exceptionalism applied to
WLS likely has the effect of the intervention being viewed as too radical, and hence real
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discussion of this intervention at a clinical level between patients and physicians may be
thwarted. Chapter three will take up the ethical principles and social constructs which
inform an understanding of obesity and WLS.
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Chapter Three: Social Constructs and Theological Concepts Applied to Obesity
As shown in Chapter Two, there are many unsettled issues and diverse opinions
surrounding the etiology and treatment of obesity; however, there is near uniformity of
social opinion regarding the negative valence with which obesity and obese individuals
are regarded.1 To explain the development and implications of this negative consensus, it
is useful to employ feminist epistemological concepts and approaches to understand how
obesity has been framed. This is important because how a problem is conceptually
framed constrains the range of solutions that are recognized as viable.
This chapter will argue, with reference to key feminist epistemological concepts,
that how obesity is framed—the currently dominant understandings of those who are
obese—is flawed and inadequate. Dominant understandings of obesity neglect or
explicitly discount important perspectives which must be considered in order to provide a
more complete picture of the problem and its potential solutions. This chapter will argue
that secular and theological social norms inhibit development of a more nuanced and
complete understanding of obesity, as well as a wider acceptance and promotion of
weight loss surgery (WLS). By examining the social construction of obesity, through the
corrective lens of feminist epistemology, it is possible to identify current flaws in the
construction of the obese identity, injustice in the treatment of obese people, and
implications for the embrace of weight loss solutions.
Section A will explore the concepts, goals, and approaches of feminist
epistemology. It will be argued that feminist epistemology‘s focus on social context and
power relationships affords a more accurate formulation of the problem of obesity and its
potential solutions than is currently employed. Feminist epistemology and its methods as
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discussed in this first section will be applied throughout this chapter to illuminate errors
in the construction of obesity and articulate the values that inform them. Section B will
examine gendered notions of appropriate bodies. To illustrate the way such norms
thoroughly infiltrate and inform social attitudes, this section will examine normative
constructions of bodies by the popular media and religious concepts. Section C will
integrate previous feminist conceptual analysis with concerns about the stigmatization of
obesity. This section will employ feminist attention to particularity and narrative to
present concrete examples of the material implications for obese individuals of these
phenomena grounded in the socially constructed norms of the body. The final section
elucidates different senses of responsibility and argues that confusing causal with moral
responsibility, as well as failing to distinguish appropriately between different goals of
assigning responsibility, has led to inappropriately moralized views of obesity. These
confusions, in turn, lead to ambivalent social attitudes towards WLS and failure to
embrace it as the most effective clinical intervention currently available. The following
section discusses the ways in which feminist epistemology can be used to correct the
present construction of obesity.
A. Applying Feminist Epistemology to Analyze the Social Construction of Obesity
It is a fundamental tenet of feminist epistemology and ethics that standpoint
matters.2 Where one stands in relation to an issue—one‘s normative commitments, the
values that inform one‘s point of view—matter as much for conceptualizing social issues
as where one literally stands at the back or front of an animal one is asked to describe.
―The insights of feminist standpoint theory,‖ writes feminist bioethicist Mary Mahowald,
―provide a corrective to the nearsightedness, unselfconsciousness, and arrogance that
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arise in health care and in bioethics, as in other areas of life and work.‖ 3 Mahowald
explains that although she ―focuses on sexism, similar arguments apply to racism and
classism‖, and there is obvious overlap in application. ―The common element is that the
differences between groups are the grounds by which one group obtains and maintains
advantages or power over another.‖4 This section focuses on the difference between those
with normal or socially appropriate bodies and those who are obese.
The first subsection utilizes feminist standpoint theory to explicate how attending
to the perspective of actual obese individuals can begin to correct the dominant
understanding of obesity. The second subsection uses the work of Iris Young to explain
how, at a conceptual level, dominant understandings are socially constructed. The third
subsection employs Young‘s theory to analyze power relationships between dominant
and marginalized groups. The fourth subsection explores the ethical and epistemological
significance of the intersection of multiple marginalizations to describe the material
implications of intersectionality for obese individuals. The fifth subsection integrates
standpoint theory with narrative approaches drawn from sociology and ethics.
A.i Standpoint, Partiality, and Privilege in Constructing a View of Obesity
‗Standpoint‘ is a term used to define any ―perspectival view of the world.‖ 5
According to Mahowald, ―feminist standpoint theory is based not only on the notion that
human knowledge derives from situated perspectives, but also on the realization that
some perspectives are privileged in comparison with others.‖6 In other words, knowledge
is situated and partial. What and how something is seen reflects the viewer‘s situation and
is both partial qua incomplete and partial qua serving the particular interests of the
viewer. Some standpoints are privileged. ‗Privilege‘ is understood in two senses. First
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and most obvious is the privilege of power. ―Because the dominant group generally
defines and evaluates the world according to its own limited perspective, the only
possibility for expanding and correcting that view is through the standpoints of those who
are dominated.‖7 Thus, feminist standpoint theory accords privileges to the perspectives
of non-dominant groups and individuals.
Paying attention to the observations, opinions, and experiences of members of
non-dominant groups corrects the nearsightedness and unselfconsciousness reflected in
the opinions and observations of those occupying a dominant perspective. As explained
further in the next subsection, power—social, political, economic, and physical—is
possessed by some people over others. These more powerful (at least vis a vis some less
powerful others) are said to occupy the dominant position or perspective and are termed
the dominant group, and have power. Those with social, political, economic, and physical
power have vested interests in maintaining that power, and exercise what power they
have to do so. Similarly, these interests and this power enables them to insulate
themselves from challenges to their epistemological authority. What Mahowald terms
nearsightedness and unselfconsciousness result.
Nearsightedness, unselfconsciousness, and arrogance are related flaws, each
reinforcing a natural tendency to construe one‘s partial perspective as the full
picture. By nearsightedness, I mean that none of us, as finite, situated individuals,
can see all of the parameters of the decisions we make. 8
But, even as she recognizes the epistemological privilege of the powerful or dominant
perspective, she foreshadows the epistemological privilege of the non-domiant. She
continues:
This limitation [of nearsightedness] says something positive as well as negative. I
allow that we at least see what is near, even though we cannot see what is beyond
our range of vision … 9
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Thus, feminist epistemology argues, there is value in attending to particular, albeit
nearsighted, perspectives. Doing so, Mahowald argues, helps to correct for
unselfconsciousness, ―used here to mean the lack of a sense of one‘s limitations. Some
unselfconscious persons assume themselves capable of ‗point-of-viewlessness, defining
their particular views as universal.‖ 10 Those in positions of social, economic, and political
power—members of the dominant group or culture—tend to be unaware of the partial
nature of their perspective, their worldview.
Thus it is with people who have normal sized bodies. While those who are obese
may be acutely aware of the bodily norms that they fail to achieve, normal-sized people
tend to think less about the existence of such norms and generally expend less energy
trying to achieve them or to compensate for failing to do so. Those who are obese may
have a constant, at least low-level awareness of the impact of their genes, diet, and
environmental stresses on their bodies. Not fitting into the dominant group of normal
bodies, those who are obese are forced to be the opposite of epistemologically unselfconscious: ―a self-conscious person acknowledges her weaknesses as well as strengths,
and acts accordingly.‖11 Again, Mahowald does not find that this epistemic position of
the non-dominant all negative. Self-consciousness in this sense affords obese individuals
a different sort of epistemic privilege. They are those who either themselves recognize, or
who provide the epistemic material for others to theorize, how bodily norms are socially
constructed and operate to create dominant/normal and non-dominant/abnormal
categories and social groups. Elizabeth Grosz and Iris Young are feminist theorists who
explain how these categories are created at a conceptual level and how they are applied to
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create material conditions of oppression. The next subsection examines their accounts of
this process.
A.ii Dichotomous Thinking, Logic of Identity, and the “Moralizing” of Obesity
According to feminist philosopher Elizabeth Grosz, the process of ―dichotomous
thinking naturally hierarchizes and ranks the two polarized terms so that one becomes the
privileged term and the other its suppressed, subordinated, negative counterpart.‖12 She
notes that this ―bifurcation‖ is not merely a ―neutral division of an otherwise allencompassing descriptive field.‖13 Dichotomy itself ―contains inherent explanatory force
which, if naturalized and used reflexively, can operate to predetermine the meaning of the
nature of A and Not-A, and the relation between them.‖14 The predilection of Westernstyle human reasoning to understand the world in terms of dichotomous categories,
either/or binaries, or polar opposites—terms used by feminist psychologist Helen
Haste15—is explained in detail by Iris Young.
According to Young, the ‗logic of identity‘ is at once an account of the
intellectual and psychological process of understanding the world and a theory of social
discourse, the ―Western philosophical and theoretical discourse that denies and represses
difference.‖16 The logic of identity is ―one construction of the meaning and operations of
reason: an urge to think things together, to reduce them to unity.‖ 17 To understand,
explain, or ―give a rational account is to find the universal, the one principle … covering
the phenomena to be accounted for. Reason seeks essence, a single formula that classifies
concrete particulars as inside or outside a category.‖18
The logic of identity denies or represses difference. … Any identifiable something
presupposes a something else against which it stands as background, from which
it is differentiated. … Understood as different, entities, events, meanings, are
neither identical nor opposed. They can be likened in certain respects, but
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similarity is never sameness, and the similar can be noticed only through
difference. Difference, however, is not absolute otherness, a complete absence of
relationship of shared attributes.
The logic of identity flees from the sensuous particularity of experience, with its
ambiguities, and seeks to generate stable categories. Through the logic of identity
thought aims to master that sensuous heterogeneous embodiment by bringing the
object fully under a concept.19
This account may begin to explain the social construction and dominance of norms of
appropriate bodies. Bodies come in all shapes, sizes, and colors. Human bodies are a
quintessential of the theorized ―sensuous heterogeneous embodiment‖ to which Young
refers. To make sense of this heterogeneity and to make a place for one‘s own body
among such obvious difference, Young argues that human reason compares and
categorizes.
This project of reducing the heterogeneity of sensuous particulars to the unity of
thought itself submits to a relentless logic of identity, as thought itself, the
thinking subject, must be reduced to unity. Such a subject is conceived as a pure
transcendental origin … it is self-generating and autonomous. … The logic of
identity also seeks to reduce the plurality of particular subjects, their bodily,
perspectival experience, to a unity, by measuring them against the unvarying
standard of universal reason. 20
People as thinking subjects come to be conceived in terms of their reason, as
fundamentally, essentially reasoners. That they also feel, love, use their five senses, and
experience emotions become secondary characteristics. People as embodied also are
subjected to this logic of identity, and as embodied people norms of appropriate bodies
apply to them, creating a narrow range or unity that marks an acceptable body and that
marks as outside that category all other bodies, including the obese.
Young then explores the negative implications of this process of understanding
and describing the world, including people and their bodies, in terms of falling inside or
outside narrowly constructed categories. She writes that ―the irony of the logic of identity
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is that by seeking to reduce the differently similar to the same, it turns the merely
different into the absolutely other.‖21 In some cases, she explains the human response to
the absolutely other is anxiety, fear, revulsion, and abjection. 22
The logic of identity‘ inevitably generates dichotomy instead of unity, because the
move to bring particulars under a universal category creates a distinction between
inside and outside. Since each particular entity or situation has both similarities
and differences with other particular entities or situations, and they are neither
completely identical nor absolutely other, the urge to bring them into unity under
a category or principle necessarily entails expelling some of the properties of the
entities or situations.23
This process is witnessed, as will be explained further below, in the process of
constructing bodily norms and, in contrast, the obese identity. Because fat people do not
fit within the category of the normal body, despite all of their similarities to those with
normal bodies—their talents, intelligence, interests—those similarities are stripped away
from their identity as they are understood. As a result of this process at a conceptual
level, obese individuals are themselves expelled from social groups and relationships, and
excluded from opportunities, to which they might otherwise have access. Young
continues to explain the pernicious effect of this way of thinking.
Because the totalizing movement always leaves a remainder, the project of
reducing particulars to a unity must fail. Not satisfied then to admit defeat in the
face of difference, the logic of identity shoves difference into dichotomous
hierarchical oppositions: essence/accident, good/bad, normal/deviant.24 (emphasis
added)
Faced with threat to its own coherence, the logic of identity transforms difference into
dichotomies. Therefore, faced with threat to their dominant status as normal bodied and
with the material threat to their normality represented by perhaps becoming overweight,
the non-obese cast obese individuals as very negative, polar opposites to themselves.
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The final step in this process of conceptualizing the world is the gendering and
moralizing of the categories. The first differences that children are taught as differences
are the difference between good and bad, right and wrong, and boys and girls. Good/bad
and right/wrong are taught as explicitly normative moralized differences. The difference
between boys and girls is taught as a natural difference, one of the first, out-there-in-theworld, differences that does not depend on what you or anyone else thinks. Theories of
biological sex (e.g., chromosomal vs. anatomical) aside, biological sex has been largely
relegated by even feminist theorists to the natural world. Gender, on the other hand, what
makes a person a man or an occupant of a male social role, is considered a matter of
socially constructed norms. By applying the logic of identity to its own dichotomous
categories, the moralizing and gendering of seemingly morally neutral, sexless, and
gender-free categories can be explained. In Western discourse, Young argues, the many
―mutually exclusive oppositions‖ the logic of identity constructs and justifies—e.g.,
mind/body, male/female, nature/culture, normal/abnormal—―are structured by the
dichotomy good/bad, pure/impure.‖25
The first side of the dichotomy is elevated over the second because it designates
the unified, the self-identical, whereas the second side lies outside the unified as
the chaotic, unformed, transforming, that always threatens to cross the border and
break up the unity of the good.26
In short, in an attempt to think things together, to unify even its dichotomous categories
into a simply binary, one pole of each supposed polar opposite is categorized as good. Its
opposite is marked as bad. This may explain how in some discourse at least what is
natural, intellectual, or normal is marked as good, i.e., the moralizing of categories that
are not on their face matters of morality. It does not explain what feminists term the
‗gendering‘ of the categories.
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Beyond boy/girl, male/female, and perhaps attributes associated with men versus
women, the attribution of gender to categories may seem obscure. This is true if ‗gender‘
is linked primarily to biological sex and apparent differences between the two opposite
sexes. 27 If instead gender is understood in terms of power or position within social
hierarchy, rather than in relation to biological sex, the gendering of seemingly sex-neutral
binaries is explained. Somewhat confusingly, but for lack of better terms, the terms of
‗male‘ and ‗female‘ are still employed, but they are best interpreted as male=more
powerful=dominant versus female=less powerful=non-dominant. Thus the gendering of
the nature/culture, science/art, and normal/abnormal binaries can be understood. The
natural, scientific, and normal are coded as male, dominant, mainstream, and at least
putatively good. Matters of culture are more suspect. ―It is an art, not science‖ marks
what is being described as more subjective, soft. The abnormal therefore stands in need
of correction and normalizing.
By considering gender in terms of various power relationships and relational
intersections,28 feminist epistemology and feminist scholarship more generally employ
gender as an analytic category. While feminism first focused on women‘s experiences
and concerns, with ―a feminist standpoint … being one that reflects the perspectives of
women while challenging the social dominance of men‘s perspectives,‖ 29 but feminist
approaches have gradually been refocused to analyze other relationships of relative
power, such as those grounded in aspects of race, class, poverty, and sexual identity.
With this expanded focus, gender has become a category of analysis, useful for
understanding associations of power and oppression, and the way that such relationships
serve to inform perspectives and construct reality. 30
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Thus far in this section feminist standpoint theory has been employed to assert
that the dominant view of obesity is partial in the senses of being incomplete and of
serving the interests of the dominant group. Examination of the processes of dichotomous
thinking and the logic of identity has explained how obesity acquires a normative,
moralized valence. The next subsection examines the interests of the normal bodied
dominant group in maintaining the moralized binary between normal and obese, their
experience of obesity as a threat, and the implications of these interests and experience
for obese individuals.
A.iii Dominant Responses to Obesity: Abjection and Border Anxiety
Even though the social, economic, or political power places some people in
powerful positions or dominant groups, and even though the logic of identity creates
dominant categories used to construct prevailing dominant perspectives on the world,
there is the threat of instability or impermanence in those dominant positions, categories,
and perspectives. The messy heterogeneous world intrudes on the neat categorizations,
and for example, a more powerful normal bodied person may recognize particular
similarities between himself and an obese counterpart. He may think, ―There but for the
grace of God, or my genes, or my circumstances, go I.‖ For some this may occasion
empathy, but feminist scholarship suggests that, instead, a common response is to feel
and defend against threat. Those in the epistemologically dominant group experience
what Young terms ―border anxiety,‖ a fear or insecurity about the ability to maintain the
dominant position. 31 Border anxiety is the result of recognizing that an individual in the
dominant position stands to lose advantage or status afforded them by this membership.
Border anxiety for those who are thin may be the result of several factors. First,
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historically the clinical diagnostic definition of obesity has changed, as has the fad of
what body types are in-style or out-of-style. At one time those who had been seen as
normal were reassigned to the category of deviant with the seemingly arbitrary
realignment of BMI categories.32 Moreover, while thin bodies have dominated recent
social norms of beauty, normality, and desirability, such has not always been the case.
The seemingly arbitrary nature of who is defined as being obese at any given moment in
time may heighten the experience of border anxiety by those who presently reside in the
dominant group. It seems reasonable that recognizing the costs associated with the loss of
such status would fortify efforts to maintain such an advantage. Second, for those
considered to be marginally acceptable, the border between fat/marginalized and
thin/privileged may be seen as being dangerously permeable. In this case it would be easy
for a thin person to cross that border simply by gaining a few pounds, thus becoming
obese and a member of the oppressed group with diminished power and status. This
border crossing would likely have serious negative consequences for the individual at a
social level in addition to potentially negative health consequences. Third, those who are
considered firmly within the category of the normal bodied by societal standards become
more aware of the advantage such status affords them when confronted by those lacking
such status. Having benefited from being considered thin, they are committed to
maintaining strong boundaries between those inside and outside the category of thin
because doing so helps to ensure their advantage. Anxiety regarding the conceptual and
material borders between thin and overweight thus spurs members of the dominant (thin),
to maintain their advantage, feeds the dominant group‘s efforts to maintain the
conceptual, social, and even moral border between themselves and the other. 33
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Obese individuals thus challenge social norms, even though their existence
presents a difference in contrast to which the dominant norm is constructed. As concrete
individuals who are not only different from their normal bodied counterparts, but also
similar in some ways and thus threatening, obese individuals may occasion strong
emotional reaction. Abjection is an emotional response that is partly the result of deeply
ingrained dichotomous thinking. Feminist philosopher Julia Kristeva explains that
abjection ―does not radically cut off the subject from what threatens it—on the contrary,
abjection acknowledges it to be in perpetual danger.‖34
Abjection is the feeling of loathing and disgust one has in encountering the
abject—certain images, phenomena, matter, and even fantasies that seem so
horrible that one can only respond with aversion, nausea and distraction. The
abject is at the same time fascinating; it draws the subject in order to repel it. 35
Abjection serves to construct and reinforce the dominant opinion of those labeled as the
Other.36 Obese people occasion such abjection in others. It reinforces the universalizing
of negative characteristics of the obese. The intensity of the reaction encourages those
experiencing it to attribute fundamental disgustingness to those who occasion it.
Obese people defined as essentially and absolutely Other may also experience
internalized abjection. Internalized abjection is the acceptance of the feelings of
disgustingness or hideousness felt by those in the dominant group towards the
marginalized group.37 The obese person takes those initially perceived and externally
projected negative feelings of the dominant group and begins to accept them as authentic
and deserved. She may come to believe that she is inferior because she violates a variety
of norms constructed as appropriate by the dominant group and therefore is deserving of
societal distain, her own self-loathing, the diminished opportunities afforded her by
society, and perhaps even the poor health outcomes associated with her obesity. As
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discussed later in this chapter, obese individuals may come to believe that their obesity is
indeed evidence of moral failing and hence justifiably subject to social sanction. The
dominant view of the obese along with the abjection it produces comes to be seen as
natural, deserved, and appropriate by those in the authoritative group and those in the
marginalized group.
With an increasing portion of the population identified as overweight or obese, it
would seem that the dominant view of obesity, constructed from the perspective of the
normal bodied, would be challenged by the sheer number of those who literally occupy a
non-dominant obese perspective. However those who are obese also, somewhat
confoundingly upon initial analysis, sometimes experience abjection of their obese peers.
Relevant to this phenomenon is Young‘s explanation that ―members of culturally
imperialized groups—themselves often exhibit symptoms of fear, aversion, or
devaluation toward members of their own group and other oppressed groups.‖38 Subject
to the same dichotomous thinking, logic of identity and incentives to align themselves
with what positive poles of the dichotomous categories they can, members of oppressed
groups find reason to subdivide their own marginalized, non-dominant group. Thus,
African-Americans distinguish between light and dark-skinned blacks, or between those
of African or Caribbean descent. To address the impact of this intragroup divide and
conquer by categorizing strategy, as well as to analyze the impact of power relationships
on members of multiple marginalized groups or identities, feminist scholars have begun
to examine the intersection of different marginalizations. The next subsection employs
intersectionality to examine these implications for developing a more complete
understanding of the social construction of obesity.
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A.iv Obesity at the Intersection of Multiple Marginalizations
Since feminist epistemology attempts to consider multiple standpoints, each
privileged in a different way (e.g., one dominant, another experientially informed by less
empowered voices, another medico-scientifically informed, and so on), employing
feminist epistemological approaches enables us to consider the intersectionality of
multiple standpoints and multiple marginalizations. The term intersectionality was coined
by Kimberle Crenshaw, a legal scholar, in the late 1980s. 39 The term was intended to
underscore the multi-dimensional nature of marginalized subjects‘ lived experiences. 40 In
feminist epistemology, ‗intersectionality‘ is typically used to refer to the combination,
and subsequent synergistic exponential effect, of occupying several oppressed groups,
social positions, or conceptual categories simultaneously.
Intersectionality originally served to inform the ways in which two particular
identities, race and gender, interacted to shape various dimensions of Black women‘s
lived experiences. 41 The approach initially recognized that the specific marginalizations
which apply by virtue of being a woman are intertwined with those marginalizations
associated with being Black. The overlap of marginalizations thus manifests itself
differently, though likely exponentially, given the number and intensity of intersecting
vectors. The purpose of intersectionality analysis is to diminish common analytic binaries
such as race/gender, obesity/gender, obesity/class in order to enable a more robust
examination of these various identities and their influence on marginalizations. 42 Its
underlying insight is feminist standpoint theory‘s recognition of the privilege perspective
of non-dominant individuals. Feminist legal activist Mari Matsuda contends that ―those
who have experienced discrimination speak with a special voice to which we should
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listen.‖43 Jennifer Nash, whose work focuses on Black feminism, states that ―for
intersectional theorists, marginalized subjects have an epistemic advantage, a particular
perspective that scholars should consider, if not adopt, when crafting a normative vision
of a just society.‖44 As a tool of feminist research, intersectionality analysis has been
criticized for being too narrowly based on the prototypical experience of Black women,
having an inadequately defined methodology, possessing ambiguity with regard to the
definition of intersectionality itself, and lacking coherence between various intersections
and lived experience. Nonetheless it provides a viable means for the complex analysis of
the implications of power relationships related to the convergence of numerous
discounted identities. 45
A more evolved application of intersectionality permits the analysis of an almost
unlimited array of marginalizations.46 This fact is particularly important for the correction
of the dominant understanding of obesity, as the intersection of numerous oppressive
circumstances and identities must be considered to more fully inform and understand the
experience of those who are obese. In fact, the dominant social construction of obesity or
an obese identity serves as yet another of the oppressive attributions that may intersect
with other oppressive identities based in gender, class, or sexual orientation. A white man
who is poor and obese may likely have a very different experience, and thus different
perspective or knowledge, than an African-American obese man who is wealthy, or a
Latino woman who is obese and poor. Similarly, the additional experience of having been
sexually abused or food insecure may have very different synergistically oppressive
effects depending on whether one is rich or poor, male or female, white, black or brown.
Compared to the effects of race, sex, and gender, the effect of social class has been
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relatively recently introduced into bioethical analysis, but theorizing the effect of class on
experiences of health, morbidity, and healthcare helps to illuminate the non-individual
systematic variation in experience of those at the intersection of multiple marginalities. 47
The intersection and synergistic effects of multiple marginalizations are evident in
the lives of obese individuals. Within a conceptual framework constructed by
dichotomous thinking, categories do not mix. Within the world, however, individuals
occupy multiple categories. It is partly for this reason that feminist epistemology has
stressed the importance of attending to the lived experience of individuals and to the
particularity of their experience and perspectives. The next subsection examines how
these insights and approaches of feminist theory integrate with goals of social science to
support their attention to particularity and their integration of narrative approaches.
A.v Epistemological and Ethical Reasons to Attend to Particularity and Narrative
Concepts drawn from feminist epistemology—dyadic reasoning, epistemic
privilege, standpoint, and partial knowledge help to articulate a more accurate
understanding of obesity, its various treatments, and the social construction of these. The
less powerful, non-dominant, experientially informed perspective of those who are
obese—like the perspective of other non-dominant groups, such as those who are poor or
abused or who are members of a minority identity group—is subverted by the socially
dominant perspectives of those who seek to maintain their dominant position within a
socially constructed hierarchy. It is through the inclusion of narrative provided by those
who are obese that the partiality of the dominant view of obesity may be seen and
challenged.48 Erroneous assumptions both about the nature of obesity itself and
inappropriate assumptions about those who are obese can be revealed by incorporating
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these subordinate voices.49 The well-regarded qualitative research tradition can be drawn
upon to support the inclusion of personal stories and narratives which highlight
particularity in understanding complex social phenomenon more fully. In this way the
inclusion and analysis of personal accounts of obesity act as a much needed counterbalance to dyadic reasoning on the topic. This method has been utilized and refined for
nearly a hundred years.
The Chicago School of Sociology developed qualitative research methods in the
early part of the twentieth-century, one of which utilizes personal interview, more
broadly conceived as personal narrative or case study, in order to seek a holistic
understanding of problems experienced by marginalized individuals. 50 Originally these
qualitative methods were used to generate data about the historical issues of race and
class. The goals of incorporating ethnography or interviewing were to evaluate more fully
the individual experience and particular circumstances of those who suffered from some
stigma or injustice and, in the longer-term, to improve inadequate social systems or
treatment. These methods were incorporated as a counter-balance to strictly quantitative
empirical research methods which had been found to provide insufficient insight into the
lived experience of those within a particular subjugated population. 51 The Chicago
School of Sociology believed that quantitative data collection was a good beginning
point, but an inadequate endpoint if the goal was to effect positive change in the lives of
those marginalized. It would be through the understanding of the particulars of the lived
experience captured through narrative that adequate levels of knowledge could be gained
and inroads made toward design of interventions and solution of complex social
problems. Feminist researchers, among others, subsequently adopted and adapted this
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qualitative research method as they too found that it provided the particularity necessary
to understand the lived experience of the marginalized. In a textbook by Pauline Young,
trained in this method at the Chicago School of Sociology at the University of Chicago,
she articulated the foundation of the method as follows: ―When people are least
interrupted when they can tell their stories in their own way…they can react naturally and
really and express themselves fully.‖ 52
In short, the stories of individuals, when properly attended to and incorporated
into an understanding of a social problem, can provide the type of highly nuanced and
contextual information which is unavailable to us through other methods. First, these
individual accounts challenge the accepted dominant understanding of obesity offered by
other sources grounded in reductionistic and inadequate dyadic reasoning. Second,
feminist ethics and epistemology have established the value of attention to particularity.
It is not just statistically significant information, but also particular, nuanced information
that can appropriately serve to inform discussion of a topic and the power relationships in
which the topic and the parties to it are embedded. 53 Young observes:
Moral reason certainly does require reflection, an ability to take some distance
from one‘s immediate impulses, intuitions, desires, and interests in order to
consider their relation to the demands of others, their consequences if acted upon,
and so on. This process of reflection, however, does not require that one adopt a
point of view emptied of particularity, a point of view that is the same for
everyone; indeed, it is hard to see how such a universal point of view could aid
reflection that leads to action at all. 54
Thus, the goal of accurate understanding and the goal of ethical action both embrace
appropriate attention to particularity.
At several points in this dissertation, first-person narratives relating the
experiences of living as an overweight or obese person and of utilizing various weight
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loss technologies are included. The inclusion of personal stories is in keeping with these
well-established feminist research methods and methods of feminist ethics. They provide
vital, highly particular information both in the subjective individual sense and with regard
to the social, historical, and cultural context of the lived experience of those who are
obese. Though not generating, providing, or even reporting statistically significant data,
the inclusion of these individual narratives provides additional information and sources to
afford a more nuanced understanding of the experience of members of this subordinated
group. What these narratives describe is not generalizable on the basis of statistical
significance, but nevertheless vividly present general themes without which an adequate
understanding of the experience of obesity and weight loss is incomplete and inadequate.
The next section turns to the social construction of gendered norms regarding
bodies and obesity. The section will explore how norms constructed in part by popular
media and religious concepts impair the lived experience of obese individuals and impede
their utilization of weight loss interventions.
B. Socially Constructed Norms of Appropriate Bodies and the Problem of Obesity
Feminist epistemological approaches reveal how norms of appropriate bodies are
socially constructed, moralized, and operate to the disadvantage of obese individuals. The
influences on social norms concerning the body come from multiple sources including
the media, religious teaching, and social institutions. Subsection B.i illustrates the social
construction of appropriate male and female bodies. This discussion illustrates the
intersectionality of gendered social roles, sex, embodiment, and relative power to reveal
not only the different norms applying to men and women, but also their application to
obese bodies. Subsection B.ii emphasizes the role of religious influences and the media
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on this social construction. Subsection B.iii analyzes the impact of norms on obese
individuals with particular attention to the stigmatization of obesity and its
internalization. Personal narratives from obese individuals will illuminate these
processes. This section‘s focus on the moralizing of body norms and obese bodies sets
the stage for discussion in Section C regarding ascriptions of responsibility for obesity.
B.i Gendered Beauty and Boundaries
The majority of Americans, including those who are overweight, maintain the
opinion that overweight and obese people are lazy and undisciplined. 55 Characteristics
such as unintelligent, unmotivated, unattractive, gross, immoral, sinful, inferior, and
primitive are often attributed to them,56 and these, frequently, go unchallenged by either
the obese individual or society.57 In addition, gender mediates and complicates social
understanding of body size and overweight. 58 The way in which overweight and obese
people are regarded differs based upon weight-associated gender expectations coupled
with the individual‘s degree of deviation from gender norms. 59 This subsection illustrates
the intersectionality of gendered social roles, sex, embodiment, and relative power and
reveals not only the different norms applying to men and women, but also their
application to obese bodies. Comparative analysis of the norms governing male and
female bodies illustrates how all bodies are subjected to such norms and the relationship
of the norms to structures of relative power and control. 60
As discussed in Chapter Two, the ideal of what constitutes an appropriate female
or male body has changed throughout history. Until recently there was greater cultural
dependence and variability in these norms, but with the ascendency of Western cultural
hegemony in arenas of fashion, media representations, and associations of norms of
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beauty with economic prosperity and political power, norms of appropriate embodiment
have become more homogenized. 61 The fluidity with which norms and idealization of
bodies has changed over the course of history indicates their socially constructed nature,
and the specific changes demonstrate the relationship between bodily norms and power.
For women especially, social status and social opportunities have long been
influenced by changing bodily norms. In some historical periods, rounded fleshy female
bodies were perceived as being both healthy and erotic and were the most highly
desired. 62 Current research on body images reflected in international media reveals that
body ideals are increasingly standardized with fewer acceptable variations based on
cultural preferences.63 Recently the feminine body ideal for both European white women
and African-American women has tended toward a seemingly impossible standard which
simultaneously integrates thinness and curvaceousness. 64 Curvaceousness is characterized
by medium to large breasts, a thin narrow waist, and wide hips or large buttocks. In other
words, the current ideal is the classic if somewhat exaggerated hourglass shape. For
women in wealthy, primarily white, dominant cultures, being thin has been seen as a
highly desirable attribute for over fifty years. 65 Possessing this body ideal has been
associated with youth, social attractiveness, and self-control or self-discipline. Failing to
meet this standard, or indeed becoming fat after having once met the standard, has
implications for overall acceptability of the woman. 66
The construction of gendered social roles and norms of appropriate bodies are
obviously intertwined. Iris Young analyzes the social construction of gender and the
development of socially acceptable behaviors, affect, and gender-specific body
comportments by girls and boys. She argues that instead of being biologically natural,
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sex-associated differences in ways of behaving are shaped by social norms reflecting
beliefs about what is gender-appropriate and therefore good. Differences between the
way boys/men and girls/women walk, sit, dress, smile, throw a ball, and use their bodies
is influenced less by biological differences in a body than by social norms governing
behavior and social roles. 67 Over time, those in positions of power—men, adults, elders,
teachers, clergy, fashion trendsetters—either approve or disapprove of behaviors,
adornments, or ways of behaving, and do so differentially with regard to boys and girls.
(That some of those in power are female, or that some powerful social roles are occupied
by women, e.g. nuns or grade school teachers, does not negate the fact that they have
typically internalized social norms shaped by male privilege.) These gender-sanctioned
behaviors and appearances become both descriptive and prescriptive social norms. With
time, what is approved and then prescribed as gender-appropriate becomes naturalized,
i.e., appears natural and is erroneously perceived as being biologically determined and
thus free from social influence. The gendered norms come to be viewed as descriptive of
a natural phenomenon, rather than as socially-constructed prescriptions.68
Some behaviors, appearances, and ways of being become so routine and uniform
that they are viewed as essential attributes of one gender or the other, e.g., the widespread belief that men are emotionally strong and women emotionally weak.
Essentializing of gender differences leads to viewing deviations as deeply problematic, as
―unnatural‖ in a pejorative and moralized sense, 69 because they challenge both dominant
notions of gender identity and the plausibility of accepting that gender differences are
anything but natural or biologically determined. Social responses to disruptive challenges
to gendered norms may have severe implications for the self and social identity of men

124

and women. Violations of prescribed and proscribed behaviors and modes of bodily
comportment impose costs on the violator, including stigmatization, discrimination, and
shame, discussed below. 70
The social construction of body and weight is particularly complex for women, as
women‘s bodies must satisfy the roles of both subject and object.71 A woman‘s body is
subject, in that it is the vehicle through which she interacts with the world. It is through
her body that she walks, talks, works, loves, bears children, relates to, and otherwise
interacts in the universe. A woman‘s body is also perceived as object, and expected to
fulfill appropriate gender roles aimed at gaining the status of wife and mother. A
heterosexual woman must adequately satisfy the sexual desires of the male gaze with her
body.72 She must be visually pleasing as an object or adornment—all the while doing so
unselfconsciously.
Through the male gaze, a woman is objectified. Jeremy Bentham‘s concept of the
panopticon elucidates how the male gaze functions to constrain a woman‘s behavior and
construct norms governing her body.73 The term panopticon was originally used to
describe an institution in which observers (e.g., prison guards) can oversee the observed
(e.g., prisoners) without their knowing whether or not they are being watched at any
particular moment. With regard to the surveillance of women‘s bodies and habits,
‗panopticon‘ connotes a similar continual societal surveillance of women. 74 The outcome
of universalization of the male gaze is that the bodies of women are always both the
object of another‘s gaze while simultaneously the material aspect of the subject (the
woman) acting upon the world by vehicle of the body.
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Foucault explored this social phenomenon and concluded that the outcome of
such societal surveillance is twofold. First, the constant surveillance provides a policing
of behaviors of the individuals being observed. Second, the individual who is under
scrutiny begins to behave as if she were being observed even when she is not. This
internalization of societal surveillance means that eventually the constant observation is
no longer required as the individual perceives it even in its absence and responds as if it
were present. In this case, the observation-cum-ownership of the female body becomes a
part of a broader system of societal control. 75 The female body is no longer under the
woman‘s own control but is now influenced by those who see her as object and by the
internalization of their scrutinizing gaze. 76
For the obese woman, the experience of societal surveillance is frequently more
explicit. That her very presence violates social norms is readily apparent, and social
responses to that violation are frequently explicit. For obese women social surveillance
has been described as harassment. One woman writes:
If you met me, one of the first things you'd notice about me is that I'm fat. Not
like, ―Oh darn, Anthroplogie doesn't have this in a 12!‖ kind of fat, but rather the
kind of fat that has to shop in the special fat-lady store. The kind of fat that has to
consider the structural integrity of thrift-shop furniture. And, unfortunately, the
kind of fat that elicits public humiliation and harrassment [sic] more often than I‘d
prefer to face.
Going on to describe her response to particular forms of surveillance she notes,
The aggressive stuff I can deal with -- I can eviscerate a jerk like a boss. I‘ve had
a lot of practice. The most recent instance took place in a Home Depot parking
lot, where I was walking to my car with a bag of potting soil. Some dude who
apparently spends his days hanging out in his car in the Home Depot parking lot
with his equally-pathetic dudebro friends saw his opportunity and seized the
moment, hollering at me, ―DAMN BITCH, YOU ARE HUGE. 77
She uses humor to deflect the harmful effect of this interaction,
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You know, I like a little creativity in my harrassment [sic]. If you‘re gonna yell,
make it something good. Ideally something I can laugh about later when I‘m
telling the story to my friends. The standard harrassment [sic] is just boring.
―SURPRISE, YOU‘RE FAT! LIKE IN CASE YOU FORGOT FOR A MINUTE.
I‘M REMINDING YOU. YOU‘RE WELCOME.‖ (Harrassers [sic] speak in all
caps, all the time, I have decided.)
My usual response is to shout back, ―YES!‖ or "IT'S SO TRUE!" or, if I‘m
feeling especially sassy, to wag my ponderous ass in their direction whilst
smacking same.78
Nevertheless she labels others‘ comments as harassment, as comments intended to
disturb, upset, and persecute. The narrator continues,
Sometimes fate takes the wheel. There was the time a guy called me a ―fat slut,‖
evidently for failing to cross the street quickly enough in front of his car, and in
his haste to zoom away, he drove into a curb and busted a tire. I like to think I
made that happen with my mind.79
In these exchanges, the response of others to her obesity and her response to them, are
characterized by aggressiveness, physicality, and even violence.
The visceral response of others illustrates what Young suggested about the
concept and response of abjection on the part of dominant others to those both less
privileged and potentially threatening of the boundary between dominant and
marginalized. This writer also articulates the connections drawn by Young between
power and the violation of body norms and gender roles.
….Street harassment is ultimately about entitlement -- it‘s about a dude (usually a
dude, though women are occasionally guilty of it too) who is emboldened by
gendered power dynamics into feeling as though your body is public property,
and he has a right to comment on it, whether he thinks he‘s paying you a
―compliment‖ for which you ought to be grateful, or trying to tear you down for
not being attractive according to his exacting specifications. 80
It is power, and the fact that men have generally held more of it than women, that
explains why men have generally not been subject to the same level of intense scrutiny.
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Where they are subject to similarly exacting social norms, however, the explanation
resides in relationships of relative power.
Overweight and obese men are subject to societal surveillance and may
experience the panopticon gaze as well. However, men are generally given more
flexibility than women with respect to violating gender-based norms for weight.81 Up to a
point, violations of gender-based norms of corporeal appropriateness for men increase
perceived masculinity. Men are expected to be larger, stronger, and more muscular than
women. 82 Therefore, overweight or obese men are more often than women given socially
appealing attributions related to their size. They are seen as being powerful, masculine,
and if it not too fleshy, athletic. Before negative social attributes are employed as
descriptors of them, men are allowed greater deviation from the ideal. 83 Specifically,
researchers have found that men begin to experience noticeable increases in weight bias
when their body mass index (BMI) reaches 35 or higher, while women begin
experiencing notable increases in weight discrimination risk at a BMI level of 27.84
Nevertheless, despite greater latitude in deviations from the ideal body image for
men, once serious violation of the norm has occurred, these men are considered effete. 85
Significantly obese men lose the social advantages afforded to most typical males and
come to be regarded much as women are, with diminished authority and power to act
upon the world. Sufficiently obese men lose their privileged position in the eyes of
society, and their authority and power gradient diminishes to more closely resemble that
of women. This connection among weight, sexuality, and power is evident in the case of
Al Roker, a prominent African-American man who has hosted the NBC Today show for
many years. After struggling with his weight he lost a significant amount. His wife
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described his hug before his weight loss saying that ―he was always a cuddly hug,‖ while
after his weight loss she commented, ―Now, he‘s this strong and sexy hug.‖ 86 His weight
loss seems to have moved him from diminished sexual status to a stronger, more sexual,
and more typically male status. Mrs. Roker‘s perceptions should not be criticized for
reflecting a dominant perspective on the obesity, sexuality, masculine power connection.
Her stated perceptions were influenced by the social construction of obesity and its
ascribed character traits.
The above examination underscores the socially constructed nature of bodily
norms. The following subsections will discuss various influences on this social
construction, beginning with the media. Further, theologically informed concepts are
examined to elucidate their role in explaining alleged causes of obesity and to reveal
moralizing about obese bodies.
B.ii Influential Sources for Social Norms Governing Bodies
This subsection discusses how norms of appropriate bodies—appropriate size,
image, and comportment—are explicitly shaped by several social sources. The first is the
constellation of media that mark normal, abnormal or aberrant, and beautiful bodies.
These media sources include art, fashion, news outlets, and the entertainment industry
which portray idealized unattainable bodies as the norm. 87 The second source is religious
institutions that explicitly teach about the appropriate care and use of bodies. 88 It will be
argued that religious teaching has been used explicitly to moralize the particular body
norms advocated. Together, these sources provide a framework upon which norms of
acceptable bodies have been constructed and within which actual bodies are evaluated.
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B.iii Media Representations of Male and Female Bodies
The current ideal male body type is similar to that observed in ancient Grecian
sculpture, and the standard of the male ideal has deviated less over time than has the ideal
of the female form. 89 It is described as a muscular mesomorphic shape with welldeveloped musculature across the arms and upper torso, and a narrow waist and hips. The
ectomorph body type is thin and angular with less developed or obvious musculature. At
the other end of this spectrum is the endomorphic body type, which would best describe
those men who are overweight or obese. 90 For the most part the modern idealized male
body norm is to be generally lean with moderate muscles. 91 Research on male body ideals
has primarily addressed body image concerns, most often stated in terms of muscularity
instead of body weight or thinness. 92 Research suggests that while muscularity is the
ideal, the boundary of acceptable muscularity has limitations. An extreme level of
muscularity, such as that found among professional bodybuilders, was perceived as being
unnatural, largely unattainable, and reflective of a conceited or narcissistic personality. 93
Additionally, lower levels of body fat are an important part of the idealized male body as
this permits the proper viewing of muscles on the male form. Too much adipose would
obscure the view of the muscles while too little is generally inconsistent with welldeveloped muscles.94 Flat, firm torsos are idealized.
The present dominant perspective on appropriate female bodily norms comes, in
large measure, from media representations which promote unnatural leanness to the
exclusion of more typical, attainable, and healthy ideals of beauty. 95 In research
conducted to reveal media trends in depicting feminine beauty, Sypeck et al. examined
images shown in the most popular women‘s fashion magazines. 96 The retrospective
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review revealed that between 1959-1999 among fashion models in three of the four high
circulation women‘s magazines there was an increasing trend towards thinness.
Additionally, the research concluded that a
…strong message communicated by the print media over the last 40 years
regarding female beauty seems to have changed from one espousing the
importance of a pretty face to one that additionally emphasized an extremely thin
figure, as women have been increasingly exposed to models‘ bodies and as these
bodies have become progressively thinner.97
In a 2012 ABC evening news segment, Diane Sawyer reported that most of
today‘s runway models meet the body mass index criteria for anorexia. Twenty years ago
the disparity between the average women and fashion models was less pronounced. At
that time the average fashion model weighed about 8 percent less than the average
woman. Current fashion models weigh approximately 23 percent less than the average
woman today. This does not accurately depict the proportions of a typical woman. 98
Research conducted on pervasive female images in the media found that the cultural ideal
of female beauty emphasizes the desirability of thinness, with content analysis
confirming the desirability of tall, young, and extremely thin models. A number of
studies have demonstrated that female centerfolds featured in Playboy magazine have
shown a significant decrease in body weight over the past 40 years. 99
Video games‘ depictions of bodies also exert influence. Martins et al. found that
among the 150 top-selling video games in the United States, games rated at high levels of
photo realism contained imagery of females who are systematically thinner than the
average female. Comparing the proportions of females depicted in the games with actual
anthropometric data, the authors concluded that video games which have a high degree of
photo realism may pose a threat to development of positive body images and may

131

promote body dissatisfaction among females routinely exposed to them. 100 As the next
section discusses, overweight and obese people are not represented favorably by the
media.
B.iv Media representations of Overweight and Obese People
Depictions of overweight and obese people help to reinforce particular
conceptions of individuals in each of these groups. Research examining body
characteristics of characters in prime-time television shows, revealed that of 1,018 major
television characters, 14 percent of females and 24 percent of males were overweight or
obese, which is less than half the prevalence of obesity found in the general population.
Overweight or obese female characters were less likely to be considered attractive, to
interact with romantic partners, or to show physical affection. Overweight and obese
male characters were also less likely to have romantic partners and friends or to talk
about dating; they were also more likely to be shown eating than engaged in more
physically active endeavors. Larger characters were more likely to be ethnic minority
group members, older, married, and unemployed. Larger characters were also more likely
to be guests on shows rather than be main characters and were more likely to be shown in
comedic than in dramatic roles. The study concluded that ―overweight and obese
characters are associated with specific negative characteristics.‖ 101
The following narrative personalizes the lived experience discussed above.
If you look at the way we are portrayed on TV we supposedly like being
identified by our fat. It makes us funny. It makes us stupid comic relief. It makes
us acceptable for other people to acknowledge our existence. In fact I've come
across people who have actually tried to cite TV characters as proof that there is
nothing wrong with being a fat guy (and let me tell you I'm making myself use
"fat guy" as much as possible in order make myself okay with using it). Yeah
Homer Simpson, Peter Griffin, and Kevin James' character on King of Queens
prove that everyone is fine with the existence of fat guys.102
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It seems that this blogger is frustrated by his designation as an obese male and by the
social implications of that part of his identity.
When obviously uninformed people make silly comments like that I just want to
commit violence. But then I'd be the crazy fat guy (and remember I‘m black so
I‘d become the Big Scary Black Man) and it would be my fault for ―taking it
personally.‖ Yeah.103
His range of socially acceptable responses is further constrained by the social
construction of another factor—namely, his race.
Repeated exposure to particular media content leads the viewer to accept the
portrayals as representations of what is real. 104 Continued viewing of an ultra-thin body
ideal has been shown to lead to increased body dissatisfaction among those whose bodies
least resemble the images being portrayed. A meta-analysis of studies on the role of the
media in the development of body image concerns strongly supports the notion that
exposure to mass media depicting the thin body as ideal is related to women‘s
vulnerability to disturbances in body image. 105 This was true across studies employing
both experimental and correlational designs, and across multiple measures of women‘s
body image, eating behaviors, and beliefs. Research suggests that men are affected
similarly by idealized male body images in comparison to their own perceived body
disparities from that ideal. 106
The social construction of male and female body norms involve the attribution of
character traits to both ideal and deviant body images. Various culturally constructed
norms of what is implicitly alleged to be the appropriate male or female body influence
the dominant view of beauty, the degree of acceptance of what falls beyond those norms,
and thus, what is likely to be rejected by a given society.
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As analyzed in the next section, another powerful mode of developing and
transmitting social norms of acceptability of the body is found in religious teachings.
Various religious teachings have served to define what constitutes an appropriate body
and to imbue bodies—appropriate or inappropriate—with moral significance.
B.v Theological Constructions of Appropriate Bodies
Theologically grounded concepts help to construct the societal understanding of
all bodies including those that are overweight. This section illuminates how the
theological concepts of human dignity, embodiment, and sin, as well as theological
norms governing the proper use of food, influence the construction of obesity.
Theological teachings present the norms governing appropriate bodies in a
particularly moralized manner associated with godliness or a lack of godliness. This
theological influence is often implicit and even operates in secularized ways and
contexts. Theological influences have infiltrated American culture in ways that influence
lives, shape the ways in which people strive to live, or frame the meanings people find in
their existence, whether or not they consider themselves religious. For many people,
theologically grounded concepts may be almost seamlessly embedded, sometimes
subconsciously, in both their self-identities and their ways of viewing other people and
their circumstances.
A colloquial expression of these theologically inspired ideas is that one‘s body is
a temple and as such, it deserves respect and care. This belief informs the admonishment
that one should be careful what one does with (or puts into) one‘s body. Respect for the
body has traditionally been included in the theological conceptualization of human
dignity. Respect for the body flows from belief that the body is the earthly home of the
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soul and that the human being is the embodied divinity of the creator.107 The concept of
imago dei, or in the image of God, as found in the Old Testament in the book of Genesis
states, ―So God created man in his own image, in the image of God he created him; male
and female he created them.‖108 While some faiths specifically hold that the physical
form of God is similar to that of humans, this passage from Genesis is uniformly
interpreted as setting humans apart from other, seemingly less complex creatures. It
suggests that humans possess unique characteristics such as reasoning, creativity,
consciousness, personality, and abstract thinking, which are intended to be used in order
to establish a relationship and be in union with God.109
In Jewish writings, the Tzelem Elohim or Imago Dei is the infused divine value
that all humans have, and this value gives rise to the sanctity of life. According to Rabbi
Doron Shultziner, ―God implanted in human beings a sacred kernel of worth, and
demanded that we protect human dignity in us and in others, and thus, damaging human
dignity is a direct offence to God.‖110 Maintaining human dignity requires the proper care
of body through the proper use of food. The President‘s Council on Bioethics suggested a
place for human dignity bioethical analysis and highlighted the religious foundations
upon which the concept is based. 111
[T]he human being has special dignity because he shares in the godlike powers of
reason, freedom, judgment and moral concern, and as a result lives a life freighted
with moral self-consciousness—a life above and beyond what other animals are
capable of. Speech and freedom are used, among other things to promulgate moral
rules and pass moral judgments, first among which is that homicide is to be
punished in kind because it violates the dignity of such a moral being. We reach a
crucial conclusion: that the inviolability of human life rests absolutely on the
higher dignity-the-god-likeness of human beings.112
The following discussion reveals the pervasive social influence of non-secular
conceptions of the body and human dignity.
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The bible is replete with stories of the evils related to violations of God‘s laws for
the proper use of food. The story of Adam and Eve is a widely known example of the
misuse of food which according to scripture, leads to original sin causing the vast
separation between humans and God.
So when the woman saw that the tree was good for food, and that it was a delight
to the eyes, and that the tree was to be desired to make one wise, she took of its
fruit and ate; and she also gave some to her husband, who was with her, and he
ate.‖113
While obesity was not an issue, the violation of the proper usage of God‘s abundant
resources and His laws surrounding food was.
Narrowly understood, obesity can be said to result from the improper use of food.
In a book of biblical limericks the implied connection is exposed:
The fruit of that tree, do not try it.
Give an order and man will defy it.
Those very first bites
Left us laden with plights
Sin, death, and opinions on diets.114
Whether one is a person of theologically-based faith or not, this story of the good and evil
nature of food and the concept of human greed has been culturally wide-spread.
Another biblical story refers to the temptation of Jesus with food following his
baptism in the River Jordan. Scripture recounts that Jesus was led by the Spirit into the
desert where He fasted. After fasting for forty days He was obviously hungry, and Satan
approached Jesus and said, ―If you are the Son of God tell these stones to become bread.‖
He answered, ―Man does not live on bread alone, but on every word that comes from the
mouth of God.‖115 Jesus is understood to be saying that food has a proper place and that it
is not only food that should fill us. Of more importance is God‘s word.
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Improper use of food in both of these instances is understood to have the potential
to cause a chasm between humanity and God. In the story of Adam and Eve, it was food,
obtained outside of the law of God, which caused the downfall of humanity. While
improper use of food in this instance is simply the vehicle for the betrayal of God‘s laws,
the story seals a strong and ongoing prohibition against using food improperly. The story
of Jesus in the desert provides evidence that desire for food should be considered, at all
times, secondary to regard for God and that a valuing of food ahead of God‘s word would
be a grievous misalignment of God‘s ideal order and the place of food within it.
Religious teachings often espouse an obligation for an intimate autonomous
relationship with God. Anything that comes between or separates an individual from
God, including those things which might be described as offending human dignity, are
considered sinful. 116 These things are to be avoided since they distance the individual
from an intimate relationship with their creator. Additionally, religious teachings often
hold that believers have social responsibilities which are communitarian in nature, or
meant to reflect a broader societal obligation of individuals, one to another. Societal
obligations, as discussed by Rabbi Shultziner, might include acting for the greater good
of the community even if that entails making personal sacrifices for the betterment of the
whole. 117 These religious concepts, both individual and societal, provide another
framework within which individuals or particular behaviors can be judged as good or
evil. Religious concepts therefore provide an additional layer of surveillance and
modification of human behavior in accordance with one‘s adherence or deviance from
socially constructed religious ideals. 118 It is partly within this broad theological
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understanding of an individual‘s obligation to God and to society that obesity is
constructed as a sign of character flaw, immorality, and godlessness.
Given the belief that the body houses one‘s divinity, a moral obligation to care for
the body follows straightforwardly. 119 Within a theologically informed framework,
failure to care for the body appropriately by being overweight or obese is construed as
evidence of committing the sin of gluttony. Obesity is viewed as prima facie material
evidence of sin—specifically, the sin of lacking respect for one‘s self, one‘s body, others
in the community, and God. Sin can be defined as a violation of our obligation(s) to
God.120 Indeed, gluttony is considered one of the cardinal sins; and thus overweight and
obesity are both evidence and the result of this vice or character flaw. 121 There is some
textual support that the original meaning of the word gluttony in the Bible was meant to
encompass more than simply overconsumption of food. Gluttony was initially construed
as a preoccupation with materialism or as the perversion of natural God-given appetites,
such as love being distorted into lust, or self-esteem being transformed into pride. St.
Thomas Aquinas further defined the sin of gluttony. He writes, ―Gluttony denotes, not
any desire of eating and drinking, but an inordinate desire...leaving the order of reason,
wherein the good of moral virtue consists.‖122
Pope Gregory the Great during the 6th century was the first to articulate the seven
deadly sins: lust, gluttony, greed, sloth, wrath, envy and pride. He outlined five actions
which were considered to be gluttonous. These actions included: eating before the time of
meals in order to satisfy the palate; seeking delicacies and better quality of food to gratify
the sense of taste, which he referred to as vile; seeking after sauces and seasonings for the
enjoyment of the palate; exceeding the necessary amount of food; and taking food with
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too much eagerness, even when eating the proper amount, and even if the food is not
luxurious.123 It has been said, that ―the concept of obesity as a moral imperfection
originated with the theological philosophy of this great early church leader.‖ 124 The
common understanding and usage of the term gluttony has now been relegated almost
exclusively to the misuse of food.125
While these influential theological writings on gluttony do not specifically
address obesity, obesity is thought to be a clear manifestation of such gluttonous, sinful
behavior. Additionally, these theologians point to the fact that gluttony is the gateway to
other sinful behaviors such as sloth or unchaste sexual appetites. 126 The Ten
Commandments‘ injunction against killing is understood to prohibit killing oneself as
well as killing others. Since obesity along with its co-morbidities has been shown to
reduce one‘s lifespan, being obese may be seen as killing oneself and therefore would be
considered similarly sinful. 127
Thus one interpretation of obesity is that those who are obese are morally
flawed—sinners. Obesity is an affront to God‘s image because it damages the body
which is the earthly home of the spirit. As humans are thought to be created in God‘s
image, destruction of that image is an example of distancing of oneself from God. A
logical conclusion then might be that the overweight and obese should indeed be
condemned by society for violating these obligations to God, to themselves, and to
society. Stigmatization, the topic of the next section, has thereby been perceived as being
morally justified on theological grounds.
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C. Stigmatization, Internalized Stigma, and the Formation of the Obese Identity
The following section discusses the impact of socially constructed norms of the
body, with particular attention to the stigmatization of those who are obese. Indeed,
prejudice based on an individual‘s body size is seen as the last socially acceptable arena
of discrimination: ―bias against overweight people has grown at the same time the
prevalence of obesity has increased.‖128
The first subsection discusses stigma and shame resulting from social
recognition—or an individual‘s own recognition—of the disparity between the
overweight individual‘s actual state and what is perceived as normal and acceptable.
Stigmatization and the feeling of shame are inherently relational; here they presuppose a
relationship—a negative one—between the overweight marginalized individual,
dominant others and society itself. 129 The stigmatization of obesity is the concomitant
phenomenon and conceptually opposite dyad of valorizing of norms of beauty and
appropriate bodies. The second subsection describes from the obese individual‘s
perspective how stigma functions like the disciplining panopticon, criticizing
inappropriate bodies even in the absence of material discrimination. The stigma of
obesity becomes internalized and functions as a means of self-evaluation by which obese
people limit themselves and their opportunities. While substantial attention has been paid
to internalized stigma of age and race,130 less attention has been paid to internalized
stigma associated with obesity. The following subsection reveals the stigma of obesity
and its effects.
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C.i The Stigma of Obesity
Sociologist Erving Goffman, who pioneered work on the mechanisms of stigma
development and the consequences of stigmatization, defined stigma as ―the phenomenon
whereby an individual with an attribute is deeply discredited by his/her society and is
rejected as a result of the attribute. Stigmatization is a process by which the reaction of
others spoils normal identity.‖131 Fat serves as such a stigma.
Stigmatization—and, in turn, an individual‘s experience of stigma or of being
stigmatized—occurs when the stigmatized person is identified as deviant. 132 Stigma
refers to the negative beliefs, attitudes, and conceptions held by the general population,
which lead to stereotyping, prejudice, and discrimination, for example, against
individuals who are obese.133 Sociologist Gerhard Falk states that existential stigma
derives ―from a condition which the target of the stigma either did not cause or over
which he has little control.‖ 134 In contrast achieved stigma is ―stigma that is earned
because of conduct and/or because they contributed heavily to attaining the stigma in
question.‖135 Both may attach to obesity, depending on which attributions of obesity‘s
underlying causality are made. If obesity is attributed primarily to genetics rather than to
individual choice or lifestyle, for example, then existential stigma would apply.
Lifestyle is frequently regarded as something which is chosen when instead it may
determined by social factors of class, economics, opportunity, and geography. 136
Nevertheless, ‗lifestyle‘ implies individual choice and autonomy, in contrast to fatalistic
genetic determinants. Research found that the more that people believe that weight is
voluntary (i.e., can be controlled by willpower and discipline through diet and exercise),
the more negative is the attitude of prejudice expressed towards the overweight
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individual. 137 As the final section of this chapter discusses, embracing different causal
accounts of obesity and different assignments of responsibility for being obese results in
different, though largely negative, social attitudes toward people who are obese.
April Michelle Herndon relates her own experience as a ―self-identified Fat
woman and a Fat Studies Scholar‖ who inadvertently lost a significant amount of
weight.138 Working with a dietician, her primary goal was to avoid diabetes, not to lose
weight. In the process she lost a significant amount of weight, but was unprepared for the
social response. Formerly obese Herndon offers a unique before and after perspective on
the experience of the stigma of obesity.
Prior to her weight loss she had become inured to the negative comments she
would routinely receive regarding her fatness. Following her weight loss, she reports
―feeling like I‘m in disguise has been especially hard for someone like me, a person who
hasn‘t bought the traditional narrative of why people are fat.‖ 139 After what she describes
as ―slipping onto the world of thin privilege,‖ 140 she found that ―losing weight seems to
have signaled to those around me that I must have always or must now believe these
stereotypes of fat people; my weight loss also seems to have suggested to them that it is
now OK for them to admit they believe those stereotypes.‖141 Herndon concludes, ―The
knowledge I‘ve gained in the privileged class is both oddly comforting, because it means
that as a fat person I wasn‘t imagining what was happening, and also disconcerting,
because it says to me….that things are worse than I thought.‖142
Another woman describing the experience of obesity in her blog connects her
obesity with the attribution of other negative traits:
Harrassment [sic] doesn‘t always take place on the street, either. A few weeks ago
I was sitting in a museum cafe, eating a salad, when I noticed a table occupied by
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three young men staring and pointing at me and giggling to one another in a
manner so lacking in subtlety that I was less upset that they seemed to be talking
about me in first place, and more offended that they thought I was too intensely
stupid to notice. 143
Such attributions wound and anger, yet because they are not explicit, the object of such
attributions cannot directly respond or refute them. The woman continues:
Sometimes I think this sort of thing is worse than being catcalled in public by
dudes -- at least with the yellers I can yell back and exorcise my fury, even though
this is not always the wisest nor the safest course of action… 144
Empirical research supports the themes revealed in these narratives. People do
attribute negative character traits to those who are obese. 145 A study of employers found
that managers routinely prefer to hire otherwise equally qualified non-overweight
employees because those who are overweight are perceived not to work as hard, cost the
company more money, take more breaks, and take more time off of work.146 Overweight
and obese people are often further regarded as being of lower intelligence in both
employment and other settings. 147
C.ii Internalized Stigma and Implications for Care-Seeking Behaviors
Internalized stigma refers to the perceived devaluation, shame, secrecy, and social
withdrawal experienced by those who deviate from social norms, such as those
constructing appropriate bodies. Living in an environment which approves the
stigmatization of people who are overweight, an overweight individual may come to
accept and internalize these attitudes and believe she is deserving of such treatment. 148
Lower self-esteem, lower social expectations, and a reinforcing cycle of social
withdrawal and rejection result.
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One blogger describes his experience of others‘ stigmatization and details the
attribution of negative stereotypes to him, based on his being situated at the intersection
of multiple sources of marginalization.
You see as a fat guy people like to draw conclusions about you. You‘re an athlete
(and let me tell you that assumption is not as cool as it sounds). You‘re not very
smart (I don‘t know how the association between fat and stupid makes sense).
You have unhealthy eating habits. You are gonna die young. You hate exercise
and physical activity (totally conflicting with the assumption of being an athlete).
The list goes on.149
He recounts how his particular experience of obesity stigma is different because he is a
man, and as such a different set of socially constructed gender based norms regarding
emotional expression apply to him.
And I get the feeling that there is an extra bit of pain that fat guys feel. You see as
part of the script of being a man we are not only not supposed to let things like
that hurt us but in the event that they do we are not supposed to talk about it. Not
show it. Just keep it bottled up inside let people pick on us and then go home and
cry ourselves to sleep at night. And the way fat guys are shown on TV its [sic] no
wonder people go around thinking it‘s all good in the hood to tease, pick on, and
otherwise harass us.150
He explains how the persistent stereotyping has changed him.
For longer than I can recall now this is the type of stuff I‘ve heard and I‘ve taken
it in so deeply that I actually pray for the very invisibility that people say they are
burdened with. Maybe its [sic] a sign that something is wrong with me but I don‘t
feel invisible with my fat. In fact I feel like I‘m the elephant in the room (yeah
you see what I did there right?). And elephant that wishes he were a fly.
To be so hurt by a simple characteristic you wish you could fade into the
background. No to be so hurt by the way people put so much stock in a simple
characteristic you wish you could fade into the background.151
He has internalized the public stigma of obesity; the stigmatizing nature of that which
stigmatizes him has become a part of his self-identity.
The internalization of stigma serves to justify and naturalize others‘ negative
reactions to obese individuals. In turn, obese individuals‘ responses are rendered
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unjustified. The dominant perspective of obesity thus exerts influence publicly and
privately, socially and psychologically. The precise nature of that stigmatization depends
in part upon the stigmatizer‘s understanding of the etiology of obesity and the degree to
which the obese person is held responsible for his condition. The next section explores
these ascriptions of responsibility.
D. Ways of Being Responsible and Ascriptions of Responsibility for Obesity
Among the social norms that inform attitudes toward obesity are norms
concerning assignment of responsibility. The first subsection considers different senses of
responsibility—causal and moral—and related concepts of causation, control, agency,
blame, liability, and ―taking care.‖ The second subsection the attempts to use these
concepts to untangle the frequently conflated senses in which people are considered
responsible for their obesity. It explores the implications of confusing backward-looking
ascription of causal responsibility with a moralized ascription of personal responsibility,
i.e., confusing causal and moral responsibility, as well as confusing ascription of
backward-looking agent-responsibility (AR) with a forward-looking, empowering sense
of responsibility-taking.152 The third subsection analyzes social manifestations of
different ascriptions of responsibility for obesity. These manifestations include a
―personal responsibility for health‖ movement, sin-taxes, and ineffective doctor-patient
communication regarding obesity. The subsection argues that appropriate ascriptions of
responsibility would instead support improved communication and access to WLS for
those who medically qualify to benefit from it. It is critical, however, to begin with the
clarification of different senses of responsibility.
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D.i Ascriptions of Thing-Responsibility, Agent-Responsibility, and Blame
Philosopher Kurt Baier provides a useful taxonomy for considering different
senses of responsibility. When we claim that failed brakes or an icy road are responsible
for an auto accident, he states, we ascribe ―thing-responsibility‖ (TR), whereby:
[T]he central idea is to single out the decisive factor that must actually be
operative when an undesirable event is being prevented or a desirable one
produced. This factor may be singled out because it is the most easily controlled
[the brakes]… or perhaps because it is abnormal [icy conditions] …Even when
the factor identified as responsible is not itself controllable, knowledge of its
responsibility may be of some, albeit limited, practical use, since it may prevent
us from wasting our efforts on controllable factors which are not efficacious, or
may warn us that there is nothing we can do …153

Baier notes that ―the rationale of ascribing responsibility is thus ultimately forwardlooking, to improve the future; but the actual ascribing of TR is backward-looking.‖154
Ascribing TR is akin to, but not identical with, identifying a cause.
As discussed in Chapter Two with regard to obesity‘s etiology, accurately
ascribing TR is often a difficult empirical matter. Nevertheless, ascribing backwardlooking AR is more conceptually complicated. Moral agents cannot only be blamed, but
also be blameworthy; they may be at fault, be culpable, be liable for damages, or be
deserving of condemnation. The complexity lies in the fact that backward-looking AR
can only be appropriately ascribed when the agent has failed to fulfill a forward-looking
AR. While brakes become thing-responsible for an accident simply by being its cause, a
driver is agent-responsible only if she failed in a forward-looking AR, for example, by
failing to fulfill her duty or the standard of care. ―The forward-looking aspect of agentresponsibility consists in a social requirement, whether customary, legal, or moral. 155
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Being the cause is neither necessary nor sufficient to be agent-responsible. In cases of
vicarious AR, for example, the party responsible for a harm is not the party who caused
it. It is a failure to fulfill the previously ascribed social requirement that makes an agent
agent-responsible for harm and other negative outcomes. (In like manner, it would seem
that fulfillment of some social role, requirement, or norms is requisite for appropriate
ascription of AR for praise-worthy, positive outcomes.)
The rationale or goal for assigning AR is also more complex. The goal of
ascribing backward-looking AR may be to blame, condemn, or punish, or it may be to
identify a source of resources to address the problem for which the party is agentresponsible. A party may be held responsible in the backward-looking agent-responsible
sense without being subjected to blame or being found blameworthy in a moralized or
punitive sense. Further, an agent may be ascribed—or may assume—responsibility in a
forward-looking agent-responsible sense. An agent may be ascribed or assume a forwardlooking AR—a social requirement—simply because he is identified as having the
resources to fulfill the requirement, or because he cares and assumes the responsibility to
take care of a problem. Sometimes mustering those resources must involve identifying a
cause, ascribing TR, or ascribing backward-looking AR (including failure to fulfill the
forward-looking social requirement). Sometimes one or more of these investigations will
divert resources from taking care of what needs to be done. The next subsection
addresses notions of responsibility for obesity. It also expresses concern about the
impairment or diversion of resources—financial, intellectual, and emotional—that can
occur for the sake of ascribing responsibility for obesity and blaming the culprit.
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D.ii Ascriptions of Agent-Responsibility for Obesity and Moral Agency
As Chapter Two established, substantial effort and financial and social resources
are expended to try to explain obesity‘s etiology. Yet identification of the cause of
obesity, the assignment of TR to a single modifiable cause, is proving a futile goal,
because myriad things contribute to obesity. This is true of the so-called obesity epidemic
and is likely true of any particular individual‘s condition of overweight or obesity. Yet
much media attention, many social policies, and even scientific studies approach obesity
with the logic of identity, focusing on one factor to the exclusion of most or all others.
Take for example New York City‘s recently overturned regulations which sought to
outlaw large portions of low nutritional value soft drinks.156 This soft drink ban would
have failed to enact similar portion control safeguards for other calorically-dense
nutritionally-poor foods, which continue to be available, unrestricted. Such efforts
misapply single source responsibility to what is a multi-factorial condition. Additionally,
research conducted on obesity often focuses on one particular factor of obesity‘s
development such as genetics, or diet, or exercise to the exclusion of other contributory
factors.157
The gold standard of research—randomized clinical trials—and genomic research
studies rely on controlling for, or assuming the consistency of, confounding factors;
however, outside of these rarified experimental environments, confounding factors mix
with the factor under study. Research must always simplify, but as the trend toward
translational research acknowledges, it is important to begin to study the causes of health
conditions and the effectiveness of interventions in the actual lived environments of the
people those interventions are intended to benefit.
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The drive to identify the ―but for‖ cause of obesity—as in, ―but for this single
contributing factor, this person would not be obese‖—seems to derive from not only the
difficulty of studying multiple contributing factors at once, but also the impulse to ascribe
moralized responsibility for the problem. Where effective intervention in, correction of,
and prevention of a problem are the goals, as Baier argues, the rationale for identifying
the cause or causes is to intervene for the sake of future improvement. When multiple
contributing factors are identified, the low hanging fruit, the factors that are most easily
or efficiently susceptible to intervention tend to be addressed. Indeed, it is frequently not
important to identify all contributing factors in order to commence intervention in some.
Popular understandings of obesity—and indeed some more scholarly treatments
of obesity—frequently fail to appreciate obesity‘s actual complexity. 158 The
overwhelming popular opinion is that overweight and obesity are voluntary conditions
brought about primarily by malleable lifestyle habits.159 Even if genetic contributions to
obesity become better established, it seems likely that the social construction of obesity
will not shift to incorporate the TR of genes as a first-order explanation for an
individual‘s obesity. It seems obvious that a person is neither agent- nor thing-responsible
for her genes. Thus if obesity were solely caused by ―bad‖ genes, then a person would
and should not be held agent-responsible for her obese condition. But, obesity is a
complex multi-factorial condition, not merely a genetic condition. Moreover, even if
there are genes that increase risk for obesity or that affect metabolism in such a way that
a person with a severely restricted caloric diet would still become overweight, human
beings need to ingest and metabolize nutrition. There is reason to suspect that were some
individuals‘ obesity shown to be strongly genetically associated, even genetically
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―caused,‖ they would still be unreflectively blamed for eating. Eating is still a voluntary
behavior, even if without doing so one would die.
Obesity is not the only health condition for which a genetic component is likely to
fail as a condition excusing the person from AR for manifesting it. Consider the
following ―genetic conditions.‖ People born with genomic anomalies e.g.,
phenylketonuria (PKU) or cystic fibrosis are not held responsible for their conditions.
Even when particular behaviors complicate management of a condition—for example,
when a person with cystic fibrosis visits an environment that exacerbates her respiratory
problems—the ascription of AR for that behavioral contributing factor may not carry
blame. In contrast, when a condition known or even just assumed to have strongly genetic
components is also experienced by people with a socially disparaged identity, they are
less likely to have access to the excusing condition of being not-agent-responsible. And
any ascription of AR is likely to carry blame as well. It is well-documented, for example,
that when African-Americans with sickle cell disease, a condition known to be genetic,
experience sickle cell crisis requiring prescription of strong pain-relievers (frequently,
narcotics), they are frequently regarded with suspicion in emergency departments as
putative drug-seeking addicts.160 Racism—and frequently class-based norms—combine
to construct the person as a likely addict, and the social construction as addict warrants
refusal of pain relief. Similarly, even when an individual‘s obesity is viewed as being the
result of a combination of genetic predisposition and behaviors (e.g., diet and exercise),
blame typically accompanies ascription of AR. In contrast, it is frequently considered
―understandable‖ that the person with cystic fibrosis would nevertheless visit a horse
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barn, or that a teenager with PKU eats pizza, triggering symptoms of their genetic
conditions. 161
Therefore, ascriptions of personal AR and blame—based on belief in person-asthing-responsible and as agent-responsible for failing to fulfill some social requirement—
complicate and undermine efforts to address obesity in a manner similar to other healthrelated conditions.162
The stigma attached to obese individuals because of their ostensibly obesitycausing conduct complicates efforts both to identify obesity‘s multiple causal
components and to devise and implement interventions to address it. This dissertation
argues that the impulse to ascribe moralized AR serves as a barrier to embracing WLS.
The search for the thing-responsible culprit, the cause, takes on a dual social goal.
Identifying the cause is not only to serve the forward-looking rationale of improving the
future but, also to ground ascription of AR and blame. AR is ascribed as soon as the
agent, the obese person, is identified as involved in the causal chain leading to her
obesity, which of course she must be, because she must eat.
American culture is heavily invested in the myth of the self-made man. 163 The
depth of cultural investment may be due to the erroneous belief that if one is not
completely thing- and agent-responsible for the good things one enjoys, then one does not
merit them. Recognition of the role in one‘s own economic success of, for example,
social infrastructure or one‘s ancestors‘ wealth or educational attainments is considered
by some to suggest that one does not merit one‘s attainment. The suggestion that a
complex web of factors, including one‘s effort and agency, is responsible for one‘s
success seems to threaten the pleasure and satisfaction some take in their positive
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circumstances. Failing to hold people responsible for their negative circumstances,
including health conditions like obesity, would similarly threaten this worldview and
sense of merited pleasure such people take in the positive aspects of their lives. As a
consequence, Americans tend to view their fates as of their own making—even when
there is legitimate evidence to the contrary, as is the case with obesity. 164
Two paradoxes result from applying to the problem of obesity these notions of
identifying backward-looking TR, ascribing backward-looking AR for failure to fulfill a
forward-looking social requirement, and blaming/being blameworthy. First,
paradoxically, even as obese individuals are frequently blamed for their obesity, they are
regarded as having diminished capacity for moral agency due to the lack of self-control
and self-governance of the body evidenced by their obesity. Having moral agency is
predicated on being able to control oneself in light of one‘s understanding of what is right
and what is wrong informed by accepted social norms. Without such ability to control,
one lacks agency. 165 ―Slenderness symbolizes being in-control.‖166 Obesity functions for
obese people as evidence of both their having made wrong judgments with regard to their
bodies and their being incapable of self-control. While being incapable of self-control
might in other contexts serve as an excuse for wrong action due to impaired or absent
judgment, for obese people, lack of self-control serves to compound their
blameworthiness and serves as a quasi-causal pathway for their culpable behavior.
Obesity has come to serve as a social marker of inferior moral character, as well as
inferior social status, because of its association with poverty. 167
Second, if an obese person exercises agency and assumes forward-looking AR for
her obesity, i.e., undertakes to reduce her weight and improve her health, she is likely to
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be ascribed backward-looking AR and blame for becoming overweight in the first place.
In the context of obesity, the moral position of assuming the responsibility of taking care
of a problem cannot be blamelessly occupied by an obese person herself. 168 This paradox
may help to explain why WLS is socially constructed as an illicitly easy way out of
obesity, even though the post-surgical protocol requires substantial effort. Compared to
dietary restriction and the exertion of exercise, WLS does not look sufficiently like
penance for the sin of gluttony.
The next subsection examines implications of these paradoxes for both obese
patients‘ care-seeking behaviors and physicians‘ treatment of obese patients.
D.iii Implications of Misplaced Ascriptions of Responsibility for Obesity
This subsection analyzes clinical implications and social manifestations of
ascribing responsibility for obesity inappropriately. These manifestations include a
―personal responsibility for health‖ movement, sin-taxes, and ineffective doctor-patient
communication regarding obesity.
Recently, a growing trend towards ascribing personal responsibility for obesity
has been observed. 169 The Patient Protection and Affordable Care Act and the 2012
Presidential election focused on questions of ―socializing‖ medicine in America, with
public discussion and state initiatives seeking to encourage personal responsibility for
health, particularly weight-related ill health. One line of reasoning seeks to impose
increased healthcare costs through increased insurance rates based on violating insurance
norms for weight.170
To address the additional healthcare costs associated with overconsumption of
high calorie low nutrient foods, a number of states are considering enacting sin taxes on
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junk foods in an effort to diminish their appeal. 171 By enacting sin taxes, states deter
consumption, encourage healthier selections, and receive some compensation for
anticipated healthcare costs associated with obesity. 172 The monies realized from food
sin-taxes would be used to promote public health initiatives aimed at the amelioration of
obesity related disease, such as diabetes or hypertension. Since sin-taxes have shown
some past success, as in the case of tobacco, there is a superficial plausibility from a
public health perspective to this line of thought.
However, there are several problems with taxation of junk foods. First, food,
unlike tobacco, is necessary for survival. Second, it is not uncontroversial to determine
with precision and fairness which foods are junk foods and therefore subject to the tax.
There is a lack of objective criteria on which to base determinations of sin tax appropriate
foods. Third, food taxes often disproportionately impact those of limited financial means,
which generally includes substantial minority populations. The outcome of such taxes
would place a greater financial burden on those already experiencing exaggerated
economic hardships, who have been shown to be the most vulnerable to obesity, and who
have the fewest options to obtain healthful foods in their communities. 173 Fourth,
revenues from such taxes intended to fund public health programs are often diverted from
the appropriate disease-ameliorating programs to cover general budget deficits. Finally,
sin-taxes can increase stigmatization and internalized stigma among those who purchase
such foods and beverages. While stigma and shame have altered the consumption of
tobacco products; however, for food and obesity, stigmatization has not yet had the same
effect.174 Additional stigma and subsequent internal shame may not serve the purpose
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intended nor may sin taxes on junk foods provide the same retrenchment to responsible
behaviors as has been seen in other areas.
Perhaps the most important social manifestation of the social construction of
obesity and ascription of moralized personal responsibility for it may be witnessed within
clinical medicine. When physicians subscribe to the societal norms of appropriate bodies,
they may treat unjustly those who present as overweight or obese in their practices. This
injustice can manifest in any number of ways including failure to discuss the medical
problem of obesity, dismissal of symptoms because it is assumed that weight is the cause,
or judgmental or disrespectful tone and affect with the patient. The problem of addressing
obesity becomes especially intractable when physicians confuse patients‘ contributions to
the causal pathway resulting in their obesity with moral responsibility for their condition.
The problem is exacerbated when physicians, like other members of the dominant
culture, universalize the ―character faults‖ marked by obesity and attribute other negative
characteristics to their patients, including laziness, voracious appetites, sloppiness, and
carelessness with regard to appearance or health. 175
Physicians are traditionally the trusted experts and irreplaceable supports to those
who are diagnosed with disease. From the time of diagnosis throughout various treatment
interventions for many patients with disease, physicians fill this role. However, in the
case of patients who are overweight or obese this supportive experience is often lacking.
When inappropriately moralized ascriptions of responsibility or negative character
attributions come from those in medicine, they are not simply emotionally painful to the
obese person; they are clinically counterproductive and may negatively influence the
implementation of potentially effective weight loss interventions.
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In his Memoirs of an Obese Physician, formerly obese physician Joseph Majdan,
M.D. tells of his own stigmatizing experiences both as a medical student and later as a
practicing physician at the hands of student and professional colleagues. 176 His
recollections reveal the liminal space he occupied as both an outsider, as an obese person,
and insider, as a medical practitioner. He recounts indignities and prejudices he suffered
for many years due to ―constant, insensitive, unprofessional attitudes of fellow colleagues
who preached empathy to their students and residents.‖177 but showed little to him.
Majdan recounts losing large amounts of weight through various diet programs only to
regain the weight each time. He tells of inappropriate jokes at his expense by mentors,
colleagues, and other medical students. Majdan, a cardiologist and award-winning
educator, describes other physicians who shared that their refusal to refer patients to him
was because of his weight. He recounts one story of a patient who, due to his reputation
for good medical care, specifically requested a referral to him. The physician responsible
for making the referral reportedly responded to the patient, ―Why do you want to go to
him? He‘s fat.‖178 It can perhaps be argued that the medical profession might be tougher
on one of their own because a fellow physician is a representative of medicine and
therefore reflects negatively upon the profession as an obese person. Nonetheless, his
story of stigma and the shame he experienced due to ongoing bias at the hands of
colleagues within this ostensibly caring profession remain, at the very least, unsettling.
Majdan also recounts episodes throughout his obesity of people feeling
comfortable in offering him unsolicited advice regarding proper ways to solve his weight
problem. He states that people would approach him and comment negatively about the
food on his tray or suggest that he exercise more or even pursue particular weight loss
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technologies.179 His actions were under near constant scrutiny. These recollections are
poignant examples of how obese individuals are transformed from subject in their own
life to object through the panopticon of the societal gaze. As object, the body normviolating obese person becomes public property, a social object for critique, because of
their perceived deviance and lack of appropriate self-control. As the obese person,
Majdan is to be helpfully managed and controlled by well-meaning and responsible
concerned medically-trained professionals and good citizens. His obesity stripped him of
his own professional identity. He was placed under societal surveillance due to what was
perceived as his obvious diminished moral agency.
While Majdan‘s experience could be anomalous, research indicates that these or
similar experiences may be quite common. Similar to the general public, physicians hold
negative attitudes about obese individuals. 180 Researchers surveyed 5,000 primary care
physicians about their attitudes toward obese patients and the causes and treatments of
obesity. Of the 620 respondents, at least 50 percent agreed with statements indicating that
they found obese persons to be ugly, non-compliant, awkward, and unattractive.
Approximately 30 percent of the same group indicated that obese individuals are lazy or
sloppy. In the same study general practitioners rated physical inactivity as the most
important factor in obesity, whereas obesity experts rated genetic factors as being the
most important contributor.181 Others in the healthcare field including nurses, dieticians,
and nutritionists showed attitudinal patterns similar to general practitioners, along with a
marked dislike of caring for patients who are obese. 182 In research designed to ascertain
medical student perceptions of patients through the use of derogatory or cynical humor in
the clinical setting it was found that patients were categorized as appropriate objects of
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humor and deemed to be ―fair game‖ based upon obesity or other conditions which are
thought to be self-inflicted.183
Another study found that physicians play a significant role in lowering the quality
of health care that both overweight and obese patients receive. These more recent studies
confirm work done by Mizrahi in the 1980s. 184 It was confirmed that among medical
residents ―patients whose afflictions were the consequence of self-abuse were evaluated
as less ‗worthy‘ of care than those whose pathology was perceived as no fault of their
own.‖185 As previously discussed obesity is often perceived as a self-inflicted condition.
Even those medical professionals working in the field of obesity treatment and
research have revealed complex implicit and explicit bias against the overweight and
obese patients with whom they work.186 On both implicit and explicit bias health
professionals working in the field of obesity associated the attributes lazy, stupid, and
worthless with obese people. 187 This is a group of professionals who are supposed to
understand that obesity is caused by the interaction of genetic, environmental, and
lifestyle factors and is not simply a function of irresponsible individual behavior and
inappropriate personal choices. The stigma of obesity appears to be so dominant that even
those most knowledgeable about the condition make the judgment that obese people are
to be blamed for their problem because they are lazy. Furthermore, these biases extend to
the characteristics of intelligence and personal worth.188
As discussed earlier, obese individuals are more at risk for developing particular
cancers than people with more typical weights or BMI.189 In light of this fact, there
should be an added imperative for people who are obese to receive adequate surveillance
for cancers. However, research indicates that many obese people do not undergo
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diagnostic examinations for these diseases at the same rate as those whose weight is
considered normal. 190 In a study on colorectal cancer (CRC), the third most common
cancer in the United States and the third leading cause of cancer death, it was found that
obese patients are less likely to receive CRC surveillance. 191 This is especially troubling
since obese people have 50 percent or greater risk of developing CRC compared to
normal weight people, including as much as a 90 percent greater risk of mortality from
CRC. Yet, if diagnosed early the 5-year survival rate is approximately 90 percent.192
Research regarding routine surveillance of other diseases disproportionately
diagnosed in those who are obese have found similar outcomes regarding the lack of
surveillance.193 While many reasons for the avoidance of routine health screenings have
been considered, research has found that the stigma associated with obesity and
evidenced in physician-patient interactions is routinely identified as a factor impeding
disease surveillance. Patients report general feelings of disrespect, embarrassment,
negative attitudes of providers, medical equipment that is inadequate for the patient size
and unsolicited advice on how to lose weight. 194 Given the stigma experienced by
individuals who are obese in daily life circumstances, it seems highly plausible that
seeking treatment for the problem of obesity is fraught with additional stress and
legitimate fear of stigmatization. For those individuals who might otherwise seek the
supportive counsel of their physicians to assist them in weight loss efforts, experiences of
stigma in other medical encounters may color patient expectations and diminish the
likelihood of their pursuing this avenue of potential assistance. 195 In essence, the
opportunity for the patient to make effective decisions and life plans is further impaired
by the bias and stigma of previous medical interactions. The obese person‘s ability to
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learn about and choose freely among potential treatment solutions is constrained by past
experience. The obese patient‘s assumption of an empowering forward-looking
responsibility for her future health is rendered more difficult and less likely because of
inappropriately moralized ascriptions of responsibility for her current obesity. As chapter
four details, WLS, for various reasons, is especially unlikely to be recommended to her as
a means of assuming such forward-looking, care-taking responsibility.
E. Conclusion
This chapter revealed several prominent ways in which obesity is a socially
constructed phenomenon. It argued that dominant understandings of obesity neglect or
explicitly discount important perspectives which must be considered. By utilizing
feminist epistemological frameworks it was possible to identify current flaws in the
construction of obesity, injustices in the treatment of obese people, and impediments to a
wider acceptance of WLS.
The first section showed that feminist epistemology‘s focus on social context and
power relationships affords a more accurate formulation of the complex problem of
obesity. The second section explored gendered notions of appropriate bodies and the
influence of media and theological teaching on the social construction of obesity. The
third section integrated feminist conceptual analysis with the phenomena of
stigmatization and internalized stigma. This section employed attention to particularity
and narrative to reveal the concrete implications for obese individuals of these
phenomena. The final section returned to the questions posed earlier regarding the
etiology of obesity and moralized questions of assigning responsibility for it. This section
argued that confusing causal with moral responsibility, and failing to distinguish clearly
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between different purposes of assigning blame lead to ambivalent social attitudes towards
WLS. Chapter Four will take up issues of justice regarding the use of WLS as an
individual-level clinical intervention.
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Chapter Four: The Concepts of Utility as Applied to Weight Loss Surgery
Commonly employed bioethical considerations such as justice, fairness, and
autonomy have not been adequately engaged in evaluating the appropriateness of
employing the technology of weight loss surgery (WLS). Moreover, it appears that what
ethical considerations have been engaged have focused almost exclusively on its social
utility—its overall benefit to the broader problem; the potential for WLS to significantly
diminish the public health problem of the epidemic of obesity, as the problem is often
framed. Even with regard to these considerations of utility, rigorous analysis of the
potential benefits of WLS has been at best insufficient and often inappropriate. This lack
of rigorous analysis appears to be a departure from levels of bioethical attention
traditionally devoted to emerging healthcare technologies and its more recent (e.g., since
the mid-1990s) attention to issues affecting relatively disempowered patient populations. 1
This relative lack of attention may evidence bias against those who are obese, even on the
part of bioethicists, or it may suggest that bioethicists fail to recognize the myriad ethical
implications of obesity and its interventions as well as the social disempowerment of
obese individuals.
Indeed, interventions initially regarded as radical or exotic, such as transplantation
or dialysis, have received extensive attention in the field of bioethics. 2 The attention
given to these interventions, including significant bioethical analysis, began almost
immediately following the initiation of their use and in many instances occurred during
developmental phases of the technology. Moreover, the pre-occupation of bioethics with
the next new technology has often been a criticism of the field. 3 The same cannot be said
of the bioethical attention afforded WLS, which rivals transplantation technologies for at
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one time being regarded as a new ―high-tech‖ intervention, even as its history is
approximately as long as that of organ transplantation. WLS is distinctive for its dearth of
immediate and rigorous bioethical attention. A review of the literature to specifically
identify ethical analysis of WLS reveals few articles. Further, it is notable that in spite of
the long history of surgical weight loss procedures significant ethical consideration and
analysis of these procedures appears to have been only recently initiated.4 These few
recent articles do attempt to address the ethical challenges of WLS, including a bias in
favor of public health efforts, issues of informed consent, patient autonomy, and some
considerations of justice;5 they serve as a much delayed starting point for such ethical
analysis.
This fourth chapter builds upon this modest initial body of ethical analysis by
evaluating WLS based upon various ways of conceptualizing and assessing its utility.
This chapter will apply three senses of utility—social, clinical, and personal—to establish
the usefulness of WLS in these different, albeit overlapping domains. Social utility refers
to the usefulness of WLS at as a population-level intervention for obesity. The clinical
utility of WLS refers to its benefit in serving individual patients in addressing their
medical problem of obesity. Finally, personal or individual utility is used to refer to the
non-medical benefit individuals receive from WLS. Recognition of both the distinction
between these senses of utility and their points of interconnection is critical to appreciate
the value of WLS as an effective clinical intervention and yet understand why WLS has
not been more widely embraced or been deemed more socially acceptable since its
emergence.
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In concrete terms, this chapter argues that it is inappropriate to dismiss WLS as a
valid intervention for obesity treatment based on its failure to address the public health
problem of obesity or its relative lack of social utility in comparison to macro-level
public health interventions. The chapter argues that such a dismissal of surgical
interventions for obesity is based on an erroneous application of public health goals to
what is also, fundamentally, an issue of clinical medicine. The chapter argues that this
category mistake—of demanding direct and primary public health benefit of a
fundamentally clinical intervention—is obscured by both modern moralizing public
health rhetoric and the ethical attraction of solving the problem of obesity through
preventive public health intervention. The chapter reveals the fallacious reasoning that
enables obesity to be cast and quantified, alternately, as a population-level problem and a
problem of individual ill health. Both characterizations serve to undermine the legitimacy
of individuals‘ utilization of WLS.
This chapter further argues that those who primarily advocate public health
approaches for ameliorating obesity are choosing to disregard a more immediate moral
obligation to the individual with co-morbid disease related to being obese in favor of
developing or altering systems to alleviate this condition for future generations and as yet
unidentified individuals. This is itself a departure from the usual bioethical and medical
response whereby the individual diagnosed with a condition in the present is generally
seen to have a stronger claim on medical support and intervention than those in future
generations. 6 This suggests that obesity short-circuits usual sympathies for those so
afflicted in a way not seen in the majority of other conditions. As discussed in the
previous chapter this again suggests that obesity results in abjection.7 The failure to
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properly regard, categorize, and support appropriate individual-level efficacious obesity
treatments, including surgical interventions for weight loss, violates the moral obligation
to the individual patient which has been the hallmark of clinical medicine.
Assessing the utility of WLS is complicated by the fact that obesity is
conceptualized and addressed within two health-related enterprises: public health and
clinical medicine. In reality, these enterprises are and should be complementary. 8 With
respect to obesity, however, they may be seen as competing, with a normative bias in
favor of public health approaches. At the very least, each offers a competing way of
conceptualizing the root causes of obesity and interventions This chapter argues that it is
a category mistake, with substantial ethical sequelae, to apply only or primarily a public
health paradigm to address obesity, given the number of obese individuals who already
need clinical intervention to prevent co-morbidity and mortality. Even if it could be
agreed that prevention is (always or usually) superior to treatment, this aphoristic
commitment yields two ironies in the context of obesity where support for populationbased approaches exceeds and undermines acceptance of WLS as appropriate treatment.
First, this view fails to recognize that WLS functions as a preventive intervention albeit at
an individual-level; it seeks to prevent further or worsening co-morbidities in the
individual. 9 Second, successful treatment of an individual‘s obesity, including WLS,
frequently has a positive weight and health-related impact on the population surrounding
him, e.g., family and friends. 10
The conflation of public health goals with those of clinical medicine in this case
inappropriately diverts the attention of bioethical analysis away from the usefulness of
WLS as the primarily individual-level clinical intervention it is intended to be. Further,
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the conflation leads those who do consider the appropriateness of WLS to criticize it for
failing to address the population-level obesity problem. Coupled with social attitudes
toward obesity as evidence of individual moral failing, as discussed in the previous
chapter, this conflation seems to underwrite further stigmatization and blaming of obese
individuals, which in turn warrants refusing to recognize WLS as an appropriate
intervention for them. In contrast, accurately assessing the usefulness of WLS to address
the clinical medical problem of individuals‘ obesity supports viewing it as both ethically
and medically appropriate. Foreshadowing the argument of chapter five, it may be noted
here that for other life-threatening health conditions, such as heart or kidney disease,
there is little evidence of a social impulse to choose between promotion of public health
approaches and endorsement of effective individual-level clinical interventions as that
would be seen as a violation of justice.
This chapter will begin by addressing WLS in light of public health practices. It
will show that the public health paradigm which requires direct population-level social
utility is misplaced in evaluating the individual-level technology of WLS. The second
section will discuss the benefits of WLS as an individual-level treatment intervention for
obesity, i.e., its clinical and personal utility for individuals. The third section will reframe
the utility of WLS within its more appropriate clinical medical context to argue that the
concept of utility must be understood and applied at an individual-level to support WLS.
A. Obesity as a Public Health Concern and the Utility of Weight Loss Surgery
After presenting an overview of the history of public health problems, tools, and
the normative framework of a ―public health approach,‖ this section argues, first, that it is
a mistake to demand direct social utility of WLS because it is fundamentally an
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intervention to treat an individual‘s health problem just like other surgeries or using
statins to prevent heart disease or anti-virals to treat infection. Second, the section further
argues that even though WLS is an individual-level therapeutic intervention, it is also
properly considered and evaluated as a preventive clinical intervention. Third, the section
discusses the positive externalities associated with successful surgical weight loss, again
paralleling population-level benefits that result from individual interventions, like
preventing others‘ infection.
‗Public health‘ as a noun or adjective has many meanings. As a system it is ―a
broad social enterprise, more akin to a movement that seeks to extend the benefits of
current knowledge in ways that will have the maximum impact on the health status of a
population.‖11 The health status of a population—typically within a geographically
defined context—may also be referred to as the public health or the public‘s health. Used
as an adjective to modify an approach to or way of conceptualizing a problem, ‗public
health‘ emphasizes this population focus. One of the earliest definitions, provided by
Charles-Edward A Winslow, defined public health as:
the science and the art of preventing disease, prolonging life, and promoting
physical health and efficiency through organized community efforts for the
sanitation of the environment, the control of community infections, the education
of individuals in principles of personal hygiene [and] the organization of medical
and nursing services for the early diagnosis and treatment of disease. 12
More recently the Institute of Medicine stated, ―Public health is what we, as a
society, do collectively to assure the conditions for people to be healthy.‖ 13 Key points in
each of these definitions include the focus on the health status of populations of people,
and the tenet that societal efforts are made to ensure environments in which people are
able avoid developing diseases. These characteristics will be of particular importance in
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properly analyzing the usefulness of WLS below. The following section briefly explores
key historical problems which gave rise to the public health system with its unique focus,
framework, and tools of intervention.
A.i History of Public Health Problems and Interventions, and the Emergence of the
Contemporary Clinical Obligation of Individual Care
Since its beginning, public health has focused on the prevention of diseases,
injury, and avoidable disability at the population-level. Historically, public health
problems included sanitation, provision of clean water, vaccination, and the eradication
of disease.14 The first public health efforts have been traced to ancient Roman and Greek
civilizations. It was during these historical periods that a rudimentary understanding of
disease contributors such as polluted water and poor sanitation systems began to
emerge. 15 These cultures‘ attempts to understand and address diseases manifesting within
large sectors of citizenry are considered the foundations of what would become public
health. The association between the presence of swamps and development of wide spread
malaria was established during this time, even though the reasons for the association and
effective interventions were then unknown. Even in antiquity, the focus was on the
prevention of population-level diseases by altering the environment. In subsequent
centuries, additional advances too extensive to detail eventually evolved to become
modern public health. In the 18th and 19th centuries those advances began to be more
systematically tied to improving societal health by eradicating population-level diseases
resulting from infection and pathogens.16
Modern public health efforts are traced globally to the 18thand 19th centuries with
major advances seen in Britain and the United States. 17 In Britain, public health efforts
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were prompted by the smallpox and cholera epidemics of those two centuries.
Devastating parts of Europe, the smallpox epidemic was reportedly responsible for the
deaths of almost a half of a million people in the 18 th century. Smallpox was eventually
eradicated through development and use of widely distributed vaccinations. Edward
Jenner, a naturalist, is generally credited with the first scientific attempt to control an
infectious disease by the deliberate use of vaccination. Strictly speaking, Jenner did not
discover vaccination, nor is he thought to have been the first to use vaccination for
smallpox, but he was the first person to elevate the practice to a scientific tool and persist
in its rigorous investigation. 18
In the 30 years following Britain‘s first confirmed case of cholera in 1831, there
would be four cholera epidemics. Initially thought to be caused by miasma or bad air,
cholera was eventually believed to result from contaminated water sources. John
Sutherland and John Snow separately advanced theories of cholera‘s pathology, with
Sutherland believing that finding clean water sources was essential to the health of the
public. Snow advanced thinking on the particular mechanisms of cholera transmission,
which eventually led to the now famous removal of the water pump handle at Broad
Street. It was not until after Snow‘s death over three decades later that the true cause of
the cholera epidemics, cholera bacillus was described by Robert Koch.19
In the United States, the first settler‘s struggles with diseases such as smallpox,
malaria, and influenza established the colonies‘ initial need for public health efforts.
Though the settlers had some immunity, Native Americans, who had not previously been
exposed, generally succumbed to these diseases. The American civil war in 1861
―enforced a national consciousness of epidemic disease: two-thirds of the 360,000 Union
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soldiers who died were killed by infectious diseases rather than by enemy fire‖. 20 In the
post-war period, industrialization brought new diseases which were the result of the
movement of masses of people into urban settings without the understanding or benefit of
the sanitation systems for waste disposal. The rise in deaths due to potentially avoidable
industrial accidents also became a growing concern of public health efforts at this time. 21
Public health also began to concern itself with the class stratification resulting
from wealth gained by some industrialists. Public health sought ways to reduce the
health-related disparities between the wealthy and others, including laborers. Social
reform initiatives on child labor, maternal health, and improved housing became a focus.
Following World War II, when public health addressed malaria, to which large
numbers of troops were routinely exposed,22 the focus of public health became less welldefined. Immediate threats were no longer to be found among communicable diseases or
large scale industrial mishaps. Shifting attention from health threats whose social
destructive power was immediately evident to health risks like poverty and obesity,
whose intricacies do not permit silver bullet solutions like vaccination or sanitation has
complicated modern public health efforts. As public health law and ethics commentator,
Lawrence Gostin states, ―Somehow, America lost its commitment to public health in the
latter part of the twentieth century.23 More recently, public health has sought to re-define
itself in light of its numerous accomplishments in overcoming its original adversaries. 24
In the early days of public health and medicine few lifesaving interventions were
curative once a disease like cholera, small-pox, tuberculosis, or influenza had taken hold.
With no means to cure those already afflicted, the only options were palliation and
prevention to avoid the spread of disease. Patterns of behavior and environmental factors
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were observed to be associated with disease and its spread.25 The identification of the
Broad street water pump as the source of transmission, the presence of mosquitoes in
malaria-affected areas, recognition of the so-called natural immunity from smallpox of
dairy-maids, and the observation that doctors did not seem to contract disease directly
from their patients, attributed to their hand-washing (personal sanitation) practices, are
examples of such observed patterns.26 Altering environmental conditions and personal
behaviors in response to such observations—a preventive strategy—emerged in part
because of the impossibility of curative intervention in the disease course of those already
afflicted.
However, once individual-level interventions such as penicillin were developed,
both attention and prestige within the medical profession shifted from population-focused
prevention to the treatment and cure of individual ill patients. 27 The contemporary
medical ethos of a physician owing her primary fiduciary duties to her individual patient,
articulated by Hippocrates, was reinforced and has remained largely unchallenged until
recently when concern about escalating healthcare costs and limited effectiveness of
some interventions had led to the notion of physicians as stewards of healthcare resources
for the good of all. 28 Historical and ethical analyses have argued that, with few exceptions
(e.g., battlefield triage) it is unethical to withhold individual-level healthcare or medical
intervention for the sake of the greater good or in pursuit of public health goals. Other
individual-level sacrifices—e.g., of personal liberty in the case of necessary quarantine—
may be required for the sake of public health, but the sacrifice of individual health in
favor of public health was deemed contrary to the goals of both clinical medicine and
public health.29 When reasonably efficacious individual-level technologies were
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discovered or developed, providing them became a moral imperative in clinical medicine.
The imperative to provide the appropriate individual-level intervention did not negate
broader public health obligations to prevent and ameliorate the disease at the population
level, but neither was it seen as appropriate to withhold individual-level interventions and
technologies if individually appropriate based on their potential individual benefit.
The ethical failures in the Tuskegee Study of Untreated Syphilis in the Negro Male are
often cited to illustrate the importance of not violating the obligation of individual care in
the interest of pursuing public health goals, including research goals. Once penicillin was
found to be an effective treatment for syphilis, withholding this efficacious individuallevel intervention from subjects was eventually determined by history to be morally
reprehensible and fundamentally unjust. Withholding access to penicillin from the
Tuskegee research subjects in the interest of answering the question posed regarding the
natural course of untreated syphilis in the Negro male violated the clinical obligation of
individual care, prevented the men from making informed decisions about their own
healthcare, and in so doing, unjustly failed to treat these men according to the same
standard of care afforded to others outside of the study.30
A.ii The Goals, Normative Framework, and Tools of Public Health
The normative framework of public health is different from that of clinical
medicine. Public health efforts necessitate ―utilitarian, paternalistic and communitarian
orientations,‖ whereas clinical medicine favors ―civil liberties and individual
autonomy.‖31 The public health normative framework requires that efforts put forth are in
service to providing the overall greatest benefit, typically the avoidance of disease for
most members of a particular population. The public health framework permits and
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sometimes requires intrusions into otherwise personal actions by making compulsory
particular activities undertaken for the good of the wider community though they may
burden particular individuals.32 In contrast, clinical medicine focuses not at the societal
level but at the individual-level and seeks the individual‘s health-related good. There is
generally no obligation that considerations of societal benefit be included in that which is
considered clinical medicine.
Public health practice and clinical medicine have different goals. Public health
directs its efforts at populations to ―create conditions under which all members of the
population can experience the maximum degree of good health, within the limits which
may be imposed by economics, genetics, or the state of our knowledge‖. 33 The success of
interventions is measured in terms of the aggregate effect on the identified population,
even if individuals are affected in the process (as when individuals are vaccinated to
avoid disease or required to wear seatbelts or motorcycle helmets to avoid injury). Public
health interventions are generally broad and are intended to change systems—social,
environmental, biological— which in turn, change the outcome, incidence, or intensity of
disease and disability. 34
Early and contemporary public health initiatives employ information
dissemination, persuasion, and as a last resort, coercion and intrusions into areas of
personal privacy. Quarantine, compulsory vaccinations, and other paternalistic intrusions
which constrain the liberties and even override the rights of individuals were and are
justified by the greater societal benefit. 35 A determinable link between behaviors which
lead to broader contamination and interventions to prevent disease spread justify
intrusions into what would otherwise be seen as matters of personal regulation.
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According to Gostin, public health tactics, particularly those that infringe personal
liberties, must be matched to the scope and immediacy of the threat, with the least
restrictive alternative chosen among the range of possible interventions. 36
Prevention efforts are elucidated in terms of their target. One framework,
proposed by the Commission on Chronic Illness in the 1950‘s, elucidates two types of
disease prevention, 37 to which a third was later added. Primary, secondary, and teriatry
prevention are explained in the Journal of Public Health Reports:
Three decades have elapsed since a working group under the Commission on
Chronic Illness proposed the classification of disease prevention into the
categories primary and secondary. An additional term, ‗tertiary prevention,‘ has
gained currency since, and the classification is now ubiquitous in textbooks of
epidemiology and preventive medicine. These classes are summarily defined as
primary-practiced prior to the biologic origin of disease; secondary-practiced after
the disease can be recognized, but before it has caused suffering and disability;
and tertiary-practiced after suffering or disability have been experienced, in order
to prevent further deterioration.38
This classification system, as envisioned at the time of its development, recognizes a
variety of appropriate interventions depending on whether or not disease had manifest or
was merely a risk. Complete avoidance of disease is one of public health‘s highly
desirable goals, however, the framework recognizes that disease avoidance is not always
feasible. In that case, secondary prevention efforts would apply to those who had already
manifested the disease but were at present asymptomatic. 39 By way of example, a person
with hyperglycemia who is unaware of it until screening occurs would be the target for
secondary prevention efforts. Tertiary prevention efforts could include active clinical
treatment which is undertaken to reduce the severity of the primary disease or to reduce
its complications. 40 As Robert Gordon‘s piece criticizes, the various levels of prevention
were not meant to be used in a hierarchical manner with primary being seen as a superior
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preventive effort to the others but instead were intended to be applied based on the
particular context of the disease and its degree of manifestation and burden. He states:
Although it was not the intention of the Commission to suggest that primary is
preferable, and secondary is second rate, this impression may develop,
particularly among lay persons who may have responsibility for important
decisions that bear on preventive programs. Careful quantitative analysis of
benefits, costs, risks, and effectiveness frequently reveals that a preventive
intervention is best applied only to a high-risk group, the evidence of high risk
being a finding that can be related to the biologic origin of disease. Though
‗secondary,‘ this may well be the optimal preventive strategy. 41
Presumably, Gordon‘s analysis that the inappropriate ordinal priority ranking of these
interventions based on the potentially misleading terms primary and secondary would
also extend to tertiary interventions.
Application of this classification to asthma prevention in minority populations
illustrates the integration of the three levels. 42 Primary prevention of asthma might
include targeting a major risk factor in its development such as low-birth weight. By
focusing on pre-natal care and increasing birth weight, children would likely be able to
fully avoid ever developing asthma. A secondary prevention activity would be early
identification through screening programs. After proper screening the child with
undiagnosed asthma and his family could make changes in their environment to avoid the
progression of symptoms and the full blown manifestation of the disease. For those
whose asthma had already manifested and were experiencing active symptoms tertiary
prevention would focus on mitigating disease complications through ensuring access to
and correct use of medications, or earlier intervention when symptoms surface. 43
As the example of asthma illustrates, the classification system of prevention
stages acknowledges the importance of clinical interventions to reduce the severity of the
symptoms associated with already present disease. Yet the concern which Gordon raised
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regarding the potential for the levels of preventive efforts to be misunderstood as
indicating priority or preferability is, this chapter argues, evident in analyses of obesity.
Consider the application of the classification framework to preventive efforts aimed at
obesity and its co-morbidities. Primary efforts at complete avoidance of obesity focus on
such things as changing the built environment. Secondary preventive efforts include
measurement of BMI, along with screening for obesity and its co-morbidities. Weight
loss surgery when used to diminish the burden of disease in those already diagnosed can
be seen as both a secondary and tertiary level intervention, designed to prevent further
obesity and to prevent obesity associated co-morbidities. As in the case of asthma, each
level of prevention should be deemed equally valuable. Each is intended to meet a
particular goal as a tool of public health efforts at various points along the disease
manifestation continuum.44 That stage of temporal intervention is confused with social
priority or ethical hierarchy among the levels of intervention evidences a continuing
confusion about their meaning and goals. For reasons discussed in the previous chapter
and explained below, the social construction of obesity and the tendency to moralize
about it, may exacerbate both this confusion and the negative impact of regarding some
types of prevention as ethically preferable.
A.iii Contemporary Moralizing Attached to Public Health Campaigns
Since the early days of public health, its evolution and successes have been both
gratifying and troubling. The success of public health initiatives has meant that as a
population, residents of the United States and other wealthy nations are safer and less
likely to fall victim to relatively avoidable, by modern standards, health threats such as
smallpox and diphtheria. Immediate dangers to life and quality of life in developed
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countries have been substantially diminished. 45 The counterpoint to that success,
however, has been a kind of identity crisis within public health. 46 Immediate health
threats which are under control require only ongoing surveillance and modification of the
interventions already in place. Annual flu vaccination campaigns require ongoing
surveillance, modification to account for variations in the strains of influenza expected to
manifest, and annual education campaigns, but the course of action and intervention need
has been fairly well-established over the years.
Modern public health efforts are substantially different from the early public
health successes. 47 The recent focus of public health has been described as increasing the
standard of living among citizens and providing expert advice on a range of issues
including nutrition, physical health, longevity, and the imposition of rules thought to
benefit the masses. Today public health is grounded in epidemiology but interventions
are shaped by economic, social, and political concerns. 48 The modern scope of public
health has been criticized for being so broad as to engender substantial confusion over its
proper place in the lives of citizens, the amount of control with which it should exert its
authority, and the type of tactics it should use to produce its desired results. 49 While many
of these questions are not dissimilar to early ruminations in the exercise of public health,
the issues to which they apply are. The majority of modern public health issues are
muddier with less well-defined immediate and communicable risks than those which
have already been addressed. 50 Public health issues, as well as the interventions to
address them, interact with economic, social, and political concerns.
Much has been written on the new moralizing vocation of modern public health. 51
Expert advice dispensed by those who are knowledgeable has sometimes been thought to
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be sufficient for rational moral agents to act in their own health interests. Unfortunately,
the expert public health advice may not be able to be wholly or even partially applicable
because of the personal situations of the individuals the advice is intended to motivate.
Thus, as described by Bernard Turnock , when the expert advice of public health, fails to
effect the type of changes anticipated, the entire field of public health, or individual
voices within it, may chastise those who ignored the advice. Targets of such chastising
may include patients who contract HIV or Hepatitis C in spite of sincere and thorough
expert public health initiatives, or the obese who fail to realize significant weight loss in
the face of health promotion and weight loss activities. 52 Public health‘s zeal and good
intentions may serve as spurious justification for its moralizing tone.
Public health initiatives directed at conditions having a substantial behavioral
component have now adopted a stance which can be described as the idealistic,
moralizing, and stigmatizing. 53 Public health efforts are idealistic because they reflect and
valorize the way in which individuals and systems should behave and should act in order
to obtain the best possible health outcomes. The modern focus of public health is the
avoidance of disease in future generations of as yet identified individuals. As in the past,
this focus on future generations ignores the risks to and manifestation of disease in
current individuals. In the past, such a future focus could be justified because of the lack
of curative interventions. Today an exclusive or excessive future focus denies the reality
of effective individual-level interventions do currently exist. In light of effective
individual-level technologies choosing one level or prevention to the exclusion of the
other is unethical.
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A.iv Obesity, Weight Loss Surgery, and Public Health
The utilization of surgical weight loss interventions has been criticized because it
provides individual benefit but fails to address the greater public health concern of
increasingly large numbers of people diagnosed as being obese. 54 In one of the rare
bioethical treatments of obesity and WLS, an article by ethicist Rosemarie Tong,
provides an analysis of the relative risks and benefits of both the ―high risk (clinical) and
population (public health) approach to obesity and overweight.‖ 55 In her comparative
analysis Tong offers the following insight:
Instead of wasting time and resources on normal weight individuals, the clinician
focuses on an already overweight individual, particularly those who threaten to
enter the obese category. Why waste money educating slim-enough people about
the dangers of a condition they do not manifest? Instead, hammer the message
about ―fat‖ home to those patients whose clothes are already painfully tight. 56
Tong analyzes the relative merits of public health and clinical strategies by likening
bariatric surgery to a ―quick fix‖ which she further suggests Americans love. Finally she
summarizes her analysis by concluding that ―the benefits [of a public health campaign]
outweigh the risks of a public health campaign against obesity.‖ 57
Tong‘s article ultimately acknowledges a need for both clinical interventions and
public health strategies to address obesity. Yet is persistently confuses the purpose and
focus of each type of initiative, and fails to acknowledge the complexity of obesity for the
individual so diagnosed. Moreover, it appears that she does not fully comprehend the
usefulness of bariatric surgery for those immediately afflicted who are seeking resolution
to serious problems within a narrow window of time. The comparative time frame of
effectiveness of these strategies is the obese person‘s own statistically diminished life
span, not one or even several generations in the future. This longer time frame of multiple
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generations has been required to realize public health‘s successes in tobacco cessation,
while this level of success has yet to be achieved by public health strategies intended to
diminish overconsumption of alcohol. 58 Tong‘s article suggests that ethicists are not
comfortable working in the realm of public health but are more comfortable in the realm
of clinical medicine. While it is indeed true that clinical medical issues have occupied
much more of bioethicists‘ attention and the bioethical literature, when bioethicists do
turn their attention to topics that cross into both the clinical and public health spheres,
they must be careful to clearly distinguish the goals and the focus of each of these
enterprises. This is particularly true if ethicists choose one strategy over the other to
address a particular issue.
Unlike Tong, who acknowledges what appears to be competition between clinical
and public health strategies addressing obesity, another article intended as comprehensive
ethical analysis of bariatric surgery fails to acknowledge this competition as an ethical
concern. An article by Bjorn Hoffmann lays out what he sees as the ethical issues
surrounding bariatric or WLS. He terms his method of ethical analysis to be an
―axiological approach.‖59 The intended goal of his approach is to pose several morally
relevant questions which are designed to reveal the ethical values applied to a particular
intervention, in this case WLS.60 His analysis fails however to take up or even
acknowledge the concern of conflating the population-level goals of public health
initiatives with the individual-level goals of clinical medicine interventions for its
treatment. In a follow-up commentary to Hoffmann‘s original piece two authors did take
up this particular concern. 61 It appears however, that they too are confused by the proper
ethical framework which ought to be applied to public health initiatives on obesity and a
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different ethical framework which applies to clinical interventions. The commentary
critical of Hoffmann‘s ethical analysis states:
Bariatric Surgery is a technology-intensive, personalized response to a global
public health problem. It is far too expensive and far too risky to be an effective
solution for a problem of that kind. 62
In stating that bariatric surgery is a response to a global health problem the commentators
misunderstand the appropriate focus of such interventions; they conflate the goals of
clinical medicine with the goals of public health. Later in the same commentary they
suggest that it is inappropriate to focus on WLS as an intervention since other venues,
primarily public health initiatives have not yet been given sufficient resources or a
genuine opportunity to ameliorate obesity. They write:
Similarly, if full-scale public health initiatives were mounted, the comparative
cost effectiveness of various treatments including bariatric surgery might change
dramatically. So, rather than pointing out the need for additional research on
bariatric surgery, the call should be for additional study of all possible parts of a
public health response and a new comparative analysis. 63
In characterizing their position, they refer to it as ―big picture approach‖ intended to offer
better conceptualization of the problem and pointing to more promising solutions. 64The
big picture approach appears to be one focused on the health of the public, not the health
of the individual currently diagnosed with obesity and its related co-morbidity. It is
equally true that theirs is a zero-sum approach; they seem to assume that public health
and clinical pathways cannot be simultaneously pursued or that pursuit of one must be
purchased by ignoring the other.
Finally, the commentators summarize their position on WLS in the following
way:
Bariatric surgery is short-term in that it is highly individualized (rather than
population based) and focused on post facto treatment (rather than prevention). As
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such, it should not be the sole, or even the primary response to a genuine public
health crisis. It is critical that the social sources of the obesity epidemic be taken
seriously in order to prevent a skewed analysis of bariatric surgery that vastly
overestimates its potential as a solution. 65
The authors are correct in asserting that WLS is not the answer to the growing public
health problem of obesity. However, their analysis fails to recognize that WLS should not
be utilized to solve the public health problem of obesity. The commentators commit the
category-mistake discussed earlier in this chapter. Furthermore, the authors fail to
recognize that by re-directing resources toward mounting comprehensive public health
initiatives to ameliorate obesity, individuals in the present will likely continue to grow
increasingly more debilitated and lose both quality and years of life.
A Danish study seems to support the prejudice that obesity amelioration through
public health initiatives should be given higher priority than clinical approaches. The
study showed that people are willing to fund public health approaches more often than
clinical treatment, including WLS.66 The survey study‘s aim was to investigate the
Danish public‘s support for publicly funded obesity treatment versus prevention. (It is
important to note that the study was conducted in a country, unlike the United States,
with publicly funded health care which would likely pay for weight loss interventions
such as surgery.) The study also examined whether levels of support, or lack thereof,
could be explained by negative attitudes toward obese people and/or the belief that those
who are obese are personally responsible for their condition. Participants (n = 1,141)
completed a web-based questionnaire designed to assess attitudes toward public funding
for obesity-related health care, and to investigate the impact, of the following attitudes:
dislike of obese people, and the perceived controllability of obesity. The study found that
public funding of some obesity treatments, such as weight-loss surgery, attracted very
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limited public support. A majority of the Danish public did support what the authors‘
term as ―softer‖ treatment interventions such as supervised diet and exercise and public
health initiatives focusing on primary prevention. Attitudes about the acceptability of
various interventions for obesity were found to be best predicted by the belief that
individuals are personally responsible for their obesity. Participants believing that obesity
is an issue of personal responsibility were more likely to favor public health strategies
than participants whose belief about the origins of obesity were less strongly tied to
personal responsibility. Furthermore, when the option of WLS was re-framed as a lifesaving intervention ―a sizable proportion who initially disapproved of public funding for
WLS changed their minds.‖67 The following article reveals attitudes on the support of
public health efforts towards ameliorating childhood obesity.
An article on childhood obesity calls for more resources to support public health
efforts to address obesity and expresses skepticism about developing additional treatment
interventions presumably including weight loss surgical treatment. The authors write:
This public health crisis demands increased funding for research into new dietary,
physical activity, behavioral, environmental and pharmacological approaches for
prevention and treatment of obesity, and improved reimbursement for effective
family-based and school-based programmes. However, because this epidemic was
not caused by inherent biological defects, increased funding for research and
health care, focusing on new treatments will probably not solve the problem of
paediatric obesity…68
While it has been shown that obesity is an increasing public health concern, 69 to discount
the benefit of obesity surgery for the individual because it does not effect a cure for
obesity as a public health issue fundamentally misunderstands the social role of clinical
medicine, a role which should co-exist with public health efforts to address obesity. In
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contrast, one commentator recognizes the potential role of WLS in the treatment and
prevention of co-morbidities, here obesity-related diabetes (diabesity):
Prevention of this diabesity epidemic through effective public health lifestyle and
environmental initiatives to change the population‘s dietary and movement
behaviors would be of highest priority. For those already suffering from diabesity,
effective treatment is important. A therapy that provides remission of both
diabetes and obesity should attract enormous interest and activity. 70
This commentary goes on to express the belief that WLS should have an important role in
the early intervention of co-morbid disease associated with obesity. The article
acknowledges the importance of both strategies and expresses what appears to be the
unique insight that, at least at the present time, public health strategies are not able do the
work of clinical medicine to resolve individual-level obesity. Instead, individual-level
treatments such as WLS must be employed to help resolve immediate problems of those
currently afflicted.
It is thus clear that the three-level classification of public health prevention
strategies discussed in the previous section permits more than one narrow conception of
prevention. 71 Although popular conceptions of prevention may be limited to ensuring
that the disease never manifests in an individual—i.e., the avoidance of disease rather
than the curtailment of disease once manifest—if the full scope of prevention strategies is
properly applied, surgery would appropriately be considered secondary or tertiary
prevention techniques and would therefore be seen as acceptable even perhaps a victory
in the domain of public health. (Indeed, in the case of breast cancer prevention,
prophylactic mastectomy is the most effective preventive intervention for those carrying
BRCA1/2 mutations.) Public health initiatives defined as primary do continue to be
confused as having ethically salient ordinal ranking ahead of other types of efforts. 72 The
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following describes several public health strategies which have been employed to reduce
obesity.
To ―combat the nation‘s obesity epidemic‖ 73 public health strategies include
increased taxation of ―junk foods‖, eat-less-and-exercise-more campaigns, state specific
bans on trans-fats, high-fructose corn syrup awareness advertising campaigns, removal of
snack and soda vending machines from elementary and high schools, requiring that
nutritional information be posted on restaurant menus, re-inventing guides to proper food
portions (e.g. phasing out the food pyramid guide in favor of the eat-well plate) among
others. Research done on public health strategies for obesity has found that such
interventions, many of which have been initiated only recently, either have not had
sufficient time, opportunity, or resources to show significant results or that it is difficult
to discern what if any improvements are attributable to these efforts.74 It has also been
noted that some public health initiatives are difficult to evaluate due to the limited
number of studies that meet rigorous research standards and the fact that they tend to
report non-comparable outcomes.75 A meta-analysis by Katz et al. examined the success
of initiatives undertaken in schools and in workplace settings reviewed all published
results of such interventions between 1966 and 2001, Initially 44 studies were included in
the school sample and 35 in the work place sample; however, after being evaluated for
quality, only 10 school and 20 worksite studies were included in the meta-analysis. All
interventions were related to altering diet or increasing physical activity; the outcome
measures were primarily weight-related measures such as BMI, weight or other
anthropometric measures (e.g., waist to hip ratio), with subjects followed for at least 6
months. 76 Some studies showed modest weight loss in six months, approximately 4
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pounds on average for participants; however, the task force conducting meta-analysis
determined that ―insufficient evidence existed to determine the effectiveness of
combination nutrition and physical activity interventions to prevent or reduce overweight
and obesity in school settings because of the limited number of qualifying studies
reporting non-comparable outcomes.‖77 This meta-analysis demonstrates that accurate
evaluation of the efficacy of school and work-based public health initiatives for weight
loss is hampered by lack of rigor, but suggests that the amount of weight loss realized
through such initiatives is likely modest.78 For those who are obese, an average of 4
pounds of weight loss in six months‘ time would likely be insufficient to improve their
overall health and well-being and rid them of both the physical and social co-morbidities
associated with extra weight.
Another concern potentially hampering public health efforts to reduce obesity
may be the lack of relatability in health promotion messages. A meta-analysis by
Malterud and Tonstad sought to analyze challenges faced by health promotion strategies
to address obesity within a Scandinavian context.79 The review of primary studies on
health promotion efforts in Norway and Finland found that these health promotion efforts
faced several challenges related to the unequal distribution of vulnerability to weight gain
within the population. Individual factors such as race, age, socioeconomic factors, and the
presence of abuse or neglect, among others, made developing effective general
population-based public health efforts an unrealistic expectation. The very nature of such
a broad-based population-wide intervention discounted variables and failed to address the
highly nuanced and individualized factors believed to influence the development and
maintenance of obesity. The authors outlined implications of their analysis for practice.
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They recommended that health promotion needs to be highly individualized and tailored
to the obese person. Preventing weight gain requires attention to the person‘s sociodemographic, cultural, and genetic characteristics. Health promotion initiatives, as a part
of the public health arsenal of tools, are unable to provide this individualized attention. 80
Even more, when such interventions fail, this failure can wrongly be used to turn weight
control into a question of morality and self-control. The study suggests that when general
health promotion messages are delivered (even those which lack reliability) and then
prove ineffective in assisting the individual to lose weight and gain health, the
assumption is that the message recipient (the obese person) has failed to appropriately
take up and use the helpful professional expertise provided.81 The situation then becomes
one of blaming the victim. The study concludes that ―cultural aspects on identity and
morality may create victim blaming and disempowerment obstructing health promotion
strategies for weight control.‖ 82 The obese person, originally thought to lack morality and
self-control, has now ―proven‖ his moral inferiority by once again failing to lose weight
in accordance with the non-specific health promotion messages promulgated.
Commentators Puhl and Heuer concur, arguing that he possibility of obesity
stigma, whether intended or unintended, should be an important consideration in the
development of more useful and helpful public health messages. ―For the public health
community to address the widespread health and social disparities faced by obese
people,‖ they state, ―we must move past the victim-blaming approach and instead
advocate a comprehensive obesity prevention strategy that includes efforts to reduce
weigh-based stigma and discriminations.‖ 83 Recognizing the additional burden that public
health initiatives can impose by seeming to blame obese people for both their condition
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and their failure to utilize expert information may be a first step toward avoiding
campaigns that are actually counter-productive to achieving the goals of public health.
Public health and clinical medicine are best used as complementary efforts. With
regard to obesity, public health efforts should be focused on the prevention of obesity, the
prevention of further weight gain, or the curtailment of disease in those who are already
obese. Clinical medicine addresses the needs of the individual who has become obese and
faces secondary and tertiary co-morbidities associated with excess weight. Neither
approach should be expected to accomplish the goals of the other, though both must
embrace preventive interventions to achieve their respective goals. Commentators who
advocate public health approaches to the exclusion of clinical medical interventions to
address obesity mix their differing foci and goals, and further, risk employing the
normative framework appropriate to population-level interventions to criticize individualfocused interventions like WLS. This category mistake may result in applying a
moralized framework within the clinical medical context where promoting patient
autonomy and well-being are the appropriate normative goals of the professional
obligation of individual care.
In summary, the goals of public health and clinical medicine are not the same.
Public health focuses at the population-level and permits for various degrees of disease
prevention from never developing disease to effectively curtailing its co-morbidities in
those who have already developed the disease. Clinical medicine is focused on the
individual and on resolving the particular, often highly nuanced, medical issues of the
identified patient and avoiding the onset of (additional) co-morbidities.84 Each enterprise
makes a distinct contribution to the development and implementation of systems intended
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to address the many problems, origins, and solutions attributable to obesity. Public health
efforts, as well as clinical medical technologies, should both be employed. 85 However,
holding WLS accountable for not alleviating the public health problem of obesity and
discrediting its clinical utility because it does not have direct social utility, is to conflate
the goals of public health and clinical medicine. This category mistake has unfortunate
ethical implications when bioethicists, policymakers, or the public are led to discount the
value of WLS. Embracing public health initiatives to the exclusion of providing a
medically warranted continuum of care to obese individuals would unjustly sacrifice
currently obese individuals for the good of future populations.
Applying the public health yardstick to measure what is essentially a clinical
medicine issue undermines assessment of the potential utility of WLS. Weight-loss
surgery has its greatest potential utility at the level of an individual‘s health, and it may
be the individual-level intervention with the greatest clinical utility, i.e., it may have the
highest probability of promoting patient well-being. It has been shown to be more
effective than other individual-level interventions, and it has also been shown to be a cost
effective clinical intervention in the long-run.
Although it is beyond the scope of this dissertation‘s argument to engage in an
exhaustive cost effectiveness analysis, both the clinical utility and the potential cost
effectiveness of WLS will be addressed in the next sections of this chapter. This project‘s
second chapter presented some evidence of the general efficacy of WLS as an
intervention for obesity. The following section will provide detailed evidence of the
ability of WLS to reduce or fully alleviate various co-morbidities—both physical and
social—and to thereby constitute an effective individual-level preventive and
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therapeutic/curative treatment. Establishing the clinical utility of WLS supports the
argument that it should be fully embraced by clinicians and the public as part of the
establishing an effective continuum of care for obesity.
B. The Clinical Utility of Weight Loss Surgery and Its Personal Utility
This section will first review the general data on the effectiveness of WLS to
effect durable weight loss. It will then provide detailed empirical evidence which shows
that WLS does indeed constitute a useful technology to employ in ameliorating the major
physical and psycho-social co-morbidities of those who are obese. It will argue that WLS
is therefore an effective clinical intervention for obesity. In short, this section will show
that WLS has clinical utility at the individual patient level. Clinical utility is defined and
used here as ―the usefulness of an intervention for, or in, clinical practice.‖ 86 Moreover,
this section will briefly discuss the financial costs of providing WLS to ameliorate its comorbidities in comparison to the financial costs associated with treating the comorbidities of obesity over the course of a lifetime. Finally, this section will use
individual narratives of those who have undergone WLS to demonstrate that WLS has
personal utility in meeting patients‘ unique, highly personal goals.
B.i Clinical Utility of Weight Loss Surgery
Where appropriate, this subsection will discuss the outcomes of specific
interventions such as gastric banding or Roux-en Y gastric bypass; however, in general,
the resolution of co-morbidities has been most effective and durable for those who are
obese and have undergone Roux-en-Y gastric bypass surgery. 87 The ability of WLS to
resolve individuals‘ obesity-related patho-physiology will be discussed and will include
the following areas: hypertension, diabetes, sleep apnea, cancer, mortality, depression,
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and other various quality of life indicators. To begin, however, this sub-section reviews
the clinical utility of WLS for weight loss itself.
As previously discussed in Chapter two various forms of WLS have been in use
for over sixty years. 88 While some earlier permutations of the surgery are no longer
utilized and have been supplanted by more successful less invasive options, WLS is
generally regarded as ―the most effective treatment‖ for those who have extreme
obesity. 89 A systematic meta-analysis of short and medium term weight-loss durability
was conducted by reviewing data from 43 outcome studies on subjects who had
undergone various types of WLS. ―The most important single observation to be drawn
from this meta-analysis is that pooled data of all operations demonstrates that bariatric
surgery can achieve a major reduction in weight which is sustained for at least ten
years.‖90 The authors conclude that current bariatric operations achieve a major and
durable weight loss in the medium term.
Bariatric surgery results in significant and durable weight loss. Specifically,
surgical patients have been shown to lose as much as 60 percent of excess weight in the
first six months following surgery and 77 percent of excess weight at the twelve month
mark following the intervention. 91 Overall, the likelihood of major complications is about
2.5 percent across all types of surgery. 92 Mortality attributable to the bariatric surgery is
approximately 0.1 percent.93 Furthermore, clinical evidence has shown that the risks of
morbid obesity outweigh the risks of bariatric interventions for obesity. 94 Bariatric
surgery has also been shown to extend the life span of the gastric bypass patient by as
much as 89 percent. The risks of premature death due to obesity have been shown to be
reduced by 30-40 percent for those undergoing WLS.95 Bariatric surgery is also useful in
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preventing, improving or resolving more than forty obesity related diseases and
conditions. 96 Several of the major and most dangerous co-morbidities, both physical and
psychosocial, associated with obesity are improved by WLS. The research in each of
these areas is discussed below.
B.i.a Hypertension
Sugerman et al. evaluated the pre and postoperative relationships between
hypertension and type 2 diabetes in severely obese patients and the effects of gastric
bypass induced weight loss. Data regarding patients‘ pre and postoperative diabetes,
hypertension, and other co-morbidities including sleep apnea and joint disease, were
collected on 1,025 patients who had surgery by one general surgeon at a Universityaffiliated hospital over a nineteen year period of time. 97 Pre-operatively, 51 percent of the
sample had hypertension either alone or in combination with diabetes. Postoperatively,
after one year with a follow up rate of 91 percent, hypertension had resolved in 69
percent of those who had undergone the procedure. At follow up of between five and
seven years the resolution of hypertension remained at 66 percent. African American
patients, who have a higher risk of hypertension in general, were less likely to have
significant resolution of their hypertension following the WLS. Additionally the study
showed that for those whose hypertension resolved it was associated with a greater
excess weight loss relative to their initial weight.98
The Swedish Obese Subjects Study, a long term longitudinal published in the New
England Journal of Medicine, evaluated the effects of WLS across many clinical
indicators at the two and ten year post-surgical intervals. Unique in its design, this study
matched 2,010 patients who underwent gastric surgery with 2,037 who were
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conventionally treated to evaluate numerous co-morbidities associated with obesity.
Initially there was significant improvement in hypertension found in surgically treated
patients as compared to matched controls. However, the improvements noted at two years
were no longer present at the eight year interval post-surgery. It was noted that those who
underwent gastric bypass surgery, as opposed to other surgical techniques, had a
significantly greater weight loss and also were better able to maintain a decrease in blood
pressure for a more sustained period of time following surgical weight loss intervention. 99
Research on the resolution of diabetes is provided in the next subsection.
B.i.b Diabetes
A meta-analysis conducted of all articles published between January 1, 1990 and
April 30, 2006, included 621 studies, on the effects of weight loss surgical interventions
indicated that overall 78.1 percent of diabetic patients showed complete resolution of
diabetes while diabetes was improved in 86.6 percent of patients.100 Diabetes resolution
was greatest in patients who had undergone biliopancreatic diversion or duodenal switch.
The second most efficacious intervention for resolving diabetes was gastric bypass
surgery. Banding interventions followed gastric bypass in resolving diabetes.101 The
meta-analysis concluded that:
the clinical and laboratory manifestations of type 2 diabetes are resolved or
improved in the greater majority of patients following bariatric surgery; these
responses are more pronounced in procedures associated with a greater percentage
excess of body weight loss and [diabetes resolution] is maintained for two years
or more.102
A 2009 study in the journal Surgery for Obesity and Related Diseases showed
that early remission of type 2 diabetes occurred in 89 percent of patients following Rouxen-Y gastric bypass.103 The study included 177 patients, and the follow up period ranged
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from 5-16 years post operatively. Of the 177 patients, 157 had a complete remission of
type 2 diabetes postoperatively. Twenty patients did not benefit from a remission in their
type 2 diabetes even though they had experienced significant loss of excess weight. The
study further showed that the durability of remission from type 2 diabetes diminished
over time. At more than 5 years post-surgical intervention 43.1 percent of patients
continued to show a remission in their diabetes. While remission of type 2 diabetes was
found to be more durable in men it was also found that weight regain was statistically
significant but a weak predictor of diabetes reoccurrence. The study posits that durable
remission of type 2 diabetes remission is most closely correlated with an early disease
stage at gastric bypass,104 which suggests that earlier surgical intervention may be
optimal as the window of opportunity time to resolve this co-morbidity may diminish
with delayed intervention.105
Two studies published in March 2012—one conducted at Catholic University in
Rome, the other at the Cleveland Clinic—further establish a positive relationship between
surgical weight loss interventions and the resolution of diabetes.106 The Catholic
University study compared two types of surgery with usual medical treatment. After two
years, the surgical groups had complete remission rates of 75 percent and 95 percent;
there were no remissions in patients who received medical treatment.107 The second
Cleveland Clinic study compared two types of surgery with an intensive medical
regimen. The remission rates one year after surgery were lower than in the Italian
study—42 percent and 37 percent—at least in part because the American study used a
stricter definition of remission. The intensive medical treatment led to remission in 12
percent of patients. The study suggests that the mechanism for resolution of type 2
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diabetes may have to do with changes in the gut which are not fully understood at the
present time.108 Limitations of the studies include that each was done at a single
institution and only report results over two years; however, the results may warrant
earlier surgical treatment for weight loss in those with type 2 diabetes. 109
In order to maximize the window of opportunity for resolving type 2 diabetes it
may be necessary that obese patients embark as early as possible on a continuum of
clinical care that takes them, from the offices of primary care physicians to specialists in
WLS. To accomplish this.the stigma currently associated with obesity and obesity
interventions would need to be addressed, since we have seen that bias and stigma can
prevent physicians from engaging in conversation about surgical interventions for
obesity. Empirical research indicating the restorative effects of surgical weight loss
interventions, with resultant remission of co-morbidities, should motivate efforts to
address physicians‘ personal negative feelings about those who are obese. Improvements
in sleep apnea are revealed in the following subsection.
B.i.c Sleep apnea
A study of the effectiveness of bariatric surgery as a treatment for obstructive
sleep apnea (OSA) in patients with clinically significant obesity demonstrated that OSA
is prevalent pre-operatively in 60 percent of patients who were to undergo bariatric
surgery.110 In this study 100 patients were evaluated for symptoms of OSA by
polysomnography before gastric bypass surgery. Pre-operativee and postoperative scores
of Epworth Sleepiness Scale (ESS), Respiratory Disturbance Index (RDI), and other
parameters of sleep quality were compared to determine if bariatric surgery altered OSA
as weight loss progressed. Pre-operative evaluation revealed that 13 patients had no OSA,
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29 had mild OSA, while the remaining 58 patients were being treated pre-operativeely for
moderate-severe OSA.111 Following bariatric surgery, at a median of 6 months follow-up,
BMI and ESS scores improved to date, 11 patients had completed postoperative
polysomnography (3-21 months) after losing weight. There was significant improvement
in ESS, minimum O2 saturation, and sleep efficiency when comparing pre-operative and
postoperative scores. The study concludes that gastric bypass is an effective treatment for
OSA in patients with clinically significant obesity. 112
Another study evaluating the impact of surgically induced weight loss on
Obstructive Sleep Apnea/Hypopnea Syndrome (OSAHS) examined electrocardiographic
changes, pulmonary arterial pressure, and daytime sleepiness in morbidly obese patients
in 16 women and 13 men who underwent bariatric surgery within a 3-year period.113
Weight loss induced by surgery eliminated OSAHS in 46 percent of obese patients with
an important improvement in oxygen saturation. Neck, thorax, waist and hip
circumferences decreased significantly after surgical intervention but only neck
circumference correlated significantly with the apnea/hypopnea index.
Electrocardiographic abnormalities were present in 9 patients (31 percent) preoperatively (sinus arrhythmia, ventricular arrhythmias, and sinus arrest). The number of
electrocardiographic abnormalities decreased after surgery but new abnormalities
appeared in some patients. Systolic pulmonary arterial pressure significantly decreased in
the group of patients in whom OSAHS disappeared after surgery. The study concluded
that bariatric surgery effectively reduces respiratory disturbances during sleep and
improves pulmonary hypertension. Electro cardiographic abnormalities change after
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surgery and that some daytime sleepiness appeared not to be related to respiratory
disturbances during sleep. 114
Obstructive sleep apnea and hypopnea syndrome are associated with high
mortality and serious morbidity, and it appears that weight loss induced through surgical
intervention will correct both, thus improving both the physical co-morbidity and
providing a useful resolution to diminished quality of life associated with daytime
sleepiness.115 From the perspective of the individual with sleep apnea or hypopnea
syndrome associated with excess weight, there appears to be evidence that surgical
weight loss intervention is individually useful in providing relief from this life limiting
co-morbidity. Post-surgical reductions in cancers are discussed below.
B.i.d Cancer/Malignancy
One study reviewed the incidence of cancer and mortality data through 2007
from the Utah Cancer Registry (UCR) which compared 6,596 Utah patients who had
undergone gastric bypass between the years 1984–2002 with 9,442 severely obese
persons who had applied for Utah Driver‘s Licenses during the same time. 116 Controls
were group matched to represent the gender, age, and BMI distribution of the surgical
patients. The study outcomes included data on the incidence, case-fatality, and mortality
for cancer by site and stage at diagnosis of all gastric bypass patients, compared to
severely obese controls that had not undergone surgical weight loss interventions.
Follow-up was conducted over a 24-year period with the mean follow up time being
approximately 12.5 years.117
Study findings included that the total cancer incidence was significantly lower in
the surgical group as compared to matched controls. A lower incidence of cancer in the
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WLS patients versus the control group was primarily attributed to decreased incidence of
cancer diagnosed at regional or distant stages. The terms regional or distant refer how far
the cancer had spread from its site of origin—regional refers to affected areas closer in
proximity, such as immediately adjacent lymph nodes, while distant refers to cancer
which has spread farther from the original site. Cancer mortality was found to be 46
percent lower in the surgery group compared to matched controls. Although the apparent
protective effect of surgery on risk of developing cancer was limited to cancers likely
known to be obesity related, the inverse association for mortality was seen for all cancers.
Significant reduction in total cancer mortality in gastric bypass patients compared with
severely obese controls was associated with decreased incidence, primarily among
subjects with advanced cancers. The study findings suggest that gastric bypass provides
useful reduction in an individual‘s cancer risk, presumably related to weight loss. The
study reported a significant 60 percent reduction in cancer mortality when comparing
post-gastric bypass patients to severely obese controls. Additional follow-up at five years
found that a 46 percent reduction in cancer mortality persisted.118
These findings suggest that gastric bypass surgery may result in lower cancer
incidence and mortality. The study authors emphasize that bariatric surgery is not an
accepted therapy for cancer, and in fact, history of an internal malignancy within a 5-year
period is often considered a contraindication for obesity surgery. The cancer-related
benefits of gastric bypass surgery were shown to be strongest in the women studied. The
study noted that since severe obesity is more prevalent in women than men and 80
percent of patients who undergo gastric bypass surgery are women, the results of our
study have important medical and population implications. Although the benefit of
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reduced incidence was limited to cancers likely related to obesity, reduction of cancer
mortality was seen for both obesity-related and non-obesity-related cancers. The research
findings support recommendations for reducing weight to lower cancer risk and suggest
that since surgical weight loss interventions have been shown to provide the most
sustainable weight loss for individuals, surgically induced weight loss may provide a
valuable tool for individuals seeking to reduce the likelihood of developing obesity
related cancers and malignancies. 119
The previously discussed Swedish Obese Subjects Study also provides
longitudinal data on the incidence of cancer in those who have undergone WLS and
matched controls. Information regarding the incidence of cancer was gleaned from the
available data set. The number of first-time cancers after subjects were included in the
study was found to be lower in the surgery group (n=117) than in the control group
(n=169). In female subjects, the number of first-time cancers was lower in the surgery
group (n=79) than in the control group (n=130), however the study showed no similar
effect in male subjects with 38 male subjects in the WLS group who developed first time
cancer compared 39 in the male control group. Study authors posit that bariatric surgery
is associated with reduced cancer incidence in obese women, however, they note that the
same positive results were not indicated for the men included in the study. 120
Improvements inoverall mortality rates are shown below.
B.i.e Mortality
A study designed to test the hypothesis that bariatric surgery can reduce long-term
mortality and the morbidly of obese patients used an observational 2-cohort method
consisting of a treatment cohort (n=1,035) which included patients who had undergone
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bariatric surgery at the McGill University Health Centre between 1986 and 2002 and a
control group (n =5,746) matched for age and gender. Subjects were identified from the
Quebec provincial health insurance database. Those with medical conditions (other than
morbid obesity) at cohort-inception were excluded. The cohorts were followed for 5
years. 121 The study found that bariatric surgery resulted in significant reduction
(approximately 67.1 percent) in mean percent excess weight loss. The study further
showed that bariatric surgery patients had reductions in risk for developing
cardiovascular, cancer, endocrine, infectious, psychiatric, and mental disorders compared
with matched controls. The only exceptions were hematologic and digestive diseases.
There was no difference found in hematologic disease mortality and morbidity, and there
were increased rates of digestive diseases found among the bariatric surgery cohort.
Overall, the mortality rate in the bariatric surgery cohort was 0.68 percent compared with
6.17 percent in controls, which translates to a reduction in the relative risk of death by 89
percent. This study shows that weight-loss surgery is useful in significantly decreasing
the overall mortality of those who undergo surgical weight loss interventions. Moreover,
surgically induced weight loss reduces the development of new health related conditions
in morbidly obese patients.122
A New England Journal of Medicine article analyzed the extensive data set from
the Swedish Obese Subjects Study to report on the overall mortality found during 10.9
year follow up. At the time of data analysis regarding overall mortality, the follow up rate
was reportedly 99.9 percent with all but three of the subject‘s vital statistics being known
to the investigators.123 With regard to overall mortality there were 129 deaths among
those in the control group (n=2,037) and 101 deaths among those in the surgery group
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(n=2,010) during the study time frame. The most common cause of death was found to be
heart attack with 25 subjects in the control group and 13 subjects in the surgery group
succumbing to the heart attack. The second most commonly noted reason for mortality
was cancer with 47 control group and 29 surgery group members dying of cancer during
the study follow up.124 Overall the study concluded ―that bariatric surgery in obese
subjects was associated with a reduction in overall mortality, as compared with
conventional treatment in contemporaneously matched, obese controls.125 In the section
below information is provided on the resolution of other co-morbidities related to obesity.
B.i.f Other co-morbidities
It is not possible to review all of the available data regarding the usefulness of
surgical interventions for obese individuals in resolving physical co-morbidities
associated with excess weight. It is necessary to limit this review to the key studies of the
many commonly experienced co-morbidities. These provide the critical empirical data
which should inform physician judgment and counsel of their obese patients. There are
several other areas of physical co-morbidity which, while not covered here in detail, have
also shown to improve physical symptoms found among obese individuals. Research has
shown that surgically induced weight loss also improves lower back pain and decreases
the pain associated with degenerative joint diseases (which decrease mobility), improves
female hormone dysfunction which can cause infertility, reduces idiopathic inter-cranial
hypertension (pseudo tumorcerebri), hernia risk, and nonalcoholic liver disease.126 These
findings may have more salience for some obese individuals than others based on their
individual goals and activities.
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This discussion of the clinical utility of WLS in addressing various co-morbidities
will now turn to depression and suicide. Depression has been strongly associated with
obesity in the literature and is common, debilitating, and complex. Like obesity,
depression has a biological basis but patients‘ experience of the condition is exacerbated
by the stigma that attaches to it as a mental illness. For those who have both obesity and
depression, the intersectionality of the associated stigma can be particularly
debilitating.127
B.i.g Depression
Research conducted as a part of a doctoral dissertation in counselor education
and supervision at Duquesne University evaluated the pre and post-surgical experience of
depression, anxiety, and general quality of life measurements at two, four, and six months
post-surgery in patients who had undergone bariatric surgical interventions at West Penn
Hospital in Pittsburgh,PA. 128 Subjects had undergone bariatric surgery between 1999 and
2005. During that time 720 individuals, 540 men and 146 women received gastric bypass
surgery for weight loss. The disproportionately male study participants were thus atypical
with regard to gender. Archival data was retrieved from pre-procedure baseline and post
procedure administration of the Beck Depression Inventory, Beck Anxiety Inventory and
the RAND SF-36 Health Survey. The study showed a significant and linear improvement
in the experience of depression found among pre-surgical candidates to post-surgical
candidates. The improvements showed steady decreases in the experience of depression
immediately following gastric bypass surgery and at the three postoperative
evaluations.129

211

In a 2011 study designed to examine whether there are improvements in
depressive symptoms following bariatric surgery and in what specific depression domains
improvements may manifest, Hayden et al. used the Beck Depression Inventory (BDI).
The study included obese patients who had undergone laparoscopic adjustable gastric
banding (LAGB) surgery and had completed the BDI at baseline and 1 year following
surgery. There were two groups of patients included in the study, a general background
group and a group identified as experiencing elevated depressive symptoms based on the
BDI.130 Study results showed that BDI scores fell for both groups, indicating a reduction
in the experience of depression post-surgery. With regard to specific changes in the
experience of depression in particular depression domains, patient scores on the negative
self-attitude subscale were significantly greater prior to surgery than the two other
subscales and showed the greatest improvement 1 year following LAGB. The study
further showed that pre-existing antidepressant therapy had little or no association on the
BDI scores or on its change following weight loss. This study showed that while high
rates of depression are generally reported in relation to obesity there is a significant
decrease in depressive symptoms experienced following weight loss due to surgical
intervention.131 Rather than pointing to an overlap in physical symptoms between obesity
and depression, this study seems to show that the negative attitudes towards self is the
reason that BDI scores are elevated pre-intervention. These results may indicate that the
social construction of the stigmatizing condition of obesity may lead to a negative selfattitude and depression prior to WLS and that improvement in social acceptability as part
of weight loss subsequently leads to improvements in perceived social acceptability and
hence decreases in the experience of depression. However not all of the data show that
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depression is adequately resolved in all patients following bariatric surgical interventions.
While this may be true for many there is a mounting body of research which indicates
that for a concerning number of patients there is an increased risk of both suicide
attempts and completions following surgical weight loss interventions. Suicide attempts
and completions are generally regarded as the outcome of untreated depression and are
discussed below.
B.i.h Suicide
This subsection reveals data on post-surgical suicides. Tindle et al. examined
post-bariatric surgery suicides, including as variables elapsed time since the operation,
sex, age, and suicide death rates, and compared this data with US suicide rates. They
studied medical data, obtained from the Pennsylvania Health Care Cost and Containment
Council, on Pennsylvania residents who had received bariatric surgery between January
1, 1995 and December 31, 2004. The study matched mortality data from suicides between
September 1, 1996 and December 28, 2006 with the medical records of those who had
undergone WLS between January 1, 1995 and December 31, 2004. Statistics were
obtained from the Division of Vital Records, Pennsylvania State Department of Health.
The data showed that there were 31 suicides in 16,683 operations. In this group the
overall rate was 6.6 per 10,000 people. Among men the rate was 13.7 per 10,000 people
and for women the rate was 5.2 per 10,000.132 About 30 percent of suicides happened
within the first 2 years after surgical intervention for weight loss, with almost 70 percent
occurring within the first 3 years. For every age category except the youngest, suicide
rates were also found to be higher among men than women. Age- and sex-matched
suicide rates in the general US population (ages 35-64 years) who had not undergone
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weight loss surgical intervention were reported as 2.4 per10,000 (men) and 0.7 per10,000
(women).Compared with age and sex-matched suicide rates in the US, there was a
substantial increase in the number of suicides among all patients who had bariatric
surgery in Pennsylvania during a 10-year period. It was concluded by the investigators
that these data show a need to develop a more comprehensive surveillance and follow-up
methods of patients undergoing surgical weight loss interventions in order to evaluate
factors which may lead to post-bariatric surgery suicide. 133
The usefulness of weight loss surgical interventions to individuals across many
commonly identified and experienced categories of co-morbidity has been validated in
numerous studies covering many domains. Due to the sheer number of variations in
surgical weight loss interventions it is somewhat difficult to make specific comparisons
with regard to the impact of particular surgical weight loss interventions as related to
specific outcomes as much of the research combines patients who have undergone any
one of a number of accepted surgical weight loss interventions. The following subsection
addresses the financial cost associated with WLS.
B.i.i Financial costs
This section will now briefly turn to the financial costs of providing WLS to
ameliorate its co-morbidities in comparison to the financial costs associated with treating
the co-morbidities of obesity over the course of a lifetime. Powers et al. examined both
the financial impact of obesity on society and the financial consequence of treating
patients who are obese with WLS across several published studies. They reviewed
various studies and quantified the economic savings and benefits to quality-of-life and
length-of-life associated with decreased mortality and health costs across these studies. 134
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While the specific studies examined found differing levels of cost savings, and savings
were unequally distributed among third-party payers, the patient, and the employers this
study concluded:
In summary, for morbidly obese people who have costly comorbid conditions,
operative therapy offers a large potential benefit in quality of adjusted life-years
and savings to the total medical expenses incurred by patients and their
employers.135
A study conducted by the Veterans Administration Health System explored the economic
burden of caring for veterans with clinical obesity and co-morbidities. 136 It
retrospectively examined the records of 25 male patients who had undergone WLS
between 1999 and 2001, and reviewed all obesity-related health care costs including
hospitalizations, outpatient doctor visits, medication usage, and the cost of home health
devices both one year prior to WLS and one year post-surgery. All patients had
undergone Roux-en-Y gastric bypass surgery (RYGBP). The study concluded that
operative treatment of clinically severe obesity reduced obesity-related costs and the
utilization of healthcare resources at the time of follow-up, which was approximately
eighteen months following surgery. The study further found that ―the cost of undertaking
RYGBP at the VA is offset by reduction of health care costs within the first year of
surgery.‖137 Furthermore, based solely on cost saving from decreased utilization of health
care relative to the cost of surgery, it concluded that the data support ―allocation of
resources to support existing bariatric surgery programs throughout the VA system.‖138
An employer-based study of WLS costs evaluated the private third party payer
return on investment for bariatric surgery. 139 The study identified morbidly obese
patients age 18 years or older through an employer claims database of more than 5
million employees between the years 1999-2005. Each patient (N=3,651) who had
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undergone WLS during this time was matched with a control subject who was also
morbidly obese but had not undergone WLS. The patient and control matching included
demographic, co-morbidity, and the types of health care expenditures which were
incurred. The two groups were compared for total healthcare costs in the six months prior
to surgery through the end of their enrollment in the employer sponsored health plan. The
average bariatric surgery cost was between $17,000-$26,000 dollars. In comparing the
two groups, the study authors state ―we estimated all costs to have been recouped within
2 years for laparoscopic surgery patients and within 4 years for open surgery patients.‖ 140
The study did not specifically evaluate quality-of-life or length-of-life benefits
attributable to the surgery. In what the study termed ―take-away points‖ the authors note,
that ―even ignoring potential quality of life and length of life benefits, as well as
disability and work loss, third-party payers can rely on bariatric surgery paying for itself
through decreased co-morbidities within 2-4 years.‖141
While an exhaustive review of the financial costs associated both with obesity and
its treatments are not possible here the above data do offer some insight that overall, the
costs associated providing WLS are lower than the costs of treating the co-morbid
diseases associated. This cost savings was reported across several different studies. The
above economic data appear to support WLS as a potentially cost effective intervention
for obesity. WLS does not appear to further burden the health care system by being
disproportionately expensive in relation to the cost of treating the co-morbidities of those
who do not receive WLS. On the contrary, there appears to be a cost savings as well as an
improvement in quality-of-life and length-of-life for these patients along with a reduction
in the overall financial burden of obesity for third party payers.
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B.ii Personal Utility of Weight Loss Surgery
Empirical research detailed above as well as a plethora of other studies not
specifically discussed in this dissertation, establish the clinical utility of WLS as an
individual-level intervention for sustained weight loss and reduction of obesity-associated
co-morbidity. That is, however, only one part of the evidence to be evaluated. Even with
widespread general agreement that WLS decreases physical and psychological comorbidities consistent with several of the generally accepted and identified goals of
medicine, these endpoints do not provide a complete picture. The usefulness of WLS may
also be evaluated in terms of its personal utility for those who choose this weight loss
option. Conceptions of the personal utility of WLS can be as unique and intricate as the
reasons for the development and maintenance of an individual‘s obesity in the first place.
Evidence of the personal utility of WLS is found throughout the narratives included in
this section.
As established in chapter three, there are few venues for those who have
undergone WLS to share their experience without concern about rejection and
stigmatization. One safe forum in which to share such narratives is a blog on WLS. The
following narrative expounds the usefulness of WLS for a particular patient, named
Rauncie who underwent Roux-en-Y gastric bypass surgery in 2010. Her story, recounted
in her words, reveals an often overlooked dimension of the usefulness of WLS. She
begins her story by informing readers that her development of obesity was complex and
partly the result of attempting to protect herself from additional victimization, having had
the unfortunate experience of being raped. She writes:
I had some struggles as a young woman and was a victim of rape and had severe
abandonment issues. Food had been my best friend. I lived my life in a daze only
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feeling from the neck up. I allowed people to abuse me and I felt life happened to
me rather than feeling I had any control over anything. I lost weight only to gain
weight back over and over and finally eating myself up to 287 pounds. At 5'4"
with a small frame that is a lot of weight to carry. 142
She goes on to describe the way in which she internalized the various victimizations
which she had experienced so that she began to accept societal stigmatization as being
deserved.
I was numb emotionally but I hated myself. I went from bad relationship to bad
relationship partly because I felt that was all I deserved. I talked to myself in the
mirror in a way that would have gotten me slapped by someone else. I was cruel
to myself and destructive in many ways.
However, she also recounts that she began to see herself in a different light, in essence to
acknowledge that a different story, one with an alternative ending, was indeed possible.
She continues:
As I grew older I began to have an inner shift. I realized that I needed to love
myself right where I was. I was never going to be able to take care of me if I did
not. I began to do deep work and my words in the mirror began to change. I began
to say "I care about you". At first there were many tears but years of hatred and
self-loathing began to fall away and I decided I was no longer going to live with
the label of victim. 143
But the realization of this alternate life story that this would require assistance.
I began to do research on weight loss surgery. It was something I had considered
before but always thought it was the easy way out. I went to an information
session for the first time about 3 years ago. I walked away thinking it was not for
me that I would just do it on my own. I continued to work on my inner self and
then the year of my 49th birthday I decided that year 50 would be my year. One
night after spending time with a very dear friend she pulled me aside in tears and
told me that she was afraid she was going to lose me. She shared how heartbroken
she was to see me using a cane. In the past I would have been upset and offended
that someone would have said something about my weight. This time I was not
offended I knew that what she was saying was true. In addition I had a friend who
offered to pay for me to attend Weight Watchers meetings at work with her.
I thought to myself ...I have people who really love me, they loved me enough to
speak up in love. It gave me that extra push to move forward and I went back to
an information session and made up my mind after weighing the options that I
was going to have RNY bypass surgery. I had diabetes, high blood pressure and
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sleep apnea. I was walking with a cane. I was tired all the time and had no
energy. 144
Like many patients who eventually undergo WLS Rauncie had to overcome the societal
stigma which she had internalized which told her she was unworthy because of
intersection of various marginalizations as a rape victim, a woman, and an obese person.
Furthermore she related additional feelings of failure based on the fact that she could not
overcome obesity without WLS, despite several attempts. These deeply entrenched
socially-constructed messages had to be de-constructed before she was able to access
efficacious treatment. Regarding the pre-surgical process Rauncie recalls:
The process began for me in July of 2010 with an initial appointment. I then had
to go for a psychological evaluation and nutritional appointments. I was finally
approved for surgery and given the date of Dec 3, 2010. I remember that the week
before surgery I was so scared that I had thoughts of backing out. I was afraid I
would die on the table. In reality...I did have a rebirth. I left behind the victim in
that operating room. For me this was a rite of passage from one part of my life to
another. This tool has changed my life. 145
Her narrative recounts numerous post-surgical improvements in physical health and
quality of life.
Today it is 13 months since I had my surgery. I weighed in this morning at 142
pounds. I have lost half my weight since my surgery. But more than that I am
healthy. I am no longer on medication for diabetes or High Blood Pressure and I
gave my cane away. I have so much energy that I have done more in the past year
than I have done in probably 10 years. I am teaching classes, going to the gym,
dancing, singing...and living my life with open arms and open eyes. My inner
work has excelled and I have found that the true key to all this is that it is a tool. I
must work at it every single day. I never thought in a million years that structure
and accountability would be the thing that freed me to live a happy life. I always
thought the opposite...146
For Rauncie, WLS assisted her in re-gaining her health and re-established many quality
of life factors which had been so diminished by obesity. For her it was a procedure which
offered and made good on opportunities to reclaim both health and the vitality of living.
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She continues:
…My life has changed in such positive ways that I would do this over again in a
heartbeat but I would not have waited so long. My advice to anyone considering
the surgery is this: If you want to be successful see this for what it is a tool for
lifestyle change. If you have the surgery and then try to figure out what you can
get away with doing afterwards you are going to end up right back where you
started from. Everyone loses in the beginning; it is the way the surgery works. But
if you are eating the same or cheating early in the game eventually the weight will
come back. I spend each day of my life awake, alive, vigilant and responsible for
my actions. I do not pray, hope or wish that the scale would stay where it is or go
lower...I work at it. We are responsible for the final outcome of the surgery. We
are given a valuable tool that can change our lives if we use it correctly. If you
think this is the easy way then follow my journey for just a day and you will see
that I and others like me must work at it every single day. I write all my food
down, I do research, I take responsibility for what I put in my mouth every single
time I open it...147
She appears to be realistic that WLS is a tool which offers significant help for a condition
she could not overcome on her own but for which she will ultimately be responsible for
maintaining in the future.
Rauncie speaks openly about the trade-offs of having surgery and some of the
side-effects which are possible. She remarks that on balance, in looking at the risks,
benefits, and side-effects relative to what she has gained she believes she made a good
decision. The very individualized criteria of personal utility were satisfied for Rauncie by
WLS. She writes:
... People ask me about loose skin, missing foods, any regrets... I do have loose
skin but I do not care about that. I would rather have loose skin than diabetes,
High blood pressure and a cane as my constant companion. I do not miss the food
that made me sluggish and fat. I have no regrets.
At 145 pounds I fit in a size 8 jeans, I can wear heals [sic], I can play on the floor
with my grandchildren and I have a lap they can sit on. My name is Rauncie. My
50th birthday present to myself was a new life. I wanted to grow old watching my
grandchildren grow up and living a life of purpose. I will live the rest of my life
grateful for this second chance to live my life fully engaged and loving myself.
Starting weight 287 Current weight 142 Surgery: RNY gastric bypass Dec 3,
2010‖148
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Rauncie‘s narrative shows that WLS was able to provide both clinical utility and
personal utility. Clinical utility was realized because the surgery used as a tool provided
sufficient weight loss to ameliorate her physical and quality of life co-morbidities. As
shown above the research indicates that her weight loss and thus likely the resolution of
her co-morbidities will remain durable for at least ten years. Moreover, WLS was useful
in assisting Rauncie to meet her own highly personal goals for weight loss which
included over-coming several forms of victimization and marginalizations which so
burdened her and which resulted in the manifestation of her obesity in the first place. For
Rauncie WLS was a tool for helping her to claim an alternative narrative other than that
of the victim of damaging life experiences. Rauncie needed assistance to claim an
alternative story. She needed the assistance of those in medicine.
The following narrative further illustrates the personal utility of WLS for another
patient:
At the age of twenty-one, I had Roux-en-Y gastric bypass (weight loss surgery).
Even though I was young, I had already reached 285 pounds, and I was saddled
with the co-morbidities of obesity. My adolescent body was bearing what should
have been the diseases of a much older adult. I was on medications for high
cholesterol, asthma, and depression and had been diagnosed with fatty liver
disease, high blood pressure, and pre-diabetes. I was a very sick young woman,
and I was in dire need of treatment. For me, the answer was weight loss surgery.
Because I was a college student, bariatric surgery was only a viable option for me
because I was still on my parent‘s excellent health insurance. 149
The author speaks not only about losing excess weight and its associated physical comorbidities, but also about having been able to abandon other signs of her obesity. It
appears that these ―badges‖ as she refers to them include the stigma associated with being
obese:
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Now, two years out from surgery, my story is very different. I no longer openly
carry the badges of obesity, and my comorbidities have been alleviated. I am a
healthy weight individual. 150
This narrative reveals that for this young woman WSL proved to be personally useful as
she recalls the difference between her impaired life prior to WLS and her co-morbidity
free life following the intervention. Some of the personal meaning of no longer being
obese may lie within her comment about no longer openly carrying the badges of obesity;
its social and thus personal meanings no longer apply to her.
The following section discusses the importance of the physician-patient
relationship. Specifically this section will address the way that this important relationship
can serve to assist or impede those who are obese from gaining access to WLS. The
physician-patient relationship, with its potential for inherent power dynamic, may be
further affected by the stigmatization of obesity and a differential application of common
bioethical principles which govern clinical medicine.
B. iii Clinical Medicine and the Doctor-Patient Relationship
In contrast to public health, the goals of clinical medical intervention are to
restore individual patient health, to prevent or ameliorate morbidity when possible, or
failing in those aims, to provide effective palliation. 151 To achieve these goals, clinical
medicine is also highly dependent on a mutually trusting physician-patient relationship.
Some have argued that the overall effectiveness of clinical medicine is mediated by the
quality of the physician-patient relationship, of which trust and trustworthiness are
integral components.152 In the ideal case, within the context of this trusting fiduciary
relationship various treatment options can safely be explored, agreed upon, and
undertaken. Although, as Dorothy Roberts describes, this ideal doctor-patient relationship
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does not occur for various disempowered members of society. 153 Roberts writes about the
experience of women of color as patients within the institution of medicine. Using
intersectionality as her approach, she expounds on the political dimension of the doctorpatient relationship. Roberts writes, ―Black women experience various forms of
oppressions simultaneously, as a complex interaction of race, gender, and class that is
more than the sum of its parts.‖154 As has been argued elsewhere in this dissertation,
obesity must be included as a form of marginalization along with those identified by
Roberts. Whether male or female, black or white, those who are obese have diminished
power and authority relative to the dominant group in much the same way as the women
of color about whom Roberts writes. With regard to the experience of women of color
who seek medical treatment Roberts says that various marginalizations intersect to alter
their experience physician-patient relationship moving it further away from the ideal:
Race, class, and gender structure doctors‘ knowledge of their patients and their
interpretation of the ethical principles they apply to their interactions with
patients. My point is not only that physicians bring to their encounters with
patients the same prejudices as exist in the rest of society. The relationship
between doctor and patient is determined by political arrangements and not solely
by the individual characteristics of the two actors.155
The outcome of the oppressions, whose sum is indeed greater than its parts, of which
Roberts writes, is that the ethical principles generally utilized in the physician-patient
relationship and intended to be foundational in the practice of medicine are applied
differently. ―The experience of women of color confirms that these principles are
themselves determined according to power. In other words, the very meaning of truth,
consent, and confidentiality depends on social arrangements.‖ 156 Assuming the accuracy
of Robert‘s analysis, the physician-patient relationship may be more susceptible to the
usual power differentials in the presence of intersecting marginalizations.
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Informed decision-making, and specifically informed consent, is predicated on the
existence of an effective provider-patient relationship.157 Failure to provide material
information regarding obesity and its treatment options may substantially undermine trust
within the physician-patient relationship, and certainly undercuts patient autonomy and
the possibility of informed decision making. Failures of trust and failure to provide
material information thus undermines the efforts of clinical medicine to treat patients‘
obesity. Lack of trust, inadequate information and communication, or all of these can also
limit the clinical and individual usefulness of WLS. These topics will be taken up in
greater detail in subsequent chapters.The final section of this chapter will provide a
superior framework from which to view the utility of WLS in light of discussions above
regarding its social, clinical, and personal utility.
C. Re-Framing Obesity and the Utility of Weight Loss Surgery
Although WLS does not adequately solve the public health problem of obesity
and as an individual-level intervention should not be held to that standard, WLS does
effectively promote the traditionally espoused goals of clinical medicine. These goals
include the promotion of individual patient‘s health and/or prevention of disease,
maintaining or improving patient quality of life, cure of disease, prevention of premature
death, improving or maintaining patient functional status, educating patients regarding
their conditions and likely prognosis, prevention of harm to the patient in the course of
care, and when all else fails, assisting the patient in a peaceful death. 158 Providing
information about the full range of treatment options—and, as this dissertation argues,
treating obesity like other medical conditions—promotes justice, informed decisionmaking, and trust within the patient-doctor relationship.
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To criticize surgical interventions for weight loss based on their limited social
utility in addressing the public health issue of obesity is to confuse the aims of these
different health-related enterprises. From the perspectives of the individual medical
practitioner and her patient the question of the utility of employing WLS to treat obesity
should be understood as an issue of clinical medicine and not of public health practice. In
this way the ethical confusion over the limited social utility of WLS as an appropriate
clinical medicine intervention should be dissolved. Therefore, it is possible to reframe a
fundamental criticism of WLS as one of mistaking clinical medicine goals for public
health goals. Viewed within the framework of clinical medicine, WLS may be seen to
have great clinical and personal utility. The following section reveals that WLS reduces
the transmission of obesity in families and across generations.
C.i Diminished Intergenerational and Familial Transmission of Obesity
It is important to note that research has shown that the effects of WLS may indeed
have a broader utility than had previously been attributed to it. In short, WLS can have
benefit beyond the individual surgical candidate. 159 The broader usefulness of the surgery
includes evidence that it may serve to curtail the generational transmission of obesity
which is often found in families. Research has shown that mothers who have undergone
WLS, and subsequently lost a significant amount of weight, prevented the transmission of
obesity to their children, who were followed up to eighteen years post maternal surgery.
Kral et al. compared the prevalence of obesity in 172 children between the ages of 2 to 18
years and born to 113 obese mothers who had realized substantial weight loss after biliopancreatic bypass surgery with 45 same-age siblings who were born before maternal
surgery. Both groups were compared with current population standards for weight. The
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researchers used data from patient records, as well as follow up telephone calls to collect
data on childhood and adolescent weights. 160 Data analysis revealed that following
maternal surgery, the prevalence of obesity in the offspring showed a 52 percent decrease
and severe obesity a 45.1 percent decrease, with no increase in the prevalence of being
under-weight. Additionally, data showed that for both male and female children who
were aged 6 to 18 years of age and born after maternal surgery, the prevalence of
overweight was reduced to population levels. Researchers concluded that the prevalence
of overweight and obesity in children of mothers with large voluntary post-surgical
weight loss was similar to that in the general population, with no increase in underweight.
The researchers suggest that study results demonstrate the importance of potentially
modifiable epigenetic factors in the cause of obesity. 161 The following section discusses
some of the broader effects of WLS.
C.ii Broader Positive Effects
Much has been written on the social contagion aspects of weight gain. 162 The
question of whether the opposite might be true, that for those who lose weight there may
be some associated benefit for family members, was the focus of study conducted by
Woodard et al. 163 The study, among the first of its kind, sought to answer whether the
experience of WLS and the weight loss effected by it for one member of the family might
have a broader usefulness for other adult family members living with the patient. The
researchers sought to better understand whether healthy behavior transmission may be
enhanced by one member of the family undergoing a Roux-en-Y gastric bypass surgery.
Prospective, longitudinal, and multidimensional health assessments were administered to
the patient and family members before and 1 year after index Roux-en-Y gastric bypass
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surgery. The study, conducted at an academic bariatric center for excellence between
January 1, 2007 and December 31, 2009, included eighty-five participants (35 patients,
35 adult family members, and 15 children <18 years old). The patient subjects underwent
Roux-en-Y gastric bypass surgery and associated dietary and lifestyle counseling. The
primary outcomes included weight and expected body mass index. Secondary outcomes
included waist circumference, quality of life (36-Item Short Form or Pediatric Quality of
Life Inventory), healthy behaviors, eating behaviors, and activity levels. Family
participants were grouped by relationship to the patient for data analysis. 164 The data
indicated that before the operation, 60 percent of adult family members and 73 percent of
children of patients undergoing Roux-en-Y gastric bypass surgery were themselves
obese. At 12 months after the operation, significant weight loss was observed in obese
adult family members (from 234 to 226 pounds; P = .01). The data revealed a trend for
obese children to have a lower body mass index than expected for their growth curve
(31.2 expected versus 29.6 observed; P = .07). Additionally, it was found that family
members had increased their daily activity levels (adults, from 8 to 17 metabolic
equivalent task-hours, P = .005; and children, from 13 to 22, P = .04). Adult family
members also had improved eating habits with less uncontrollable eating (from 35 to 28;
P = .01), emotional eating (from 36 to 28; P = .04), and alcohol consumption (from 11
drinks per month to 1 drink per month; P = .009).165 The researchers concluded that
gastric bypass surgery may ―render an additional benefit of weight loss and improved
healthy behavior for bariatric patients' family members.‖ 166 While this study sample was
small and the data gathered were from only one bariatric center for excellence,
nonetheless broader effects of WLS were observed in the sample, which indicates that
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WLS can have beneficial outcomes for other family members with modest improvements
in healthy behaviors and weight loss.
In addition, a meta-analysis examining the psychosocial outcomes of bariatric
surgery especially considering the presence of or reduction in psychiatric co-morbidity,
psychopathology, psychosocial functioning, econometric data, and general quality of life
indicator suggests that WLS has clear benefits. A review of literature reporting all
controlled and non-controlled published trials between 1980 and 2002 that examined the
relationship between pre and post bariatric surgery psychosocial functioning reveals that
patient perceptions of stigma (including self- stigmatization), their employability, risk for
depression, experience of depression and anxiety, social functioning, eating pathology,
self-esteem, income, use of sick time, disability benefits, and other quality of life
indicators improve at statistically significant levels following weight loss produced with
the assistance of surgical intervention. 167 The relevant literature was identified by a
search of computerized databases and included all articles published in English and
German during the two decade period. The study included only research which met the
requirements of the evidenced-based guidelines of the Agency for Health Care Policy and
Research and the Scottish Intercollegiate Guidelines Network. In all, there were 171
publications which met criteria and were included for review. There were 63 articles,
including two systematic reviews, identified. A total of 40 studies were focused on
psychosocial outcomes after obesity surgery. This meta-analysis of available research
concluded that mental health and psychosocial status, including social relations and
employment, opportunities improve for the majority of people after bariatric surgery.
This led to an improved quality of life among bariatric surgical patients. The presence of

228

psychiatric co-morbidity, predominantly affective disorders, and psychopathologic
symptoms decreased post-surgically. One exception noted to the improvements found
among bariatric patients was with those who had a severe pre-existing (pre-surgical)
psychiatric co-morbidity. In this group no significant improvements in psychosocial
functioning were found. The researchers concluded that concerns that obesity surgery
will reinforce psychiatric symptoms and lead to a reduction in patient quality of life seem
to be unfounded. In fact the opposite appears to be the case. In general, improvements in
psychosocial functioning were reported across the studies reviewed and these
improvements led to increases in reported overall quality of life. 168
Each of these quality of life indicators can be shown to have an impact on familial
relationships and parental choices regarding how to care for children. In other words,
weight loss surgical interventions may indeed have some measure of positive influence
on third parties and thus potentially on populations, the focus of the public health
enterprise. Moreover, quite obviously obesity is manifested in individuals just like
influenza or HIV. If each of these disabling conditions could be effectively treated in the
individual, their public health threat—their burden at the population level—would be
significantly decreased. In each case, primary or secondary prevention may be more costeffective, but effective individual treatment may also reduce the population-level societal
burden of obesity.
D. Conclusion
This chapter has argued that it is inappropriate to dismiss WLS as a valid
individual-level clinical technology based on the erroneous application of public health
goals to what is, fundamentally, also an issue of clinical medicine. To conflate the goals
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of public health initiatives with the goals of clinical medicine was shown to be
unacceptable in light of the availability of WLS which carries with it both acceptable
levels of known risk, and an empirically substantiated ability to meet several of the goals
of medicine and reduce co-morbid disease. Moreover, this conflation further diminishes
the relevance of a trusting and caring physician patient relationship in addressing
obesity—also identified under the goals of medicine. The conflation between public
health goals and the goals of clinical medicine thus applies an unattainable and
inappropriate set of outcome standards to WLS. In light of a clearer understanding of the
standards by which weight loss surgical interventions should be evaluated, substantial
empirical evidence of its clinical usefulness, and bolstered by patient narrative extolling
its personal utility, more should be done to assist patients in understanding WLS as a
valid choice along a continuum of care. This, as yet to be adopted, obesity continuum of
care could and should be offered to obese patients attempting to resolve their co-morbid
diseases associated with excess weight.
Chapter five will argue that given the myriad of social, environmental, and
biological factors associated with the development and maintenance of obesity and in
light of the empirical and narrative evidence of its clinical and personal utility as a
treatment which provides resolution or improvement of various life limiting comorbidities, medicine is obligated to recognize and overcome its own biases and stigma
in order to present a complete picture of the available continuum of care to obese
patients, including the recognition that surgical intervention for obesity is an ethically
valid option. Issues of justice, fairness, autonomy in treating this condition and promoting
patient welfare requires that the present medical system and those working within it
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overcome outdated personal bias in favor of empirical evidence, on which such science
should rightly rest, of the usefulness of WLS as an individual-level intervention.
Moreover, continued failure to do so violates the goals of medicine and the obligation of
patient non-abandonment to which physicians, on behalf of the medical system, are called
to abide and promote.
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Chapter Five: Justice, Fairness, and Autonomy in Treating Disease and Promoting
Patient Welfare
This chapter discusses how interactions between physicians and obese patients
may fail to fulfill the demands of respect for autonomy, patient welfare promotion, and
justice. These problematic interactions may occur in the context of appointments whose
primary purpose is to address the patient‘s obesity, but they can also occur in the contexts
whose focus is on another health concern of the patient. The chapter will argue that
physicians‘ failure to address patient obesity is a form of patient abandonment, and
further that the healthcare system abandons obese patients. Physician failure to address
patient obesity, and to do so with respect and compassion, effectively re-victimizes obese
patients. This is particularly ethically problematic because the healthcare system should
protect and promote the welfare of the vulnerable, not participate in their victimization.
The chapter will further argue that in these respects obesity is treated in a manner
different from other health conditions. It will argue that this differential treatment of
patients with obesity constitutes an injustice. Physicians address patient obesity less
frequently, less adequately, and less respectfully than they treat other life-threatening and
co-morbidity producing conditions such as hypertension. This is, the chapter will argue,
unfair. Further, physician reluctance to refer obese patients for weight loss surgery
(WLS) constitutes a specific injustice, as well as being contrary to patient welfare. In
contrast to discussion and referrals for surgical intervention in other conditions, WLS is
frequently not presented as a treatment option.
Even in the context of cirrhosis secondary to alcoholism—similar to obesity
because the health condition arises from ingestion that harms the body—designations of
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blame have been largely replaced by more compassionate treatment. The focus is on
resolution of the disease-causing behavior and curtailment of the disease. For instance,
liver transplantation for the former alcoholic is not seen as being particularly ethically
problematic even though there may be a residual charge of failed personal responsibility. 1
In this instance the physician‘s obligation to continue to care for the patient with endstage liver disease through this difficult and life-threatening ailment supersedes her
personal feelings regarding the cause of the disease. Moreover, the bioethical literature
supports the physician‘s obligation of continued care and the healthcare system‘s
provision of treatment. Most analyses support the former alcoholic‘s equal status in
competing for scarce organs for transplantation. A similar shift away from ascriptions of
moral failing and toward provision of a continuum of appropriate, compassionate care
has occurred with regard to those who have HIV in the United States. 2 The once highly
contentious backward-looking ascriptions of responsibility and moral depravity have
subsided in favor of a clinically based continuum of care which seeks to find solutions to
symptoms and disease processes as they arise. To the extent that physician and healthcare
ascription of responsibility in these instances is backward-looking, the point is not to
moralize, but to understand causation in order to prevent further harm and to provide
efficacious treatment. A new liver for an active alcoholic will only temporarily resolve
his health issue; discovering whether an HIV-infected person is having unprotected sex,
and seeking to persuade him not to, maximizes protection of future partners from HIV
infection and the patient from opportunistic infections. The overall goal of identifying
cause is forward-looking, and all viable treatment options are rightly considered. The
physician does not abandon such patients in their time of greatest need. Instead the
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physician examines all viable treatment options and often encourages the patient to
consider previously unconsidered options. Doing so may enhance the physician-patient
relationship, promotes patient self-determination, and fulfills the physician‘s fiduciary
responsibilities vis-à-vis her patient. This chapter argues that a similar shift from a
moralizing stance must occur in obesity treatment. Physicians should examine their obese
patients‘ behaviors not to ascribe backward-looking moralized responsibility, but to
identify opportunities for future-oriented intervention. Physicians should not ignore their
patients‘ obesity, but address it and discuss the full range of viable treatment options.
Doing so would promote patient welfare and autonomy. It would also treat obesity in a
manner similar to other similarly serious health conditions. Justice demands no less.
Section one of this chapter will take up systemic barriers, violations of respect for
patient autonomy, informed consent, and veracity as they relate to obese patients‘
accessing WLS. This section provides insight into the ways that foundational principles
and practices have been disregarded with deleterious outcomes for patient welfare and
self-determination. The second section of this chapter will discuss how ascriptions of
moralized responsibility or blame to obese patients have permitted physicians and the
healthcare system to transgress the demands of fair treatment with regard to obese
patients‘ access to WLS. Comparison to the treatment of other conditions will be made to
establish that obesity and obese patients are not treated fairly. Section three will offer an
alternative approach to improve current practices which will better promote and support
commonly accepted ethical principles and the goals of medicine. This alternative,
consistent with feminist thought and focused on holistically caring for those marginalized
by their obesity, takes into account the need to infuse care into healthcare interactions

242

and systems in the treatment of obesity. An ethic of care which incorporates an
understanding both of the vulnerability and overlapping marginalizations of those who
are obese, along with recognition of the medical relevance of highly personal factors, will
facilitate a more comprehensive continuum of care and more just and beneficial treatment
of obesity. The outcome of implementing this approach will be improved clinical care
which offers true care of those who are obese and affords them the opportunity to make
more fully informed decisions based on their vision of their own welfare and values. The
first section begins by discussing autonomous decision making, informed consent, and
physician veracity in light of the goals of medicine with regard to obesity and access to
WLS.
A. Barriers to Accessing Weight Loss Surgery, Autonomy, Informed Consent, and
Veracity
This section briefly reviews the goals of medicine and the commonly accepted
ethical practices which have come to support them. This section will address the ways in
which current practices observed in the physician-patient relationship involving obese
patients violate the goals of medicine and the obligations of physicians. Specific breaches
of physician obligation with regard to patient welfare, autonomy, informed consent, and
veracity are elucidated, in part with reference to research on the attitudes and practices of
physicians with regard to the referral of obese patients for WLS. Research findings
highlight the disparity between physicians‘ belief in the efficacy of WLS and physician
referral practices for WLS. Various reasons for the disparity between strong evidence of
effectiveness and low referral rates will be addressed. Subsection one explores systemic
and other impediments to accessing WLS. Subsection two discusses physician

243

obligations to their patients including respect for autonomy, informed consent doctrine,
and the concept of veracity.
A.i Goals of Medicine and Systemic Barriers to Accessing Weight Loss Surgery
As briefly discussed in the previous chapter, the goals of medicine include:
promotion of health and prevention of disease; maintenance or improvement of quality of
life through relief of symptoms, pain and suffering; cure of disease; prevention of
untimely death; improvement of functional status or maintenance of functional status;
education and counseling of patients regarding their condition and prognosis; avoidance
of harm to the patient in the course of care; and when no other options exist assisting in a
peaceful death. 3 In both clinical medicine and much of bioethical literature, there is an
assumption that the goals of medicine are well understood and thus do not require further
inquiry. 4 One implication of this assumption is that in the practice of clinical medicine
carrying out the goals of medicine are routinely and uncontroversially pursued no matter
the diagnosis. Bioethicist Daniel Callahan states that the goals of medicine are
treated as a topic to which, it is thought, everyone already knows the answer and
thus is not worth spending time on: or as an interesting but highly abstract,
academic topic of little importance to clinicians and busy health care workers. 5
However, it seems that a common understanding or acceptance of the goals of medicine
as they relate to the treatment of those who are obese should not be so readily assumed.
The use of WLS in the treatment of obesity and its manifold co-morbidities has
plateaued in the United States.6 Comparative data on the utilization of bariatric surgery
between 1993 and 2007 reveal that while obesity continues to generally be on the rise the
use of bariatric surgery for sustained weight loss has ―remained stable since 2003‖. 7
While there are many possible system-level contributors to this plateau, one may be the
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requirement of bariatric center of excellence designation to be eligible for Medicare
reimbursement. In November 2003, the American Society for Bariatric Surgery
established the Surgical Review Corporation (SRC) as an independent nonprofit entity
for quality control of bariatric surgery and as a resource for data collection and analysis
in an effort to discern best practices. SRC developed standards that were accepted and
implemented by the bariatric surgical community. A system was developed for hospitals
and clinics to receive designation as a center for excellence. The process takes substantial
time and resources.8 Obtaining center for excellence designation is generally easier for
larger hospitals with substantial resources than it is for community facilities with modest
resources. Hence, this requirement has effectively moved access to bariatric surgery
farther from rural patients and has funneled services to larger, urban, university affiliated
programs thought to produce better results. Another possible reason for the plateau in
utilization is the near simultaneous reductions in the number of third-party insurances
providing coverage for surgical weight loss procedures and reductions in reimbursements
for re-hospitalizations following surgery. 9 As a result of these factors it is more difficult
for people to access WLS as treatment for their obesity and its co-morbidities.
In addition to system-level concerns about access, which certainly can impair selfdetermination and autonomy, individual-level contributors impair access to WLS. In
questioning the overall low usage of various types of metabolic/bariatric surgery worldwide Henry Buchwald and Danette Oien, physicians at the University of Minnesota in the
Department of Surgery, state in their address to the 14 th World Congress of the
International Federation for the Surgery of Obesity and Metabolic Disorders:
It is also difficult to believe that only 1 percent of eligible individuals would elect
surgery if it were available to them. The answer, therefore, must be denial of
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patient access to bariatric surgery by private or governmental payers for
healthcare, lack of knowledge of the bariatric surgery option in some
communities, misunderstanding about the management of obesity as a disease,
and the continuing underlying prejudice against the obese.10
Buchwald and Oien acknowledge both systemic and individual-level barriers to accessing
WLS. They specifically posit issues of prejudice against obese people among the barriers.
Influence of prejudice against obese people to which they refer can be identified within
the physician-patient relationship, specifically in violations of respect for autonomy, the
requirements of informed consent, and the obligation of veracity. It is upon these
physician-patient based relationship barriers to WLS that the following subsection will
focus.
A.ii Respect for Autonomy, Informed Consent, and Veracity
Respect for autonomy is of immense importance in medical ethics and in ethics
more generally. Bioethicists Tom Beauchamp and James Childress observe that ―respect
for the autonomous choices of persons runs as deep in common morality as any
principle...‖11 According to Beauchamp and Childress, to respect the autonomy of agents
is:
…to acknowledge their right to hold views, to make choices, and to take actions
based on their personal values and beliefs. Such respect involves respectful
action, not merely a respectful attitude. It requires more than non-interference in
others‘ personal affairs. It includes, in some contexts, building up or maintaining
others‘ capacities for autonomous choice while helping to allay fears and other
conditions that destroy or disrupt autonomous action. Respect, in this account,
involves acknowledging the value and decision-making rights of persons and
enabling them to act autonomously, whereas disrespect for autonomy involves
attitudes and actions that ignore, insult, demean, or are inattentive to other‘s rights
of autonomous action. 12
The goals of respecting autonomy in the doctor-patient relationship have at their root
both considerations of human dignity and patient welfare. Beauchamp and Childress
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continue:
Personal autonomy encompasses at a minimum self-rule that is free from both
controlling interference by others and from certain limitations such as inadequate
understanding that prevents meaningful choice. The autonomous individual acts
freely in accordance with a self-chosen plan, analogous to the way an independent
government manages its territories and establishes its policies. A person of
diminished autonomy, by contrast, is in some respect controlled by others or
incapable of deliberating or acting on the basis of his or her desires or plans. 13
With regard to obese patients, physicians can fail to respect autonomy and fail to promote
autonomy in several ways. Firstly, physicians often fail to address or even acknowledge a
patient‘s obesity. Secondly, physicians can fail to discuss WLS as a possible treatment
option at all and finally, they can choose to discuss surgical options for weight loss in
only very advanced stages of the disease process where few or no other technologies are
available.
In the first case, when obesity is not acknowledged by the physician at all,
patients are denied the opportunity to avail themselves of assistance and education about
associated a potentially serious medical problems. In a study conducted on the initiation
of weight loss discussions with patients in primary care it was found that although 65
percent of the random sample of patients was overweight or obese, discussions were
initiated by the physician about excess weight in only 17 percent of these interactions. 14
In this case patients may not be made aware of the potentially serious nature of their
problem and thus will not be able to take evasive measures to avoid co-morbidities in the
future. Additionally, in cases where earlier intervention might be feasible, this
opportunity is lost if the discussion of weight never occurs. In essence, patient autonomy,
which in this instance includes the ability to act sooner rather than later, is not promoted
when physicians fail to address legitimate concerns about patient weight.
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In the second instance, when the option of WLS is never discussed with the
patient as a matter of course in clinical care, the patient may not see it as a viable option
or conversely may not be motivated to take alternative actions, if possible, to avoid
surgery down the road. In the absence of physician discussion of WLS, the patient may
assume that if bariatric surgery were a viable option to achieve sustained weight loss, the
physician would discuss it. Alternatively, when the option of WLS is not introduced until
the patient is in advanced stages of obesity perhaps with multiple co-morbidities prevents
the patient from utilizing WLS to avoid those co-morbidities or their further advance.
Each of these situations fails to evidence respect for patients‘ right of self-determination
and to maximize opportunities for autonomous decision making and self-care.
Avidor et al. surveyed over 478 physicians from six subspecialties to learn their
attitudes and practices regarding the treatment of their morbidly obese patients. 15
Bariatric surgery was perceived as the most effective treatment option available to the
patient with 49 percent of respondents indicating that they believe the intervention to be
effective. One component of the study focused on the referral rates for bariatric surgery.
Across this diverse group of cardiologists, gynecologists, endocrinologists, internists,
family practitioners, and bariatricians in comparing physician recommendations for
bariatric surgery and other interventions for weight loss such as diet and exercise or
pharmaceuticals, it was found that overall, ―notwithstanding physicians‘ strong
perception of the successful outcomes associated with bariatric surgery, all six groups
surveyed recommended it infrequently, suggesting surgery to only 15.4 percent of their
morbidly obese patients.‖16 While the patients met the criteria for bariatric surgical
interventions based on the BMI guidelines set forth by the National Institutes of Health,
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the physicians cited various reasons for not making appropriate referrals: they preferred
to manage the patient by themselves, they did not believe in referring patients for
bariatric surgery, and they felt that most patients meeting criteria for surgery would not
benefit in the long term. Additional reasons cited were that referrals require too much leg
work, the physician was unfamiliar with local bariatric surgeons, or they thought their
patients would not meet criteria for the surgery.17 The study authors concluded that
―therapy for the morbidly obese, therefore, does not mirror accepted
guidelines….Morbidly obese patients deserve to benefit from improved care, the
hallmark of which could be referral for bariatric surgery.‖18
This study above reveals a complex relationship between physicians‘ personal
beliefs and evidence based medicine (EMB) indicating that WLS does indeed produce
long-term sustained improvements in co-morbidities while improving longevity and
quality of life and personal beliefs. Personal beliefs, likely based at least in part on the
social construction of obesity and stigmatization of obese people as lazy, unmotivated
and unworthy, coupled with the medical acceptability of particular technologies for the
resolution of obesity (e.g., individual diet and exercise, commercial weight loss
programs, pharmacology) appear to dissuade physicians from discussion of efficacious
surgical treatment. As a result, patients must work harder to overcome practitioner bias to
access an intervention that the physicians themselves believe to be effective.
Furthermore, utilization of WLS will require the support of the physician throughout the
evaluation process and through post-intervention follow up.
Respect for autonomy obligates healthcare providers both to act ways that
enhance their patients‘ autonomy or afford them opportunities to exercise and advance
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their autonomy, and not to act in ways that impede or impair patients‘ autonomous
decision making. Failing to discuss potentially efficacious WLS violates both obligations.
Insofar as obesity itself impairs patients‘ abilities to pursue their life plans, failure to
discuss a means of addressing their obesity fails to afford them autonomy-enhancing
opportunities. Failing to present material information regarding their health condition and
its treatment prevents patients from making autonomous healthcare decisions and, as the
following argues, violates requirements of informed consent, a doctrine and practice that
seeks to enable such autonomous decision making.
As a legal doctrine, informed consent in medicine has a long history evolving
from tort law regarding battery. As an ethical, legal, and regulatory doctrine governing
research, informed consent has developed from hard lessons learned about the need to
respect persons and protect their welfare. 19 In the twentieth century, the doctor-patient
relationship evolved from a paternalistic one in which decisions were made for patients to
one usually characterized by shared decision making20 and governed by the requirements
not merely of consent,21 but of informed consent.22
Several conceptions of informed consent have been elucidated including viewing
informed consent as a ―specific rule-governed practice, as autonomous authorization, and
as shared decision making‖. 23 Informed consent as a rule-governed practice focuses on
the way it functions institutionally—both within healthcare settings and within the law
(for clinical care) and regulatory structures (for research). 24 The rule or norm-governed
practice prescribes how informed consent should be obtained and its components, and
establishes the legality of obtaining an individual‘s authorization or refusal as
subsequently documented in physician notes or on a consent document. The model of
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autonomous authorization refers to informed consent as an action whereby the patient (or
research subject) authorizes the physician (or investigator) to act on the patient‘s behalf
and whereby the patient/subject retains responsibility for having so authorized.25 Social
scientist and bioethicist Ruth Faden and her co-author philosopher bioethicist Tom
Beauchamp carefully explain the ways in which these two senses of informed consent do
and do not overlap. Philosopher bioethicist Dan Brock explains the model of shared
decision making, the presumed facts-values ―division of labor‖ within the relationship,
and how the model interacts with the demands of informed consent.26 Brock provides
reasons to question the notion that physicians provide the medical facts within the doctorpatient relationship, while patients provide their values, and then through some dialogical
process a shared decision is reached. Instead, he argues, patients also bring factual
information to the interaction, patients form values and preferences in light of the medical
information physicians disclose, and the medical information itself is not value-free as
the ―division of labor‖ would imply. What all conceptions of informed consent share,
however, is that at its core informed consent is a process which is intended to promote
patient autonomy and support pursuit of the patient‘s conception of her own welfare.
As a clinical and legal practice, the process of informed consent is generally
considered to involve five elements: competence (of the patient), disclosure (of material
information by the physician), understanding (of that information by the patient),
voluntariness (of the patient‘s decision), and the decision (i.e., the patient‘s consent or
refusal).27 Disclosure cannot be of all information that is true of the clinical situation, nor
can patients be expected to understand all such information. Instead, what is required is
that physician‘s disclosure the information that is material to the patient‘s decision, and
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in turn, the patient must have substantial understanding of it. The commonly accepted
―information elements‖ considered material to such decision making are the patient‘s
disease process, prognosis, benefits and burdens of the recommended treatment option,
the benefits and burdens of reasonable alternative treatments, and the likely outcome of
choosing to forgo any treatment.28 These elements must be disclosed for informed
consent in the norm-governed, legally effective sense to have occurred. A prerequisite for
such informed consent is that the patient must be competent to make the particular
decision being asked of her. Further, informed consent is to be obtained from a patient
with free will, i.e., one who is not unduly influenced by pressure from others, fear,
internal compulsions, or some other factor that overwhelms her free will. 29
Returning now to the patient-physician interactions in the treatment of those who
are obese, it becomes clear that physicians‘ failure to discuss WLS as a treatment option
may violate the disclosure requirements of informed consent and fail to fulfill the ideal of
shared decision making. For patients currently meeting the eligibility criteria for the
surgery, failure to discuss it is a clear violation of the requirement to provide information
regarding treatment options. Even for those who do not currently meet such criteria, the
failure to discuss it as a potential future option may be considered a violation. At the very
least, not discussing WLS fails to educate and empower obese patients and does not
enhance opportunities for autonomous action. For those patients for whom WLS would
be either a potentially efficacious treatment, or potentially the most efficacious option,
failure to provide such information fails to promote their welfare.
It appears that there could be a residual charge of apparent paternalism in the
approach taken by physicians with regard to their obese patients. Paternalism is defined
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as a policy or practice of treating or governing people in a fatherly manner, especially by
providing for their needs without giving them rights or responsibilities. 30 Paternalism is
generally seen to have two interwoven parts: overriding patient rights or liberties and
doing so to preserve patient welfare. A paternalistic approach would limit the options
available to the patient to those which the authority believes to be in the patient‘s best
interest. In medical contexts, any potentially justifiable paternalism would require that the
physician seeking the patient‘s good would have adequate knowledge of the highly
personal factors which patients find relevant to their welfare, or it assumes that the
clinical outcome is the only consideration and therefore the path to be chosen is clear
based on these limited and subjective considerations. Yet insofar as physicians fail to
afford their patients access to WLS in cases where WLS would be an efficacious
treatment option, their withholding of information cannot be truly paternalistic, as it does
not adequately provide for patient needs or seek their welfare. Clearly physicians who
routinely withhold information about WLS where it may be efficacious do not accurately
give priority to the clinical outcome of weight loss, as the evidence surrounding it
establishes its potential efficacy. Moreover, as previous chapters have established, there
is also reason to think that many physicians ignore or discount the personal factors
relevant to their patients‘ experience of obesity.
An additional aspect of paternalism pertinent for considering physician interaction
with obese patients is provided by considering philosopher Joel Feinberg‘s distinction
between hard and soft paternalism.
Hard paternalism will accept … that it is necessary to protect competent adults,
against their will, from the harmful consequences even of their fully voluntary
choices and undertakings. Soft paternalism holds that the state [or others have] …
the right to prevent self-regarding harmful conduct…when but only when that
253

conduct is substantially nonvoluntary, or when temporary intervention is
necessary to establish whether it is voluntary or not.‖31
The distinction rests on whether the party interfering with another‘s freedom of action or
self-regarding conduct believes that person to be competent and autonomous (hard
paternalism) or believes him to be somehow less than fully autonomous (soft
paternalism). Perhaps physicians who withhold information about WLS from their obese
patients believe that these patients are less than fully autonomous. They may take their
patients‘ obesity as evidence of their inadequate will (willpower) or less than full moral
agency. Where these physicians might generally avoid hard paternalism with patients
they deem competent, they may find soft paternalism acceptable with regard to obese
patients to whom they apply stereotypes of being less intelligent or out of control. This
line of reasoning is purely speculative. Moreover, these physicians would still have to be
able to reasonably assume that these patients‘ pursuit of WLS would be self-regarding
harmful conduct, and this assumption cannot be supported by current data.
If a physician believes that the patient lacks some relevant information about the
procedure, its risks, benefits, or necessary post-surgical changes in life-style, or is in
some way being unduly pressured and hence is unable to make an autonomous decision
soft paternalism may well be justified in the short run. However, these elements which
may initially be seen to necessitate such soft paternalism can be overcome. If a physician
believes that a patient is not capable of understanding and making a decision about WLS,
or of undertaking post-surgical life-style changes, then the appropriate response is not to
withhold the option, but to pursue alternate means of patient education or to seek a
supportive party or even surrogate decision maker. If a physician believes that a patient is
being pressured into seeking WLS, it is incumbent on her to learn who or what may be
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applying pressure on the patient and determine whether these pressures can be addressed.
Rather than pursuing soft paternalism, creating the conditions of information exchange,
understanding, and voluntariness necessary for truly informed consent would enable the
patient to access the treatment option with maximal potential for clinical and personal
utility. Failing to discuss the full range of treatment options available to obese patients is
morally unjustified because it violates both the physician‘s obligations to respect patient
autonomy and promote patient welfare and the tenets of a valid informed consent process.
Another possible reason for withholding information about WLS could be that the
physician is skeptical about the efficaciousness of various treatment options and believes
that withholding information about it is for the patient‘s own good. Nevertheless, it is
incumbent upon the physician to be able to provide appropriate evidence based
information regarding various treatment options. 32 The obligation is grounded in the
ethico-legal doctrine of informed consent and in the ethical requirement of respecting and
supporting the patient‘s autonomy. If the physician is unable to fulfill this obligation, she
should provide the proper referral for her patient so that the patient can obtain accurate
information that meets the standard of care.
If, instead of being motivated my misguided but ―good intentions,‖ the failure to
provide information about WLS is based upon the physician‘s own bias against those
who are obese, perhaps a moralizing attitude that people responsible for their weight gain
should not be afforded a ―quick fix‖ of surgery, then the physician cannot be deemed
paternalistic, but simply acts unethically in terms of concerns for justice and patient
autonomy and welfare. In either case—explained by either misinformed paternalism or
outright bias—the outcome is similar: information is withheld from patients which is vital
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to making informed decisions about any of their medical conditions and treatment
options. Additional moral obligations such as that of truth-telling are also infringed upon
by current practices.
The obligation of truth-telling flows from respect for autonomy and the
requirements of informed consent. This obligation of veracity is violated when physicians
fail to discuss the full range of available treatment options with their obese patients.
Beauchamp and Childress discuss this as a moral rule which among others is vital to the
professional-patient relationship and to promoting trust within it. 33 Veracity refers to
providing the ―comprehensive, accurate, and objective transmission of information, as
well as the way the professional fosters the patient‘s or subject‘s understanding. In this
regard, veracity is closely related to respect for autonomy.‖ 34 Furthermore, veracity is
closely tied to obligations of fidelity, promise keeping and contract.
[When] … we communicate with others, we implicitly promise that we will speak
truthfully and that we will not deceive listeners. By entering into a relationship in
health or research, the patient or subject enters into a contract that includes the
right to truthful information regarding diagnosis, prognosis, procedures, and the
like… .relationships between health professionals and patients and subjects
require trust, and adherence to rules of veracity is essential to trust. 35
Failure to discuss the full spectrum of options for weight reduction in accordance with the
standards of informed consent is therefore a breach of trust and veracity. Moreover, while
the full scope of treatment options for weight loss should rightly be discussed, it is
particularly ethically troubling that the most efficacious technology to date for sustained
weight loss would be excluded in discussions with obese patients who may well benefit
from the procedures.
The discussion of surgical intervention for weight loss serves several purposes
which enhance the goals of medicine and more fully meet the physician moral obligations
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to their patients. Specifically, discussions about the option of WLS may better prepare the
patient for the evaluation process and assist in understanding that WLS is but one of the
long term tools needed for sustained weight loss and reduction in life-threatening comorbidities. Further, a candid compassionate discussion of WLS can help to reduce the
internalization of cultural stigma which can impair patients from accessing WLS. In
essence, honest discussion of WLS as a viable option enhances patient autonomy; it treats
the patient as an agent with decisional authority. It may increase some patients‘ selfesteem. It respects the patient as a moral equal in a process of shared decision making.
Failure to discuss this option seriously diminishes the opportunity for patients to make
informed decisions based on their conceptions of well-being and is an untruthful
representation of the options available. The following section argues that failure to
discuss the full range of medically appropriate treatment options with obese patients is
also unjust.
B. Blame and the Principle of Justice in the Context of Obesity Treatment
This section takes up justice concerns with regard to obesity treatment. It is
argued that obese patients are treated unjustly when the full range of treatment options is
not disclosed to them or when their obese condition is ignored by their physician. There
is injustice in treating obese patients as putatively less capable of participating in shared
decision making, less entitled to the protections afforded by disclosure within informed
consent, or less worthy of a potentially life-saving and quality of life enhancing
intervention, in comparison to patients with conditions other than obesity. This chapter
argues that violations of the principle of justice continue unabated in the sphere of obesity
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treatment when treatment of obesity is compared to treatment of other medical conditions
with complex lifestyle, genetic, or environmental origins.
The first subsection argues that attributions of moral blame and personal
responsibility for obesity have been relied upon to justify this disparate treatment. The
second subsection analyzes the injustice of such attributions and then advocates changes
in the healthcare system and doctor-patient relationship that will make the treatment of
obese patients more just by them equal treatment and less restricted access to evaluation
for efficacious treatment.
B.i Blame and Access to Treatment
Blameworthiness and personal responsibility for one‘s medical condition have
historically influenced the way in which the individual with the disease, the disease itself,
and the application of potential interventions has been seen. 36 History has shown that
perceptions of blame are often inaccurate as they tell only part of the complex story.
Moreover, with thoughtful focused efforts these misperceptions of culpability can be
changed or dispelled leading to more just treatment of patients and a reduction in the revictimization of the individual with the medical condition.37 This section will first discuss
the concept of blame for various diseases and for obesity. Then, the way in which
perceptions of blame influence access to potential treatments will be discussed.
The writings of Susan Sontag articulate the experience of illness and the
metaphors which surround various types of illness and which are applied to those who are
ill. Often the metaphors involve the perceived guilt of the patient either for causing the
illness or for failing to avoid illness. In Sontag‘s first book she writes of her own
experience of having been diagnosed with cancer. She recounts that some forms of cancer
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such as lung cancer are seen as being more blameworthy (having been caused by the
patient‘s cigar smoking). The perception of patient culpability permits both the medical
profession and society at large to pass judgment on the moral character of the person. 38
Obesity is subject to similar charges of blameworthiness and occasions similar
metaphors.
In her second book Sontag takes up the once highly charged issue of personal
responsibility and derelict moral character for acquiring HIV 39 Sontag argues that as with
cancer, the metaphors of HIV have influenced societal response to those so diagnosed
and their clinical care. Sontag suggests that diseases whose cause is uncertain and whose
treatment is limited tend to evoke fear and revulsion. 40 In the beginning of the HIV/AIDS
epidemic, society at large and the culture of medicine was focused on issues of blame,
personal responsibility, and sin. 41 Since the first reports of American men dying of
Pneumocystis Carninii Pnemonia in the early 1980‘s stigma and shame were attached to
the diagnosis. The first deaths due to HIV/AIDS were among those already marginalized
and considered to be deviant based on sexual orientation or personal behavior. ‗If only
they weren‘t homosexual‘, ‗if only they weren‘t IV drug users‘, were common ascriptions
of culpability. These various ascriptions were used against sufferers as a means of
avoiding caring for these marginalized patients.42 From the perspective of dominant,
majority culture, all four phases of care that Tronto identifies were withheld from those
with HIV/AIDS. They were not cared about; no one took responsibility for them;
caregiving was not afforded them by mainstream communities, and they did not receive
care. The uncertainty of the cause of AIDS, its modes of transmission, and the then
undetermined likelihood that caring for those with AIDS would lead to deadly infection

259

seemed to legitimate the failure of the healthcare system to respond compassionately or
quickly. Some saw the diagnosis as appropriate punishment for the immoral behaviors of
homosexuality, bisexuality, promiscuity, prostitution, or drug use. The early HIV/AIDS
epidemic was fraught with ascriptions of blame which were as unhelpful in one-on-one
clinical interactions as they were stigmatizing and divisive at a social level. These
ascriptions are said to have delayed appropriate investigation into the disease, its
potential treatments, and their application under President Reagan‘s administration. The
slow governmental response to this epidemic is said to have facilitated additional
potentially avoidable deaths early on. 43 At the time a widely distributed quote, which was
unable to be properly attributed but was said to come from an anonymous surgeon, stated,
―We used to hate faggots on an emotional basis. Now we have a good reason.‖ 44 It was
the attribution of moral depravity to those infected which was seen to warrant both a slow
response to the epidemic and a paucity of compassion within the medical community and
from the society at large. As discussed in previous chapters, a similar though perhaps less
overt lack of compassion exists for those who are obese. This failure of compassion is
based upon the construction of obese people as Other, as being inferior both morally and
intellectually, and as being outside or marginalized from dominant mainstream culture.
Moreover, the presumption that obesity is primarily a self-inflicted condition has fostered
ongoing ascriptions of blame.
An analogous situation occurred around alcoholism. However, based on medical
evidence and the promotion of the disease model of addictions, the construction of those
who are alcoholic softened. 45 The attributions of personal blame and responsibility which
once overwhelmed the medical treatment of alcoholism have abated, or at least overt
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attributions of blame are less acceptable.46 Now the healthcare system treats the disease
of addiction to alcohol, not an irresponsible, non-compliant, ―did it to themselves,‖
resource draining, morally flawed character. The changes which have been realized in
attributions of blame for those who are alcoholic have been lead in part by changes
initiated by the medicine. These changes included a shift in the construction of
alcoholism and drug abuse from being caused by moral failure to instead being a disease
state which is progressive in nature. Though the disease of alcoholism is not fully
understood, ascriptions of blame have receded. The shift away from unhelpful ascriptions
of blame paved the way for increased access to appropriate treatment interventions for
this disease and decreased stigma of those who are alcoholic.
The ideological shift with regard to both alcoholism and HIV/AIDS reinforces
that present ascriptions of blame against those who are obese can be altered. By similarly
diminishing ascriptions of culpability for this highly complex multifactorial condition it
may be possible to improve both the experience of compassion and access to effective
treatment for those who are obese.
Patients are vulnerable on many levels, including financial and personal levels.
As Sontag succinctly puts it, ―Etymologically, patient means sufferer.‖ 47 Moreover many
patients experience altered concepts of their own identity which can be deeply
disturbing.48 Much has been written about the various aspects of patient vulnerability. 49
Even if patients bear some degree of responsibility for their condition, once they become
a patient—a sufferer—ascriptions of blame are no longer useful. The patient suffers, and
the role of medicine is to reduce suffering whenever possible by utilizing the full scope of
available technologies to do so.50
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In chapter three the influences of theology on the construction of both obesity and
those who are obese was discussed. Examination of evolving theological constructs
around suffering provides insight into the unhelpful nature and plausible consequences of
assigning blame to those who suffer. In a recent work by Father James Keenan SJ,
Professor of Theological Ethics at Boston College, he focused on the evolution of the
concept of suffering in moral theology in the twentieth century. 51Tracing the
understanding of suffering across this time span he focuses on the work of four scholars:
Bernhard Häring, 52 Gustavo Gutierrez,53 Edward Schillebeeckx,54 and Margaret Farley. 55
In discussing the work of Gustavo Gutierrez, Keenan acknowledges his significant
contribution in identifying a deep concern for the oppressive suffering of the poor.56
Gutierrez‘ work summoned people to stand in solidarity with those who are marginalized
by power and economic forces beyond their control. 57 Much like feminist theorists who
employ the concept of intersectionality, Gutierrez urged action to reduce the suffering of
those who are marginalized by ―interlocking patterns of oppression and domination,
established by structures of economic and social power.‖58 Since the publication of
Gutierrez‘ seminal work, the ―preferential option for the poor‖ has come to encompass all
those who are marginalized or pushed to the periphery of society, including those who
are ill. 59 Those who are obese have been shown to be marginalized in several key life
areas including health and economic advancement. Moreover a disproportionate number
of those who are obese are also marginalized due to race or class or geographic location.
As such, Gutierrez would likely urge that the obese are sufferers to whom a particular
obligation of solidarity, advocacy, and compassion are owed.60
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Schillebeeckx‘ work on suffering is notable for his analysis of the common
response to suffering shared by religions. Schillebeeckx suggests that the proper response
to suffering of any kind is to find a way to eliminate it.61 Keenan takes exception
however to Schillebeeckx‘ distinction between merited suffering and unmerited suffering,
stating:
I think holding onto this distinction is deeply problematic. To the extent that we
leave the distinction intact, to that extent we still believe that we can determine
who should be the beneficiaries of our compassion and who should not. But, how
can we know that someone‘s suffering is really ―unmerited?‖ How do we arrive at
such divine judgment? Does the AIDS victim really have to be a child or a
hemophiliac? Does the cancer victim really have to have been taking every
precaution against carcinogens? Does [the] tortured political activist really have to
have been politically prudent? Does the date rape victim really have to be
insisting on ―No‖ the entire time?...if we insist on the distinction, it seems to me
that a deep residue of moralism is apparent whenever listeners are encouraged to
sift out the ―merited‖ from the ―unmerited suffers. 62
One might similarly ask if it is appropriate to demand that a person who is obese have
avoided every dessert, exercised at least three times a week, and tried all possible
solutions for weight loss from diet and exercise to Weight Watchers to pharmacology in
order to gain compassion for her suffering. Furthermore, one might ask if we also need to
inquire whether those who are obese also have sufficiently attempted to overcome other
overlapping marginalizations such as race or gender or genetics which also influence the
development of obesity. Keenan summarizes the consequences of continued failure to
relinquish the concepts of merited and unmerited suffering, stating:
Let us not deny that evidently some suffering is tragically unmerited but I am sure
that in most instances our difficulty is not in acknowledging that, but in our
propensity to judge another‘s suffering as merited. Is not the ultimate purpose of
the distinction to winnow out those people whom we believe are not worthy of
our compassion?...So are we not finally left with the distinction as little more than
a device that allows us to withdraw compassion and confirm our self–serving
righteousness? The distinction allows us, I think, the opportunity to parse out our
sympathy in very condescending and stingy ways. 63
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For those in medicine who retain the distinction that obesity is merited suffering, the
result may be a lack of compassion and a parsing out of which interventions are
appropriate or inappropriate based on the blameworthiness of the individual. This may
serve to prevent the physician from exploring the full scope of efficacious treatments,
including WLS, with the sufferer. Being able to re-conceptualize suffering to reject the
distinction between merited and unmerited suffering would be a strong step forward in
reducing unhelpful attributions of blame found in the treatment of those who are obese.
It may be possible to positively influence efforts to reduce this unhelpful
distinction between merited and unmerited suffering among physicians. In one study,
Roberts et al. paired a small group of third-year medical students with obese patients
undergoing evaluation for bariatric surgery. 64 Students established a longitudinal
relationship with the patient and family members lasting approximately a year, received
faculty mentorship from the physician caring for the patient, and kept a journal in which
they reflected on their various experiences. Students‘ reflections were analyzed for
common themes and changes in perceptions or attitudes. Goals of the study included:
determining whether such extended interactions with obese patients would alter the
perceptions, attitudes, and potentially the future practices of the medical students. Two
specific goals of the study were to determine whether students would develop a better
understanding of the impact of obesity on individuals from a personal, social, medical
and financial perspective and to determine the impact, if any, of this extended
relationship on medical students‘ beliefs about obesity as a disease and those who are
obese.65
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Questionnaires at baseline and at the study‘s conclusion queried student attitudes,
stereotypes, ability to accurately estimate body size and BMI as well as the ability to
ascertain deficits in other physicians‘ knowledge and attitudes about obesity. With regard
to accurately estimating body size and BMI it was hypothesized that if students
underestimated patient weight these inaccurate estimations may serve as a barrier which
would preclude any discussion of weight or weight loss options. Student responses to
knowledge and attitude assessment queries were found to differ from those previously
reported for practicing physicians on many survey statements, including student
participants more strongly agreeing with the relationship between obesity and serious
medical conditions, the need to educate patients about obesity risks, and willingness to
recommend bariatric surgery evaluation. These differences were maintained after clinical
clerkships had been completed. Reflection themes included a growing ability to recognize
obesity stereotypes, improved estimation of body mass index, and an awareness of other
physicians‘ negative attitudes about obesity and those who are obese. 66
The investigators concluded that those students who get to know patients who are
obese, thus relying on personal experience instead of social construction of those who are
obese, may have different, more compassionate, and more accurate attitudes toward
obesity than those reflected in prior data regarding attitudes of physicians in practice.
This development, implementation, and assessment of a novel pilot program to teach
third-year medical students about obesity and bariatric surgery suggests a potential
impact on student attitudes and understanding of obesity and obesity surgery. It is
important to emphasize that the study also concluded that this small group of medical
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students would be more likely to recommend evaluation for bariatric surgery to their
patients in the future.67
Ascriptions of blame and personal moralized responsibility have once again been
shown to be as unhelpful for solving the problem of obesity as they have been for other
medical conditions. In fact, these backward-looking ascriptions of responsibility shift the
focus away from solutions. As has occurred with HIV, alcoholism, and other complex
diseases, it is possible to reduce the ascription of blame for obesity and to erase the
distinction between merited or unmerited suffering. In order to accomplish these goals, a
concerted effort to change the way obesity and suffering are conceptualized, as well as
concrete efforts to alter physician understanding of those who are obese, will be
necessary. The following section discusses the ways in which concern for justice may
help to motivate such efforts. The section opens with an analysis of the unfair treatment
of those who are obese.
B.ii Justice
All conceptions of the demands of justice share the underlying principle of formal
justice: relevantly similar people or situations must be treated similarly. 68 Formal justice
in medicine requires treating patients similarly on the basis of their similar need for care.
This section argues that the withholding of access to WLS constitutes a failure to fulfill
the demands of formal justice and that this failure may be attributed to general social
attitudes and physicians‘ beliefs that obese people fail to merit interventions in the same
way as patients afflicted with other medical conditions. Employing merit as the basis for
access to healthcare interventions has been determined to be ethically unacceptable since
there was social and bioethical rejection of the criteria employed by the Seattle God
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Committee in allocating dialysis. 69 Second, insofar as merit can be meaningfully
considered, obese people merit treatment for their condition as much as people with
hypertension, multiple sclerosis, diabetes, cancer, and alcoholism do. All of these
conditions are complex, multifactorial conditions to which the individual patient's
behavior may contribute to symptom manifestation; however, in no case is it considered
appropriate to say that the person merits her disease and therefore does not merit
treatment.
For many other invasive medical procedures, including high cost and technologyladen transplantation, bioethical analysis appears to have effectively dealt with the issues
of social justice and patient deservingness by employing the principle of respect for
autonomy as well as stringent clinical protocols for medical appropriateness. 70 For
instance, candidates for liver transplantation whose liver disease can be attributed to
alcoholism are subject to appropriate clinical measures to determine their clinical
suitability but are no longer treated as less deserving of transplantation because of the
behavioral components of their disease process. 71 Discussion and exploration of the
option of liver transplantation is not withheld from those suffering with liver disease
because they have in the past been causally responsible for the damage to their liver.
The first step in a developing a more just system for the treatment of obesity is to
ensure that obesity is addressed, and that it is routinely raised with patients as a health
concern and topic appropriate for clinical discussion (not a moral problem). In keeping
with the goals of medicine, the patient should be educated on the risks of excess weight
and potential for life-threatening co-morbidities. Educational dialogue such as this meets
the goal of medicine which encourages ―education and counseling of patients regarding
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their condition and prognosis.‖72 The physician‘s willingness to initiate such discussions
may help to create an environment of appropriate trust and mutual respect. The clinical
encounter should be one that is marked by respect, emotional safety, and a lack of stigma,
embarrassment, blame, and ridicule. 73 As established before, failure to broach this
important health topic constitutes a breach the goals of medicine. What makes this a
matter of justice, is that the entire continuum of individually appropriate treatments
should be presented to obese patients as would be done for patients with cancer, leukemia
or any other disease. As with all medical conditions, all treatment options should be
considered with the patient from least invasive and lowest risk to more invasive, higher
risk interventions; in the case of obesity this continuum would include diet and exercise,
pharmacological interventions and when appropriate, the option of surgical weight loss
should be discussed.
Chronic kidney disease is one condition for which a continuum of care focused on
appropriate clinical indicators and best practices has been instituted. Like obesity, chronic
kidney disease is a progressive and debilitating health problem. It is caused by and
influenced by a myriad of factors including lifestyle choices and genetics. 74 For this
medical condition, steps have been taken to standardize diagnosis, staging, and the
appropriate interventions to be considered at each stage. A consensus statement by the
Kidney Disease Outcomes Quality Initiative outlines a progressive clinical management
system which attempts to standardize clinical understanding of this disease as well as
appropriate clinical interventions across the spectrum and in keeping with best practices
at each stage. While the recommendations are focused on avoiding invasive, expensive
interventions needed at later stages of disease progression, there are specific guidelines
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for initiating both discussion of and the use of renal replacement therapy through various
forms of dialysis. Moreover, consideration of patients for kidney transplantation, an
invasive surgical technology, is also addressed as part of this comprehensive clinical
continuum of care.75 This document institutionalized a continuum of care for those who
are identified as having chronic kidney disease. 76 No such continuum of care has been
adopted for the treatment of those who are obese. 77
The current lack of a continuum of care for obesity is in direct violation of the
formal principle of justice and appropriate standards of medical care. This problem has
deep roots and is systemic.78 John Dixon, Head of Obesity Research at Monash
University in Australia, discusses the disparity between indications for bariatric surgery
and actual referral rates for evaluation for surgical weight loss interventions which he
cites as being ―less than 1 percent of those eligible.‖79 He goes on to say, ―…even
discussion of surgical referral is optional. It is time we articulated and defined a group of
patients where referral for a surgical opinion is no longer merely an option but a
physician‘s responsibility as best care for the patient.‖80
…currently, we have no indications or guidelines that physicians could use for the
obligatory referral for bariatric surgical assessment as a best practice. In turn,
health care providers, insurers and payers can use their discretion in providing
bariatric surgical services.81
Citing the 1991 National Institutes of Health criteria for patient selection for
gastrointestinal surgery for severe obesity he notes these expert recommendations:
1. Patients seeking therapy for severe obesity for the first time should be
considered for treatment in a non-surgical program with integrated components of
dietary regimen, appropriate exercise and behavioral modification and support.
2. Gastric restrictive or bypass procedures could be considered for well-informed
and motivated patients with acceptable operative risks.
3. Patients who are candidates for surgical procedures should be selected carefully
after evaluation by a multi-disciplinary team.
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4. The operation be performed by a surgeon substantially experienced with the
appropriate procedures and working in a clinical setting with adequate support for
all aspects of management and assessment, and
5. Lifelong medical surveillance after surgical therapy is a necessity to monitor
for complications and lifestyle adjustments. 82
In spite of these broad recommendations made over two decades ago, as yet there
remains no standard for physicians to use regarding when, or even whether, to refer or
initiate a discussion of bariatric surgery with patients who meet the BMI criteria.
Physicians are left to rely on their own, socially influenced, potentially biased judgment
and personal experience.
Dixon suggests areas of refinement in the broad recommendations of the NIH. His
refinements would take the broad NIH recommendations to a level which standardizes
and institutionalizes a clinically appropriate continuum of care for patients who are
obese. He outlines two clinical criteria based on BMI and/or co-morbidities, which
include more clearly defined situations under which the physician would either be
―obligated to discuss surgery as an option‖ or ―when surgical referral is appropriate and
indicated as best care for the patient.‖83 His proposed refinement of the NIH
recommendations would serve to align discussion of a continuum of obesity treatment
with the approach employed for other medical conditions. Dixon makes clear the
connection between concern for justice and the development and implementation of
standards of, and guidelines for, obesity care.
If those familiar with the current evidence regarding the net benefits of surgically
induced weight loss cannot define and articulate a specific group of patients that a
caring physician must refer for a surgical opinion, then we allow, by our silence,
the current arbitrary and discretionary approach that is applied by health care
providers, payers, insurers, and referring physicians.
He concludes his recommendations with a call for the advocacy necessary to institute
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such change.
It is time for leaders with a clear understanding of outcomes of bariatric surgery to
stand up and advocate for a standard of best care for those suffering from the
more serious forms of this serious chronic relapsing condition. Guidance and
education will be needed for both patients about their opportunities, and their
primary care physicians about their responsibilities.84
With regard to other conditions, and in medicine generally, it has been recognized that
development of evidence-based clinical practice guidelines can help to ensure the
equitable treatment of patients.85 Therefore, respect for patient autonomy and concern for
patient welfare, along with considerations of justice support ensuring access to a
continuum of obesity treatment.
Individual practitioners should not be enabled to appoint themselves as
gatekeepers, restricting access to important treatment information which should instead
be provided to inform patients and empower them to make truly informed decisions about
treatment. To withhold information or access to treatment alternatives is a violation of
respect for patient autonomy, patient rights, and the requirements of informed consent
doctrine. Further, as this section argued, the present system of obesity treatment is not
just because it fails to treat patients with similar serious chronic conditions similarly.
The final section of this chapter returns to physicians‘ obligations and the goals of
medicine to argue for the non-abandonment of obese patients and then applies a feminist
ethic of care to the treatment of obesity to provide an ethical framework for improving
the medical care of obese patients. In the first subsection, the obligation of nonabandonment and the ethical goals it serves are discussed in relation to the harms obese
patients in particular may experience if physicians refuse to provide them appropriate
care. The second subsection presents an ethic of care and then applies it to the problem of
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address obesity and the health problems of obese patients. It is argued that an ethic of
care provides an ethical frame work for improving the treatment of obese patients and
providing them the continuum of care that characterizes treatment of other lifethreatening chronic and acute conditions.
C. The Physician Obligation of Non-Abandonment, and the Application of an Ethic of
Care to Obesity
The previous section argued that justice demands similar treatment of those
similarly situated and highlighted the ways in which justice is lacking in the clinical
treatment of those who are obese. It was argued that patient welfare can be improved by
adopting an appropriate continuum of care for those who are obese and that justice
requires doing so to the extent that a continuum and guidelines for implementing exist for
other conditions.86 The proposed continuum should not be solely reliant on physician
discretion and lack of bias, but should be institutionalized as a matter of professional
practice guidelines to ensure that all available technologies are explored, including
discussion of surgical weight loss options. This final section of the chapter provides
additional grounds for implementation of a continuum of care and locates these grounds
in the physician‘s obligation of non-abandonment. In the first subsection, the obligation
of non-abandonment and the ethical goals it serves are discussed in relation to the harms
obese patients in particular may experience if physicians refuse to provide them
appropriate care. The second subsection presents an ethic of care and then applies it to the
problem of addressing obesity and the health problems of obese patients. It is argued that
an ethic of care provides an ethical foundation for improving the treatment of obese
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patients and providing them the continuum of care that characterizes treatment of other
life-threatening chronic and acute conditions.
C.i Non-Abandonment
This chapter has addressed several obligations incumbent upon physicians in
exercising their professional duties. These have included the obligation to evidence
respect for persons, to respect autonomy, to be truthful, and to obtain informed consent.
The professional obligation of non-abandonment also strongly supports provision of
information about WLS to obese patients. In writing about the ethical obligations central
to the social role of physicians, physicians Timothy Quill and Christine Cassel assert that
―non-abandonment places the physician‘s open ended, long term caring commitment to
joint problem solving at the core of medical ethics and clinical medicine‖.87 Especially in
the context of chronic conditions like obesity, non-abandonment becomes an important
obligation. While in the past, the acute nature of illness for which there were few curative
interventions often caused quick death, today chronic conditions are an increasing focus
of medical attention. 88 While Quill and Cassel do not specifically address obesity as a
chronic illness it easy to see how obesity and its co-morbidities fit the description of the
types of diseases to which they refer and how issues of abandonment and a call for nonabandonment are warranted here.89 Quill and Cassel discuss the obligation of ―nonabandonment as an obligation to respond to vulnerable persons whom we contact in our
daily work.‖90 According to them, non-abandonment involves advocating for what is in
the best interest of the patient, based on his unique clinical predicament, and in
accordance with the patient‘s goals and own conception of welfare.
Similarly, in an article on patient-centered duties and limitations placed on the
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right to refuse treatment for moral, religious or ethical reasons, Jill Morrison and Mikole
Allekotte, attorneys with the National Women‘s Law Center, outline an argument
regarding physician refusals of reproductive technologies that cites various harms and
other unintended consequences of such refusals for patients.91 Though their argument is
not centered on refusals to treat obesity or those who are obese much of the analysis
applies and will be used here to explicate types of refusals and the potential patient harms
they may cause to those who are obese. They begin by linking non-abandonment, trust,
internal morality, and goals of medicine.
By entering the medical profession, practitioners agree to a set of ethical
principles which ensure that they will put the patient‘s interests before their own.
Medical professionals have superior scientific knowledge and skill to that of the
patient, which puts them in a position of trust and influence. Modern medical
practice continues to move away from a model of paternalistic physician control
over patients towards patient decision-making, which requires the professional to
impart enough medical information for the patient to make an informed
decision.92
Quill and Cassel discuss the interplay of the obligation to non-abandonment with
traditional bioethical principles. With regard to respect for autonomy, they write that
―passively acceding to a patient‘s request that defies the physician‘s recommendations
and clinical judgment without fully informing the patient and actively exploring
alternatives can be a form of abandonment.‖93 In the case of a patient who prefers not to
discuss her weight issues it certainly may be easier for the physician to choose not to
bring up the subject at all since the patient ―doesn‘t want to hear it.‖ However, according
to Quill and Cassel this would be a form of abandonment by failing to empower the
patient to explore her options to seek her health-related welfare in light of her own values
and priorities. Or the physician may fail to provide comprehensive information on weight
loss alternatives because various weight loss technologies are not in keeping with the
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physicians own values which dictate that weight loss should be earned and that surgical
weight loss is too simple. That too would constitute a violation of respect for autonomy
and is also a form of patient abandonment.94
Quill and Cassel align the obligation of non-abandonment with the principle of
beneficence through the benefit afforded by the physician-patient relationship itself:
adherence to the principle of beneficence, they write, ―ensures that a physician‘s actions
benefit the patient…Whether a given act is beneficent may depend on the nature of the
act itself or on its meaning to the participants in the context of their relationship.‖95 For
patients who may have internalized the stigma of their obesity or experience obesityrelated abjection, the persistence of a physician in a relationship may afford special
meaning and thus benefit.
Despite the potential importance for obese patients of non-abandonment, there is
evidence that obese patients are abandoned and refused treatment because of their
condition. The popular media reported, for example, that some physicians refuse to
accept new patients who are obese.96 Specifically, in South Florida a group of
obstetricians-gynecologists (OB-GYNS) have refused to accept obese patients. Some of
these physicians cited that they are concerned with doing more harm than good in treating
such patients, while still others have simply stated that their equipment (such as
examination tables or gowns) are ill-equipped to handle larger patients. Still others are
worried about malpractice suits following difficult births to mothers who are obese. The
implications of such refusals to treat are far reaching.
First, when professionals refuse to treat obese people, there may be nowhere else
in the patient‘s community to obtain similar care, or the cost of seeking treatment
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elsewhere may have impose additional financial burdens on the individual or family. At a
minimum, the obese person may experience a delay in obtaining necessary treatment.
Moreover, a patient turned away by a practice may experience the emotional sequelae of
rejection or abandonment, even if it is easy for him to access care elsewhere. For a
member of a stigmatized or marginalized group, such emotional sequelae may be
particularly damaging and reinforcing of already internalized stigma. When a physician
refuses to treat an obese person for any ailment or condition, then no physician-patient
conversation regarding obesity and treatment options can occur. The physician who has
refused to provide treatment has effectively cut off an avenue to educate and potentially
improve the condition of the patient.
Second, within an existing physician-patient relationship, a physician may refuse
to provide an obese patient information about the full range of treatment options for
obesity, including WLS. The patient may not even be aware that he has been denied
potentially medically desirable treatment options. Failure to discuss options, give
complete information about the likely consequences of obesity, or blatant disregard of the
topic because it is too difficult or too fraught with emotion could equally be considered
varying forms and degrees of patient abandonment.
A third type of refusal of care occurs when physicians fail to make appropriate
referrals for evaluation to bariatric surgery when requested by the patient. The 1991 NIH
recommendations laid out a rudimentary clinical pathway. 97 Physicians who fail to make
appropriate referrals for WLS—either for those patients who request such referral, or for
whom referral is the next appropriate step in providing care—breach of their duty of care.
This either effectively denies patients potentially efficacious treatment, or leaves the
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patient to seek alternatives without support. Because ongoing support is needed
throughout the evaluation process for WLS and for post-surgical follow-up, the
unwillingness of a local, primary care physician may effectively render a patient
ineligible as a WLS candidate.
These three types of treatment refusal constitute different degrees of patient
abandonment. They fail to serve the patient‘s interest and the goals of medicine. Such
partial and total abandonments subject obese patients to serious physical, emotional and
financial consequences.
They diminish the opportunity for the patient to access efficacious treatment
along the continuum of their obesity. For instance, if when a patient is 25 pounds
overweight detailed and ongoing discussions occurred with various physicians the patient
may be able to make significant changes through diet and exercise or pharmacological
interventions, which would ultimately enable him to avoid bariatric surgery. If the patient
were unable to do so, then earlier conversations about all potential options, including
WLS, would facilitate better informed decision making as a process which unfolds over
the course of time. A process of shared decision making about obesity treatment could
unfold over time, and if WLS is eventually deemed appropriate, informed consent for it
would not be a relatively perfunctory event-based act which merely meets the legal
criteria of consent. Instead, evaluation of and consent to WLS could fulfill the spirit of
the doctrine of true informed consent.
Ironically, by refusing to treat obese people or provide them with appropriate and
timely information and referrals, physicians may be contributing to the need for WLS
when in fact their expressed or unrecognized goal was to avoid surgery. 98 Failing to
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provide information about each of the treatment options‘ benefits and burdens may mean
that patients fail to take seriously the nature of obesity and its potential to damage bodily
function and quality of life. If the discussion is not undertaken with the patient, it may not
be possible for the patient to realize its seriousness early enough to avoid permanent
damage. In this case, patients for whom earlier interventions might have been possible
may have advanced beyond that window of opportunity and now have fewer viable
options to save their life and improve their condition. Take for example this personal
story, recounted by a social worker who had worked on a surgical bariatric floor. 99 The
social worker was waiting with a patient who was preparing for WLS later that day. The
patient was tearful, obviously distraught, and very afraid according to the social worker.
The patient shared with the social worker that no one had ever mentioned WLS to her
before the last year, even though she had been overweight for decades and had suffered
from a number of obesity-related diseases. The patient now she felt she had no option but
to go through with WLS because the physicians were telling her now that it was either
WLS or death from her co-morbidities. The patient felt that she really had no choice at
this late stage of disease even though she was told that she may indeed die on the
operating table as at this point she was a marginal surgical candidate. The choice she
faced was risking death due to co-morbidities or death during surgery. The patient
wondered aloud why her doctors had been willing to treat her diabetes, hypertension, and
other diseases but had been unwilling to discuss WLS with her. She wondered if she
could have been better prepared if she had known about WLS sooner when she was
healthier. While the patient did choose the option of surgery, she shared that she did not
feel she had a true choice. She was angry and disillusioned by those who had taken an
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oath to help her through sickness. This patient articulated that she felt as though her right
to make a truly autonomous choice about her care had been denied her because pertinent
information needed to make a fully informed decision had been withheld over a period of
several years.
Refusals of treatment, information, or referral can serve to reduce the
effectiveness of surgical weight loss interventions when they are eventually accessed. If a
patient is refused information or is refused appropriate referral for treatment she may
delay in seeking time sensitive treatment which if obtained earlier may have been more
likely to succeed.100 For instance, research has shown that in the case of effectuating
sustainable remission of type II diabetes, earlier intervention via WLS is superior to
surgical intervention for weight loss once the patient‘s body has sustained greater
damage. 101 In essence there is a point of diminishing returns for ameliorating co-morbid
disease even with the use of the most efficacious treatment currently available.
Treatment refusals can present financial harms to patients and reduce the
efficiency in health care delivery patients.102 Additional costs associated with seeking
another provider who offers more comprehensive care of the obese patient may mean that
low income people are denied access altogether. Moreover, patients may have limitations
placed upon them by their insurance providers that are exacerbated by treatment refusals.
For instance, some insurance limits the number of physician or specialist visits per year
for patients. Any access to healthcare above that limit will need to be paid for by the
patient out of pocket or at a higher rate. In addition to insurance and access issues,
refusals can impose additional costs for treatment.103 If the patient does eventually access
WLS it may be later rather than sooner and therefore additional patient share costs
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incurred due to hospital day stays or co-payments may be present which would not
otherwise have applied. Since the incidence of complications is greater the longer surgery
is delayed and the sicker patients are it seems reasonable to assume that the financial
burden to patients will be greater by delaying efficacious treatment as well.
The obligation of non-abandonment requires that obesity and its treatment
options, including bariatric surgery, be addressed by medical professionals. Nonabandonment is marked by a willingness to engage the patient in ongoing discussions
about what options exist for treatment even when those treatments are not optimal, and
even if professionals believe that personal responsibility is at play in the patient‘s
condition. The obligation of non-abandonment therefore requires medical professionals to
discuss surgical options for weight loss when it might be clinically warranted in the
future and certainly if it is clinically warranted under present circumstances. The
following section discusses incorporating an ethic of care in the treatment of those who
are obese and argues that this relational model which is sensitive to individual nuance and
recognition of patient vulnerabilities, affords an ethical foundation for improving the care
of those with obesity.
C.ii An Ethic of Care
Deontological, consequentialist, or rights-based approaches in ethics share a
commitment to viewing individual moral agents as the fundamentally important unit of
ethical analysis, societies as composed of individuals, and have tended to varying degrees
to view individuals as substantially independent, autonomous, and rational. The emphasis
of these theories is on rules, duties, justice, positive and negative rights, impartiality,
universality, or utility. 104 Care ethics on the other hand, evolved from a different
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conception or construction of the person in society. The understanding of the individual
as conceived by the ethic of care is that of an interdependent, essentially relational
person. The individual is not an island but is instead part of multiple overlapping larger
groups which begin in the family and continue into the larger society. An ethic of care
emphasizes the ethical importance of human relationships and emotion based virtues such
as benevolence, mercy, care, friendship, reconciliation, and sensitivity. 105 According to
philosopher Joan Tronto, an ethic of care is best understood not only as an approach in
moral philosophy, but also as a political theory with relevance for all aspects of
society.106 To be implemented in a just, productive, and non-self-abnegating way, she
argues, an ethic of care requires a political structure that supports care activities.
In the literature of ethics, the word care is frequently defined as a practice, value,
disposition, or a virtue. These descriptors are often explained as overlapping and
interrelated.107 For philosopher Virginia Held care is a form of labor and an ideal that is
intended to guide normative judgment and action. Held explains care as ―clusters‖ of
practices and values.108 Another definition of care, advanced by Tronto and Berenice
Fischer, defines care as ―a species of activity that includes everything we do to maintain,
contain, and repair our ‗world‘ so that we can live in it as well as possible. That world
includes our bodies, ourselves, and our environment.‖109 Care in this regard is a holistic
notion meant to encompass a broad swath of activities and domains including the body.
Care requires morally good persons for fulfillment. ―To be a morally good person
requires, among other things, that a person strives to meet the demands of caring that
present themselves in his or her life‖.110

281

An ethic of care is often explicitly tied to medicine and bioethics. 111 This seems a
somewhat natural pairing since medicine is a profession based on entering into a
relationship the foundation of which is caring for patients. In essence by entering into the
practice of medicine physicians and other healthcare professional have chosen to put
themselves in a position where opportunities for caring present themselves continuously.
In fact, meeting the care demands of people is at the heart of these professions. Treatment
of obesity, as with other medical conditions, occurs in large part due to the efforts of
those in caring professions such as physicians and nurses. Physicians enter the field of
medicine for many reasons. Presumably one primary motivator to enter into the field of
medicine is because of a desire to care for people in various states of health or illness. 112
Hence there is an expectation that taking up the demands of care will be present among
those who enter become physicians and will manifest in particular ways.
The work of Tronto on both the practice of an ethic of care and its elements will
be the starting point for this analysis. This framework will then be applied to the clinical
care and treatment of those who are obese. Comparisons between the current and
proposed systems will highlight the superiority of an approach grounded in an ethic of
care for clinical engagement with obesity and its treatments.
In discussing an ethic of care Tronto points out that ―an ethic of care … requires
some specific moral qualities.‖ 113 These include: attentiveness, responsibility,
competence, and responsiveness. 114 Attentiveness refers to recognizing that areas of need
exist in the first place. Tronto states that this is the starting point of an ethic of care
because without well-honed skills at noticing an opportunity for care there can be no
subsequent action of providing care or meeting the need. 115 Following that logic,
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inattentiveness or blatantly ignoring areas or situations in need of care is considered a
violation of this standard and a form of failure to provide care. Lack of attentiveness
would then seem even more of a moral failing within a profession whose purpose it is to
recognize the needs of caring for a person. Tronto goes on to say that ―one needs, in a
sense, to suspend one‘s own goals ambitions, plans for life, and concerns in order to
recognize and be attentive to others.‖116 While this may be idealistic, traditional medical
ethics requires physicians to suspend their own interests to act for the sake of their
patients‘ interests. It would also seem appropriate to require suspension of physicians‘
socially constructed bias regarding obesity; even temporary suspension may be required
in order to be attentive to the needs of the obese patient. The second quality required of
an ethic of care is responsibility. Recognizing the potential for confusion between the
concepts of responsibility and obligation (such as those found in the Hippocratic Oath)
Tronto distinguishes between the two by positing that responsibility deals with cultural
practices which support care rather than a set of formal rules or duties which arise from
caring obligations.117 Thus responsibility of caring might entail how a parent is to
respond to the needs of his children. On the other hand, an obligation would be manifest
in the duty of informed consent by a physician. For physicians it would seem that there is
both a responsibility and subsequent obligations which arise from this professional caring
role. As discussed in chapter three, responsibility involves taking care of the problem that
attentiveness identifies.
The third quality required for care is competence. Tronto explains the importance
of this element when she says, ―Intending to provide care, even accepting responsibility
for it, but then failing to provide good care, means that in the end the need for care is not
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met.‖118 Failure to act competently fails at caring. Physicians who fail to recognize the
relative merits of different weight loss interventions, for example, may be said to fail at
caring for want to competence, not for lack of good intentions. In fact, some physicians
who withhold information about WLS or refuse to refer patients for evaluation may be
acting with paternalistic intentions, but fail to be truly caring because they lack particular
competencies—namely, understanding their patients‘ particular needs and the potential
benefits of WLS, overestimating the risks of surgery, or misunderstanding the etiology of
obesity so they think surgery cannot truly benefit their patients. The final quality which
Tronto discusses as being necessary to an ethic of care is that of responsiveness.
Responsiveness is understood by Tronto as the care receiver‘s reaction to or acceptance
of various elements found in the ethic of care. Responsiveness and vulnerability are
closely linked according to Tronto.119 It is in the care receivers‘ recognition of
vulnerability (need) that independence is challenged and interdependence acknowledged
so that the moral actors can move forward together. The integrity of care is the
culmination of each element described above which ―must fit into a whole.‖ 120
Tronto acknowledges the complexity of care as a practice stating that:
… it involves more than simply good intentions. It requires a deep and thoughtful
knowledge of the situation, and of all of the actors‘ situations, needs and
competencies. To use the ethic of care requires knowledge of the context of the
care process.121
At present the treatment of obese people by medicine seems to be lacking elements
expected to be found in an ethic of care.
An ethic of care, if properly applied, is of value in understanding the needs of
those who are obese and the requirements of improving their treatment. Moreover, an
ethic of care as applied here stands to ―allow us to move to a more just and caring
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humane society.‖122 for those who are obese and suffer from its disabling co-morbidity.
This is true for several reasons. First, an ethic of care stresses the importance of attending
to particularity or to the specific circumstances surrounding an issue. 123 Thus an ethic of
care reinforces the individual-level attention demanded by all clinical medical
encounters, including those where obesity or its co-morbidities is the health concern.
Second, an ethic of care focuses on intervening with an understanding that individuals are
in relationship (both with others and within systems such as the medical system). 124
Finally an ethic of care understands care to refer to some sort of active engagement which
requires both an outward reach (on the part of the physician and the patient) as well as the
implicit action towards resolution of the problem. 125 It seeks a forward-looking goal, not
the backward-looking assignment of causal or moral responsibility.
Multiple factors of an ethic of care make it a productive normative framework for
medical care in general and for obesity specifically. An ethic of care urges that
engagement with the patient that begins at the level of the individual and her particular
circumstances, not at the level of a condition considered generally. In other words, the
person is the focus and not the obesity. An ethic of care provides for a vigorous
engagement of potential solutions based upon needs of the individual while
simultaneously focusing on the broader social and moral context of the care of all people
with obesity within the medical system. Thus, an ethic of care allows for greater
contextualization of the individual‘s problem of obesity, which simultaneously
diminishes blame attributions while bolstering the focus on solution. 126
It is necessary to analyze why this distinction between person-first versus
condition-first is important and how it will serve to positively alter the experience of the
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patient. In starting with the person there is acknowledgment of obesity as a multi-factorial
and highly contextualized problem, one requiring examination of the factors associated
with this particular person‘s obesity and not obesity in general. So while it may be true
that the patient does not get enough exercise and eats out too often, attending to obesity
as multi-factorial and highly contextualized problem would lead the caring physician to
examine in greater detail the contributors to lack of exercise and eating out frequently. If
the inquiry is taken a few steps further by the caring physician then it may be revealed
that patient is now caring for a disabled sibling which severely limits the time available
for exercise and food preparation. Or it may be revealed that the patient has been verbally
abused by his parents and now by his spouse and that he manages his emotions by
covering them with food. Having done so for years in an effort to protect himself from
one type of harm other types of harm have occurred. His body has borne substantial
damage from this protective mechanism. Each of these highly contextual factors may be
vital in determining the most appropriate course of clinical action and developing an
individualized care plan with the goals of the patient and the patient‘s best interest at the
forefront of the encounter.
Contrast this approach with a more typical encounter which places the obesity at
the center and the individual who is obese on the periphery. In this model, not based on
the patient as individual but on the patient as a manifestation of the obesity, the process,
the outcome, and the level of care experienced by the patient is likely to be vastly
different. In more traditional models of patient interaction the physician observing that
the patient is obese based upon BMI may counsel her on the importance of weight
reduction and may even go so far as to discuss likely potential outcomes of failing to do
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so. However, this more traditional model is likely to be lacking in an exploration of the
multi-factorial etiology of the disease for this particular individual. As the patient is obese
he or she obviously does not exercise and obviously eats more on a regular basis than is
necessary. What is missing here is the exhaustive exploration of particularity which is
found in a model which more closely attends to caring. The outcome of such an
interaction may well be a superficial analysis of the problem leading to a faulty
application of what is intended to be helpful professional advice. The patient is left
feeling misunderstood and dissatisfied with perhaps no greater insight into the problem or
its solutions while the physician is left feeling that discussing weight or weight loss
options is futile. These feelings have now been reinforced for both parties.
An ethic of care with its focus on attentiveness, responsibility, competence, and
responsiveness concentrates on the various aspects needed to for healthcare to provide a
more compassionate and active response to the medical condition of obesity. An ethic of
care motivates and justifies forward-looking responsibility-taking in order to achieve a
positive outcome, and will frequently eschew ascription of blame or backward-looking
moral responsibility. An ethic of care seeks to understand a web of causes of a problem
that needs to be taken care of; it therefore is not particularly concerned with looking
backward to identify the cause of the problem. It instead views the multiple causes of a
problem as multiple potential points of intervention or multiple resources for redress. The
incorporation of the unique particularity of each person, upon which an ethic of care is
based permits a system which is first concerned with the sufferer and second concerned
with the obesity. It acknowledges the intersection of marginalizations and offers more
compassionate understanding of the struggles associated with an individual‘s obesity. As
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was shown in the research conducted with medical residents, perhaps both the patient and
the practitioner can benefit from interventions that encourage active engagement of
practitioners with patients as individuals. Such engagement increases understanding,
builds mutual trust and respect, and facilitates finding potential resources to help address
patients‘ needs. Such engagement and more nuanced understanding of the patients‘ needs
promotes identification of solutions which are in keeping with the patient‘s conception of
well-being and in alignment with accepted clinical standards for treatment. An ethic of
care provides the ethical foundation that justifies and informs such a project of
engagement.
D. Conclusion
This chapter argued that the present system for the treatment of obesity fails to
meet the goals of medicine, violates commonly accepted ethical principles and
obligations, and is unjust. The current unjust approach to treating obesity was shown to
have serious material implications for the welfare of those who are obese including
delayed access to WLS or the withholding of WLS as a viable option. The current
approach was revealed as violating the principle of formal justice by failing to afford
patients with obesity the same care and access to efficacious treatment that is routinely
provided to similarly situated patients with chronic, complex, debilitating, and lifethreatening conditions. This disparate treatment was attributed, in part, to unhelpful
ascriptions of culpability for the condition. It was posited that such ascriptions may also
lead physicians, imbued with the dominant social construction of obesity, to act in ways
that are not truly in their patients‘ interests even as they misguidedly believe that they are
acting paternalistically.
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The chapter further argued that physicians‘ failure to address patient obesity is a
form of abandonment, and moreover that the healthcare system abandons obese patients.
Physician failure to address patient obesity, and to do so with respect and compassion,
was shown to effectively re-victimize obese patients and cause them additional harms.
This was shown to be particularly ethically problematic because the healthcare system
should protect and promote the welfare of the vulnerable, not participate in their
victimization.
Such attitudes and failures were shown to reduce the opportunity for patient selfdetermination and access to effective treatment. In examining the ways in which the
current system curtails or violates respect for autonomy and patient welfare while
perpetuating injustice, a picture of how the current system should be amended was
introduced and grounded in an ethic of care. The new system requires abandoning the
concepts of merited and unmerited suffering, facilitating a more comprehensive system
based on an ethic of care, and finally adopting the proposed continuum of treatment for
those who are obese. These changes will improve upon an unjust system thus providing
one which is more caring, responsive, and ethically sound.
The final chapter of this dissertation reviews the argument of this dissertation and
provides a synopsis of individual chapter topics.
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Chapter Six: Dissertation Conclusion
The final chapter reviews the overall argument of this dissertation and provides a
synopsis of each of the chapters. The dissertation conclusion is provided in two sections.
Section A summarizes the main points of the dissertation‘s argument while section B
provides a brief review of material contained in each of this dissertation‘s chapters. The
following section begins with a review of the arguments.
A. Dissertation Argument Reviewed
This dissertation provided an ethical justification of surgical weight loss
interventions in the treatment of obesity. Situating obesity as not only as a public health
concern but also fundamentally a clinical medicine problem confronting individual
patients and physicians, the dissertation argued that the time frame of public health
interventions is too long for individuals presently facing obesity and its deleterious
physical and social co-morbidities. It reviewed the risks of morbidity and mortality
associated with obesity and the rates of success in reducing these risks associated with
various interventions. It further argued that it is inappropriate to hold WLS to the goals of
public health. This dissertation argued that failure to address weight loss on an individual
level, and specifically to consider the clinical appropriateness of weight loss surgery
(WLS) along a clinical continuum, raises serious questions about patient abandonment,
failure to respect autonomy, and failure promote patient welfare. Moreover, social
skepticism or rejection of WLS as a treatment option was revealed to raise concerns
about fairness as these failures indicate that obesity is not regarded in relevantly similar
ways to other life-threatening and health-impairing conditions.
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To ground this argument, the dissertation examined various reasons that obesity
and its myriad interventions, including WLS, are inadequately addressed in the clinical
setting. It argued that considerations with cultural and ethical valence play a critical role
in obesity‘s different and unfair treatment within clinical medicine. Gendered and
theologically informed attributions of blame, shame, and self-stigma were shown to
influence the attitudes and actions of both patients and clinicians with regard to
addressing obesity. Inappropriate and conceptually confused ascriptions of responsibility
were shown to impede social acceptance of, and access to, WLS. The dissertation
criticized and subsequently reconceptualized these ascriptions of responsibility from a
perspective informed by feminist epistemology and ethics in order to provide a more
humane and nuanced foundation upon which reform of current clinical practices
surrounding treatment of obesity can be built. These reforms included improvements in
doctor-patient discussions of obesity and the adoption of clinical practice guidelines
providing for a continuum of care. Informed by these feminist insights and a systems
theory approach drawn from social work, the dissertation suggested specific revisions of
the customary candidate selection process for those seeking WLS. Finally, this
dissertation concluded that WLS is a valid option for those seeking resolution to lifethreatening co-morbid obesity related disease and that barriers to its access should be
removed in healthcare. In support of the overall argument of this work, individual
chapters provided areas of support which are briefly reviewed below.
B. Chapter Synopses
Chapter one provided relevant background information on the problem of obesity.
The chapter examined controversies surrounding the most widely used tool for the
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diagnosis of obesity, the measurement of BMI, along with reviewing several proposed
alternatives which might provide a more accurate clinical data. Obesity trends as seen
throughout the past fifty years of government data collection were reviewed. These
surveys showed that obesity has become both more prevalent and more serious in the
United States. Other international indicators revealed that obesity is a global problem.
Increased obesity has subsequently led to increased physical and social co-morbidities
such as diabetes, hypertension, reduced longevity, increased mortality, and in general
diminished quality of life. Contested theories on the etiology of obesity and thus various
ascriptions of blame were discussed. This chapter introduced the notion that various
conceptualizations of obesity, including the appropriateness of its diagnostic tool, the
acceptance of obesity as a disease, the understanding of obesity as a modern-day
epidemic, and the subsequent approval or rejection of various interventions as applied to
this problem, may serve to violate commonly accepted ethical frameworks such as those
found in medical decision making, considerations of justice, and patient welfare.
Chapter two explored the numerous technologies from self-help initiatives to
surgical interventions and their associated normative frameworks which have been
employed to treat obesity. Each of these technologies was shown to have met with
varying degrees of success. Among organized self-help initiatives and commercial
programs, it was shown that Weight Watchers, Inc. provided participants with superior
weight loss results which may assist in diminishing co-morbidities associated with excess
weight. Overall, self-help initiatives and commercial weight loss companies were shown
to have a normative framework of self-reliance with some additional guidance offered to
assist in overcoming a problem with myriad contributory factors. These programs were
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shown to diminish one or several of the identified factors which are beyond an
individual‘s direct control but which have been associated with the development or
maintenance of obesity. Largely disappointing or failed efforts at pharmacological
interventions were reviewed. Pharmacological interventions for obesity were shown to
have traditionally suffered from either poor overall results or from an imbalanced riskbenefit ratio for patients prescribed these medications. The result of this imbalanced
equation has been serious and irreversible patient outcomes which necessitated the
removal of some weight loss drugs from the market. The use and development of
pharmacological treatments were shown to have advanced the normative framework to
include an understanding that obesity may require more robust interventions than diet and
exercise alone can produce. In fact pharmacological treatments revealed that obesity may
be amenable to medical technologies. Finally, chapter two reviewed the development of
various surgical interventions for weight loss which have developed over the course of
the past half-century. Data were provided from various research studies indicating that
surgery for weight loss thus far provides the best long-term outcomes when combined
with subsequent lifestyle changes, and that the risks of surgery have been greatly
diminished to the point of being considered manageable and similar to those experienced
by patients when the gallbladder is removed. In spite of the efficacy of WLS and its
manageable risks, this chapter revealed that exceptionalism has been and continues to be
erroneously applied to this intervention. It was posited that continued exceptionalism
applied to WLS likely has the effect of the intervention being viewed as too radical and
hence real discussion of this intervention at a clinical level between patients and
physicians may be thwarted.
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The third chapter of this dissertation revealed several prominent ways in which
obesity is a socially constructed phenomenon which relies on a faulty and fundamentally
inadequate epistemology to frame the problem, an understanding of who are obese, and
the appropriateness of various solutions to ameliorate the problem for the individual who
is burdened, either physically, socially or both by their obesity. This chapter argued, that
the dominant understandings of obesity neglect or discount important perspectives which
must be considered in order to provide a more complete view both of the problem and the
solutions. This chapter shed light on several social norms which inhibit the evolution of a
more nuanced and enlightened understanding of obesity, as well as a wider acceptance
and promotion of WLS. By utilizing feminist epistemological frameworks, current flaws
in the construction of the obese identity, injustices present in the treatment of obese
people, and the impediments to a wider acceptance and promotion of WLS were
identified.
Chapter four argued that it is inappropriate to dismiss WLS as a valid individuallevel clinical technology based on the erroneous application of public health goals to
what is, fundamentally, also an issue of clinical medicine. To conflate the goals of public
health initiatives with the goals of clinical medicine was shown to be unacceptable in
light of the availability of WLS which carries with it both acceptable levels of known
risk, and an empirically substantiated ability to meet several of the goals of medicine and
reduce co-morbid disease. This conflation was shown to further diminish the relevance of
a trusting and caring physician patient relationship in addressing obesity. In light of a
clearer understanding of the standards by which WLS should be evaluated, along with
substantial empirical evidence of the clinical usefulness of this intervention further
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supported by patient narratives which expounded on the personal utility of this
individual-level intervention, it was argued that more should be done to assist clinicians
and patients in understanding surgical weight loss technologies as a valid choice along a
continuum of care. This chapter argued in support of adopting a proposed continuum of
care which includes consideration of surgical interventions in response to appropriate
clinical indicators which do not rely solely on physician discretion.
This dissertation‘s chapter five argued that the present system for the treatment of
obesity fails to meet the goals of medicine, violates commonly accepted ethical principles
and obligations, and is unjust. The current approach to treating obesity was shown to
have serious material implications for the welfare of those who are obese including
delayed access to WLS or the withholding of WLS as a viable option. The current
approach was revealed to violate the principle of formal justice by failing to afford
patients with obesity the same care and access to efficacious treatment that is routinely
provided to similarly situated patients with other chronic, complex, debilitating, and lifethreatening conditions. This disparate treatment was revealed to be attributed, in part, to
unhelpful ascriptions of blame. It was posited that these ascriptions may also lead
physicians, imbued with the dominant social construction of obesity, to act in ways that
are not truly in their patients‘ interests though they misguidedly believe that they are
acting paternalistically in doing so. The chapter further argued that physicians‘ failure to
address patient obesity is a form of abandonment, and moreover that the healthcare
system abandons obese patients. Physician failure to address patient obesity, and to do so
with respect and compassion, was shown to effectively re-victimize obese patients and
cause them additional harms. This was shown to be particularly ethically problematic
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because the healthcare system is obligated to protect and promote the welfare of the
vulnerable, not participate or perpetuate patient victimization. These attitudes and failures
were shown to reduce the opportunity for patient self-determination and access to
effective treatment. This chapter revealed how the current system should be amended by
establishing a foundation in an ethic of care. The proposed system was shown to require
abandoning the concepts of merited and unmerited suffering, facilitating a more
comprehensive system based in an ethic of care, and adopting the proposed continuum of
treatment for those who are obese. It was argued that these changes would improve upon
an unjust system by providing one which is more caring, responsive, and ethically sound.
This dissertation has provided a heretofore absent ethical analysis of obesity, the
obese identity, and various technologies for its treatment. This dissertation has concluded
that the use of WLS in the treatment of an individual‘s obesity is not only clinically
appropriate but should be more fully supported in healthcare by reducing bias and
employing just practices in keeping with accepted ethical standards for other multifactorial conditions. Moreover, this dissertation has sought to provide a voice for those
marginalized by the erroneous and partial construction of the obese identity which has
until now served to silence those who are so afflicted and impede access to efficacious
WLS. Ultimately, this dissertation has argued for the ethical and compassionate care and
treatment of those who are obese.
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